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Summary 
Cervical cancer is the 12th most common cancer affecting Australian women. In 2010, 818 
women were diagnosed with cervical cancer, and in 2011 there were 229 deaths from this 
disease. A screening program introduced in Australia in 1991—the National Cervical 
Screening Program (NCSP)—has been effective at reducing cases of cervical cancer to these 
current levels, in line with its aim to reduce incidence, morbidity and mortality from cervical 
cancer. 
Reporting statistics about the NCSP in a standardised way is vital to ensure that 
governments, researchers and health workers have access to relevant and reliable statistics 
about the performance of the program over time, and how changes to the cervical screening 
environment—such as the introduction of the National HPV Vaccination Program in 2007—
may affect it.  
The National cervical cancer prevention data dictionary version 1 is an assemblage of data 
elements developed by the Australian Institute of Health and Welfare (AIHW) to support the 
program’s aim of achieving national consistency in data reporting through promoting 
standardisation and comparability of data across state and territory jurisdictions.  
The objectives of the National cervical cancer prevention data dictionary version 1 are to: 
• support operation and monitoring of the National Cervical Screening Program 
• establish uniform definitions for the National Cervical Screening Program 
• facilitate consistency across jurisdictions in national reporting, including the national 
reporting of performance indicators for the publication Cervical Screening in Australia 
• promote uniformity, reliability, validity, consistency and completeness in the data 
• support future linkages between the state and territory cervical screening registers and 
the National HPV Vaccination Program Register 
• support potential future directions of the National Cervical Screening Program. 
The National cervical cancer prevention data dictionary version 1 was developed in partnership 
with state and territory and Commonwealth components of the NCSP, and was endorsed by 
the Standing Committee on Screening for the Community Care and Population Health 
Principal Committee on 27 March 2014.  
It comprises a comprehensive set of data elements covering the woman, HPV vaccination, 
provider and cervical tests (cytology, histology and HPV DNA), as well as detailed data 
specifications for the performance indicators of the NCSP.
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1 What is the National cervical cancer 
prevention data dictionary version 1? 
1.1 Development and objectives 
The National cervical cancer prevention data dictionary version 1 is an assemblage of data 
elements used by the National Cervical Screening Program (NCSP). This data dictionary was 
developed by the Australian Institute of Health and Welfare (AIHW) to support the 
program’s aim of achieving national consistency in data reporting through promoting 
standardisation and comparability of data across the jurisdictions. 
The development process started when NCSP program managers and data managers saw 
the implementation of Screening to prevent cervical cancer: guidelines for the management of 
asymptomatic women with screen-detected abnormalities as an opportunity to standardise data 
collections across jurisdictions through the development of a national cervical screening data 
dictionary.  
The then-called Standardised cervical screening data dictionary was originally developed as  
3 subsets: the first subset comprised data items related to demographic information for 
program participants, practitioners and laboratories, as well as cytology and human 
papillomavirus (HPV) testing results, and was published on the Department of Health 
(Health) website in April 2007. The second subset comprised data items for procedures for 
obtaining histology specimens and reporting of histology codes. The third subset was 
developed concurrently with the incorporation of the 3 subsets into a single document, and 
comprised definitions and algorithms for the performance indicators reported nationally in 
the annual publication Cervical screening in Australia. 
At an NCSP program managers meeting held in June 2008, it was decided that the dictionary 
should be further developed into a comprehensive document, comprising Essential, Desirable 
and Aspirational data elements to support the NCSP as a whole. The original dictionary was 
expanded into the National cervical cancer prevention data dictionary version 1 in July 2008, and 
continues to be developed to accommodate changes that impact on the NCSP. 
The objectives of the National cervical cancer prevention data dictionary version 1 are to: 
• support operation and monitoring of the National Cervical Screening Program 
• establish uniform definitions for the National Cervical Screening Program 
• facilitate consistency across jurisdictions in national reporting, including the national 
reporting of performance indicators for the publication Cervical Screening in Australia 
• promote uniformity, reliability, validity, consistency and completeness of data 
• support future linkages between the state and territory cervical screening registers and 
the National HPV Vaccination Program Register. 
• support potential future directions of the National Cervical Screening Program. 
The development of the National cervical cancer prevention data dictionary version 1 is an 
ongoing process, reliant on the support and professional input of the state and territory 
cervical screening programs. 
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1.2 Endorsement 
The National cervical cancer prevention data dictionary version 1 was endorsed by the NCSP 
(through state and territory program managers and the Screening Section (Population Health 
Division) of Health), and was subsequently endorsed by the Standing Committee on 
Screening for the Community Care and Population Health Principal Committee on  
27 March 2014. 
The roles of the National cervical cancer prevention data dictionary version 1 dictated the 
endorsement protocol adopted for this document. In order for the National cervical cancer 
prevention data dictionary version 1 to support the uniform collection of data, the document 
and the data elements within need to remain static; however, to support potential future 
directions of the NCSP, this document needs to be able to change and grow along with new 
developments and requirements. 
Thus, although the National cervical cancer prevention data dictionary version 1 was officially 
endorsed as described above, there is a change management protocol to allow individual 
data elements to be introduced or changed on an ad hoc basis, without the requirement for 
all data elements to be subsequently reviewed or endorsed. 
1.3 Change management protocol 
A change to the National cervical cancer prevention data dictionary version 1 may be initiated by 
a state or territory cervical screening program (this should occur through the program 
manager, but may also occur through a data manager or another staff member associated 
with the program such as a medical advisor or laboratory liaison), the Screening Section of 
Health, or by the Cancer and Screening Unit of the AIHW itself (the AIHW may also initiate 
a change on behalf of a third party if required). 
A change may be initiated for a variety of reasons, such as to meet updated definitions,  
e-health requirements, or to provide data elements and definitions to support an initiative of 
the program at the national level. 
Initiation of a change should use the table provided in Appendix E in the first instance, with 
this forwarded to the Cancer and Screening Unit of the AIHW on completion. This will then 
be considered through the change management protocol. 
Note that any change to the National cervical cancer prevention data dictionary version 1 that 
results from this process requires official endorsement through the NCSP and the Standing 
Committee on Screening for the Community Care and Population Health Principal 
Committee, and the assignment of a revised official endorsement date for the altered data 
dictionary. 
1.4 Structure and scope 
The National cervical cancer prevention data dictionary version 1 is comprised of 4 chapters and 
Appendices. Chapters 1 and 2 are introductory and provide general information about the 
data dictionary, its structure, and its use. Chapter 3 contains data elements used by the 
National Cervical Screening Program, arranged in sections that reflect the way that these 
data elements are used. Chapter 4 defines the Performance Indicators used for national 
monitoring of the program in the annual Cervical screening in Australia report. Appendices 
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include histology codes for each jurisdiction mapped to the higher level histology codes used 
in the National cervical cancer prevention data dictionary version 1. 
It should be noted that the contents of this data dictionary have not been assessed for 
inclusion in the National Health Data Dictionary and may not be comparable with existing 
national standards. 
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2 Technical aspects of the National 
cervical cancer prevention data 
dictionary version 1 
2.1 Data elements 
The data elements in the National cervical cancer prevention data dictionary version 1 are 
described and defined using a standard format endorsed by the National Health Data 
Committee. This standard format is based on the first edition of the ISO/IEC 11179–2:2000 
Specification and Standardization of Data Elements—the International Standard for defining 
data elements issued by the International Organization for Standardization and the 
International Electrotechnical Commission. The current standard used by the AIHW’s 
metadata registry (METeOR) is ISO/IEC 11179-2003 second edition. 
The standard rules applied to each data element definition are designed to ensure that each 
is clear, concise, unambiguous, comprehensive and provide sufficient information to ensure 
all those who collect, provide, analyse and use the data clearly understand its meaning. 
These rules describe the data. In technical terms, these rules are called metadata, or data 
about data. 
It should be noted that the fields that describe the representational form of the data element 
are not meant to prescribe how the state and territory database systems should store the 
information. The layout in the dictionary describes how the data element should be 
represented for national reporting purposes. The information may be stored differently in 
each state and territory’s computer system as long as the information required can be 
extracted and mapped to the format required. 
2.2 How to use the information on data elements 
Identifying and definitional attributes 
The name of the data element is a multi-word designation assigned to a data element. This 
appears in the heading for each unique data definition in the dictionary. The technical name 
of the data element is made up of an object class, a property and a value domain, and 
describes how the value for that data element should appear; for example, A4 Woman—
family name, text X[X(39)]. Identifying and definitional attributes include the common name 
and sometimes a synonymous name or context for the data element, a definition, and 
collection status within the Program. 
Value domain representational attributes 
Representation class refers to the form of the data element, such as identifier, text, date or 
code. The data type refers to the type of symbol, character or other designation used to 
represent the data element (e.g. string, date/time, number, text), and the format and 
character length describe how the value should appear for that data element. 
Formats can be alphabetic character (denoted by the letter A), numeric (denoted by the letter 
N) alphanumeric (denoted by the letter X), or specific to dates (D for day, M for month, Y for 
year). Characters that are not in brackets denote a value that must be represented. Round 
brackets are used to indicate the number of repeats if a character is repeated more than 6 
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times in succession (X(9) indicates 9 alphanumeric characters). Square brackets are used to 
indicate that characters are optional in any ordered combination ([XXX] indicates 0, 1, 2 or 3 
alphanumeric characters). Curly brackets are used to indicate that characters are entirely 
optional (X{XX} indicates 1 or 3 alphanumeric characters) (see Tables 2.1 and 2.2 for 
examples).  
Table 2.1: Data element format—codes 
Code Definition Description Example 
A Alphabetic Supports letter characters (including 
punctuation) only (i.e. no numbers) 
AAA = ABC not A1C 
N Numeric Supports numeric digits only (i.e. no alphabetic 
characters) 
NNN = 123 not 1B3 
X Alphanumeric Supports both alphabetic characters (including 
punctuation) and numeric digits 
XXX = ABC or 123 or A1C 
or 1B3 
D Day Date specific: day number within a month. 
Represented as DD in DDMMYYYY date format 
23rd day of August 2013 
23082013 
M Month Date specific: month number within a year. 
Represented as MM in DDMMYYYY date format 
8th month of 2013 
23082013 
Y Year Date specific: year number. Represented as YYYY 
in DDMMYYYY date format. 
2013th year 
23082013 
Table 2.2: Data element format—use of brackets 
Bracket type Description Example Notes 
No square or curly 
brackets 
Characters must be entered in the format 
presented. Note: number in round brackets 
( ) represents characters repeated 7 or 
more times in succession. 
AAA 
NN 
X(8) 
 
Exactly 3 alphabetic 
characters 
Exactly 2 numeric 
characters 
Exactly 8 alphanumeric 
characters 
 
Curly brackets  
/braces 
{ } 
Characters are optional, but if entered, 
they are fixed in length and must match 
exactly the format presented. 
{AAA} 
{NN} 
{X(8)} 
 
0 or exactly 3 alphabetic 
characters 
0 or exactly 2 numeric 
characters 
0 or exactly 8 
alphanumeric characters 
 
Square brackets 
[ ] 
Characters are optional, but if entered are 
variable in length up to the maximum 
length designated 
[AAA] 
[NN] 
[N(8)] 
Either 0, 1, 2 or 3 
alphabetic characters 
Either 0, 1 or 2 numeric 
characters 
Either 0, 1, 2, 3, 4, 5, 6, 7 or 
8 numeric characters 
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Value domain format examples 
• X(10)—No square/curly brackets, therefore exactly 10 alphanumeric characters must be 
entered. 
• {X(10)}—Curly brackets, therefore optional with fixed length. Either 0 or exactly 10 
alphanumeric characters must be entered. 
• [X(10)]—Square brackets, therefore optional with variable length—either 0 or between 1 
to 10 alphanumeric characters entered. 
• X[X(39)]—At least 1 alphanumeric character is required (an X is outside any 
square/curly brackets) and optionally supports an additional 0 to 39 alphanumeric 
characters, which means the maximum total length is 40 alphanumeric characters. 
• {N(10)[N]}—Curly brackets, therefore optional with fixed length. Either 0 or 10 numeric 
characters with a further optional single numeric character entered. This allows for 0, 10 
or a maximum of 11 numeric characters. 
• {AAX[XXX]}—Curly brackets, therefore optional with fixed length. Either 0 or 2 
alphabetic characters followed by a single alphanumeric character with a further 
optional 0 to 3 alphanumeric characters allowed. This allows for 0, 3, 4, 5 or a maximum 
of 6 characters (2 alphabetic, and 4 alphanumeric). If only 3 characters are entered, then 
they must be 2 alphabetic followed by 1 alphanumeric. 
Collection and usage attributes may be included to ensure that data are captured correctly 
and to aid in the correct interpretation of permissible values. 
Data element attributes 
This section of the data element may also include: 
• a guide for use, which takes the form of additional comments or advice on interpretation 
or application  
• collection methods, which are comments and advice concerning the capture of data for a 
particular data element, including guidelines on the design of questions for use in 
collecting information, and treatment of ‘not stated’ or non-response. 
Additional information relates to source, and related metadata, and reference documents. 
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3 Data elements of the National cervical 
cancer prevention data dictionary 
version 1 
3.1 Source of cervical screening data elements 
The cervical screening register in each of the 8 states and territories of Australia are the 
repositories of cervical screening data for the NCSP. Pathology laboratories are the primary 
source of data for cervical screening registers, which are in turn the primary source of 
cervical screening data—a relationship that is illustrated in Appendix A. 
Laboratories reporting cervical cytology in Australia are required to send information to the 
cervical cytology registries in each state and territory on a regular and timely basis, 
depending on each jurisdiction’s legislative requirements.  
The registries operate on an opt-off basis and are required to send reminder letters to women 
overdue for a Pap test, follow up cervical abnormalities, send screening histories to 
laboratories for reporting of cervical cytology, and also provide data for the purposes of 
monitoring and evaluating the National Cervical Screening program. These functions are 
critically dependent on timely data provided from the laboratories.  
Laboratories are required to send the following information to the cervical screening register 
in the woman’s jurisdiction of residence: 
• demographic information, including name, address, Aboriginal and Torres Strait 
Islander status (when the clinician has provided this information and the register is 
capable of receiving it), date of birth, Medicare number 
• Pap test provider demographics, including name, address, provider number 
• cervical cytology result and recommendation, coded according to the 2006 Cytology 
Coding Schedule 
• histology results relevant to the cervix 
• HPV test results. 
The data should ideally be sent electronically from the laboratory to the register on a regular 
basis (this would usually be daily or weekly depending on the volume of tests), but other 
arrangements may be in place. 
Box 3.1 
Data elements have been arranged to reflect an entire record that may be sent from a 
pathology laboratory to the cervical screening register, since a woman’s record on the 
cervical screening register is updated on a test by test basis. 
In this context, it is useful to consider data elements at the time of test’. 
This means that if a woman has a cervical cytology test, histology test or HPV DNA test, all 
other data elements relate to that test through the date of that test, since this is the date at 
which other data elements will also be collected and sent through from the pathology 
laboratory. 
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3.2 Organisation of data elements 
Data elements have been organised into the following sections:  
A Woman data elements—these are the details for each woman on the cervical screening 
register 
V HPV vaccination data elements—these are details of HPV vaccinations from the National 
HPV Vaccination Program Register 
B Provider data elements—these are the details of the provider requesting and collecting 
specimen/s  
L Laboratory data elements—these are the details of the laboratory analysing the 
specimen/s 
T Test type data element—this section contains a single data element that determines the 
type of test performed (cytology, histology or HPV DNA) 
C Cytology test data elements—these are the details of a cytology test if the specimen was 
collected by way of a Pap test (Pap smear)   
H Histology test data elements—these are the details of a histology test if the specimen was 
collected by way of a biopsy 
D HPV DNA test data elements—these are the details of an HPV DNA test 
F Follow-up data elements—this section contains 2 elements that allow information about 
the 27-month cervical screening register reminder letter to be collected. 
These sections reflect the way in which the data elements are used in the cervical cytology 
registries that support the state and territory cervical screening programs. 
It should be noted that differences exist in the way that each jurisdiction reports and records 
data, and this is therefore not reflective of all cervical screening registers, but aims to capture 
the main elements of all registers, and therefore present a ‘generic’ model that is applicable 
to all. 
Box 3.2 
Although the first subset of the Standardised cervical screening data dictionary was published 
in April 2007, the development of this document into the more comprehensive National 
cervical cancer prevention data dictionary identified many data elements that needed to be 
either added or altered.  
Therefore differences exist between the data elements in the first subset and this document.  
Another important change is the organisation of data elements into sections to increase the 
ease of use of the data dictionary, which means the numbering system used in the first and 
second subsets has been abolished.  
To allow transition between the published first subset of the Dictionary and this data 
dictionary, any data elements that existed in the first subset have their previous number and 
technical name included in the related metadata references section of the relational 
attributes for these data elements. 
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3.3 Data element status 
The current status of each data element in the National cervical cancer prevention data dictionary 
version 1 is identified by its collection status. 
Data elements currently used by cervical screening registers: 
 Essential status indicates that this data element is required for cervical screening 
registers to conduct their core business, although the data may be collected and stored 
differently to the way in which the data element is described here. 
 Desirable status indicates that, although desirable, this data element is not essential for 
cervical screening registers to collect. There may also be differences in the way in which 
the data items are collected and stored on the registers. 
 Conditional status indicates that the recording of this data element is conditional on the 
defining event having occurred. For example, A25 Woman—date of death is conditional 
(nullable) until such time as the woman is confirmed as deceased by the cervical 
screening register. A further example is F2 Follow-up-date letter sent, which is 
conditional on whether a 27-month reminder letter is considered to have been sent. 
Data elements not currently collected routinely by cervical screening registers: 
 Potential status indicates that this data element is feasibly able to be collected, although 
there may be barriers to this at present. This status is used for data elements such as HPV 
vaccination status, for which a route for collection has been identified, in anticipation that 
in the near future these may be able to be used.  
 Aspirational status indicates that this data element has been identified as one that would 
be required to support directions to which the program aspires, but which may never be 
realised. Data elements of this status include HPV genotyping information, which may 
never be able to be collected by cervical screening registers. 
Since the National cervical cancer prevention data dictionary version 1 aims, in addition to 
supporting current data collection and reporting of the National Cervical Screening Program, 
to support potential future aspirations that may never be realised, there are a number of 
‘potential’ and ‘aspirational’ data elements in this document. 
Potential and aspirational data elements are likely to require further development if they 
were to be collected by cervical screening registers (this is particularly the case for 
aspirational data elements, many of which are skeletal and only indicative of what may be 
collected in the future). 
It should be noted that potential and aspirational data elements may not reflect the directions 
of all state and territory cervical screening programs, and in some cases may be in direct 
conflict with current legislation. These are considered important to include in this document, 
however, so that if states and territories chooses to incorporate these data into their cervical 
screening register in the future, they can do so within a framework that will allow national 
consistency. This is particularly important for the potential data elements that have general 
support, if not appropriate legislation, at this time. 
It should be noted that, regardless of the status, these data elements are intended to support 
the state and territory cervical screening programs in achieving national consistency and 
validity in data rather than to prescribe how data should be collected or stored in each 
cervical screening register.  
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3.4 Data elements 
Woman data elements 
A1 Woman—client identifier, identifier X[X(19)] .....................................................................................11 
A2 Woman—Medicare card number, identifier {N(10)[N]} .....................................................................12 
A3 Woman—individual healthcare identifier, identifier {N(16)} ..............................................................13 
A4 Woman—family name, text X[X(39)] .................................................................................................14 
A5 Woman—given names, text  X[X(39)] ...............................................................................................18 
A6 Woman—other family name, text  [X(40)] .........................................................................................21 
A7 Woman—date of birth, date DDMMYYYY ........................................................................................22 
A8 Woman—Indigenous status, code N ................................................................................................23 
A9 Woman—main language other than English spoken at home, code (ASCL 2011) {NN{NN}} .........27 
A10 Woman—country of birth, code (SACC 2011) {NNNN} ..................................................................30 
A11 Woman—residential address, text [X(180)] ....................................................................................32 
A12 Woman—residential suburb/town/locality name, text [A(50)] .........................................................33 
A13 Woman—residential alternative or other names for suburb/town/locality, text [A(50)] ...................34 
A14 Woman—residential Australian state/territory name, code {AA[A]} ................................................35 
A15 Woman—residential Australian postcode, {NNNN} ........................................................................36 
A16 Woman—mailing address, text [X(180)] .........................................................................................37 
A17 Woman—mailing suburb/town/locality name, text [A(50)] ..............................................................38 
A18 Woman—mailing alternative or other names for suburb/town/locality, text [A(50)] ........................39 
A19 Woman—mailing Australian state/territory name, code {AA[A]} .....................................................40 
A20 Woman—mailing Australian postcode, code {NNNN} ....................................................................41 
A21 Woman—hysterectomy status, code N...........................................................................................42 
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A1 Woman—client identifier, identifier X[X(19)] 
Identifying and definitional attributes 
Data element name Client identifier 
Definition Client identifier unique within state or territory cervical screening 
registry. 
Collection status Essential 
Value domain representational attributes 
Representation class Identifier 
Data type String 
Format X [X(19)] 
Maximum character length 20 
Collection and usage attributes 
Guide for use  
Data element attributes 
Source and reference attributes 
Origin State and Territory cervical screening registers 
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A2 Woman—Medicare card number, identifier {N(10)[N]} 
Identifying and definitional attributes 
Data element name Medicare card number  
Synonymous names Medicare number 
Definition A numeric number on a medical card allocated by Medicare Australia 
for the purpose of identifying those people eligible for specific 
services.  
Collection status Desirable 
Value domain representational attributes 
Representation class Identifier 
Data type Number 
Format {N(10)[N]} 
Maximum character length 11 
Collection and usage attributes 
Guide for use This data item is desirable, as it is not currently collected by all 
cervical screening registries. 
Format allows the collection of full Medicare number for an individual 
(i.e. family number plus person (individual reference) number), or 
truncated Medicare number. 
Comments The Medicare card number is printed on a Medicare card and is used 
to access Medicare records for an eligible person. 
Up to 9 persons can be included under the one Medicare card 
number with up to five persons appearing on one physical card.  
Persons grouped under one Medicare card number are often a 
family, however, there is no requirement for persons under the same 
Medicare card number to be related.  
A person may be shown under separate Medicare card numbers 
where, for example, a child needs to be included on separate 
Medicare cards held by their parents. As a person can be identified 
on more than one Medicare card this is not a unique identifier for a 
person. 
Data element attributes 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 9 Persongovernment funding 
identifier, Medicare card number identifier N(11) 
 
  
  
National Cervical Cancer Prevention Data Dictionary Version 1 13 
A3 Woman—individual healthcare identifier, identifier 
{N(16)} 
Identifying and definitional attributes 
Data element name Individual healthcare identifier 
Synonymous names IHI 
Definition An individual healthcare identifier (IHI) is a unique 16 digit number 
that will be allocated to each Australian resident and others seeking 
healthcare in Australia. 
Collection status Aspirational 
Value domain representational attributes 
Representation class Identifier 
Data type Number 
Format {N(16)} 
Maximum character length 16 
Collection and usage attributes 
Guide for use An individual healthcare identifier (IHI) is allocated to all 
individuals enrolled in the Medicare program or those who are 
issued with a Department of Veterans' Affairs (DVA) treatment 
card, and others who seek healthcare in Australia. 
Data element attributes 
Source and reference attributes 
Origin National E-Health Transition Authority (NEHTA) 
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A4 Woman—family name, text X[X(39)]  
Identifying and definitional attributes 
Data element name Family name 
Definition The text that represents the part of a name a woman usually has in 
common with some other members of her family, as distinguished 
from her given names 
Collection status Essential 
Value domain representational attributes 
Representation class Text 
Data type String 
Format X[X(39)] 
Maximum character length 40 
Data element attributes 
Collection and usage attributes 
Guide for use The agency or establishment should record the client’s full family 
name on their information systems. 
This metadata item should be recorded for all clients. 
A full history of names is to be retained. 
Collection methods Note that the following collection methods are not intended to 
be prescriptive, but rather are intended as a resource that 
cervical screening registries may find useful. 
Family name should be recorded in the format preferred by the 
person. The format should be the same as that indicated by the 
person (e.g. written on a form) or in the same format as that printed 
on an identification card, such as Medicare card, to ensure 
consistent collection of name data. 
It is acknowledged that some people use more than one family name 
(e.g. formal name, birth name, married/maiden name, tribal name) 
depending on the circumstances. Each name should be recorded 
against the appropriate Name type (see Comments). 
A person is able to change his/her name by usage in all States and 
Territories of Australia with the exception of Western Australia, 
where a person may only change his/her name under the Change of 
Name Act. Care should be taken when recording a change of name 
for a minor. Ideally, the name recorded for the minor should be 
known to both of his/her parents, so the minor's records can be 
retrieved and continuity of care maintained, regardless of which 
parent accompanies the minor to the agency or establishment. 
A person should generally be registered using their preferred name 
as it is more likely to be used in common usage and on subsequent 
visits to the agency or establishment. The person's preferred name 
may in fact be the name on their Medicare card. The Name type 
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metadata item can be used to distinguish between the different types 
of names that may be used by the person. The following format may 
assist with data collection:  
What is your family name?  
 
Are you known by any other family names that you would like 
recorded? If so, what are they? 
 
Please indicate, for each name above, the 'type' of family name that 
is to be recorded: 
Please indicate, for each name above, the 'type' of family name that 
is to be recorded: 
(a) Medicare card name (if different to preferred name).  
(b) Alias (any other name that you are known by). 
Whenever a person informs the agency or establishment of a change 
of family name (e.g. following marriage or divorce), the former name 
should be recorded as an alias name. A full history of names should 
be retained. e.g. 'Mary Georgina Smith' informs the hospital that she 
has been married and changed her family name to 'Jones'. Record 
'Jones' as her preferred family name and record 'Smith' as an alias 
name. 
Hyphenated family names: 
Sometimes people with hyphenated family names use only one of 
the two hyphenated names. It is useful to record each of the 
hyphenated names as an alias. If the person has a hyphenated 
family name, e.g. 'Wilson-Phillips' record 'Wilson-Phillips' in the 
preferred family name field and record 'Wilson' and 'Phillips' 
separately as alias family names. 
Punctuation:  
If special characters form part of the family name they should be 
included, e.g. hyphenated names should be entered with a hyphen. 
Examples: 
- hyphen, e.g. Wilson-Phillips 
Do not leave a space before or after a hyphen, i.e. between the last 
letter of 'Wilson' and the hyphen, nor a space between the hyphen 
and the first letter of 'Phillips'. 
- apostrophe, e.g. O'Brien, D'Agostino 
Do not leave a space before or after the apostrophe, i.e. between the 
'O' and the apostrophe, nor a space between the apostrophe and 
'Brien'. 
- full stop, e.g. St. John, St. George  
Do not leave a space before a full stop, i.e. between 'St' and the full 
stop. Do leave a space between the full stop and 'John'. 
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- space, e.g. van der Humm, Le Brun, Mc Donald 
If the health care client has recorded their family name as more than 
one word, displaying spaces in between the words, record their 
family name in the same way leaving one space between each word. 
People with only one name: 
Some people do not have a family name and a given name, they 
have only one name by which they are known. If the person has only 
one name, record it in the 'Family name' field and leave the 'Given 
name' field blank. 
Registering an unidentified health care client: 
The default for unknown family name, should be unknown in all 
instances and the name recorded as an alias name. Don't create a 
'fictitious' family name such as 'Doe' as this is an actual family name. 
When the person's name becomes known, record it as the preferred 
family name and do not overwrite the alias name of unknown. 
Registering health care clients from disaster sites: 
People treated from disaster sites should be recorded under the alias 
Name Type. Local business rules should be developed for consistent 
recording of disaster site person details. 
Care should be taken not to use identical dummy data (family name, 
given name, date of birth, sex) for two or more people from a 
disaster site. 
If the family name needs to be shortened: 
If the length of the family name exceeds the length of the field, 
truncate the family name from the right (that is, dropping the final 
letters). Also, the last character of the name should be a hash (#) to 
identify that the name has been truncated. 
Use of incomplete names or fictitious names: 
Some health care facilities permit females to use a pseudonym 
(fictitious or partial name) in lieu of their full or actual name. It is 
recommended that the person be asked to record both the 
pseudonym (Alias name) in addition to the person's Medicare card 
name. 
Prefixes: 
Where a family name contains a prefix, such as one to indicate that 
the person is a widower/widow, this must be entered as part of the 
'Family name' field. When widowed, some Hungarian women add 
'Ozvegy' (abbreviation is 'Ozy') before their married family name, e.g. 
'Mrs Szabo' would become 'Mrs Ozy Szabo'. That is, 'Mrs Szabo' 
becomes an alias name and 'Mrs Ozy Szabo' becomes the preferred 
name. 
Ethnic Names: 
The Centrelink publication, Naming Systems for Ethnic Groups, 
provides the correct coding for ethnic names. 
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Misspelled family name: 
If the person's family name has been misspelled in error, update the 
family name with the correct spelling and record the misspelled 
family name as an alias name. Recording misspelled names is 
important for filing documents that may be issued with previous 
versions of the person's name. Discretion should be used regarding 
the degree of recording that is maintained. 
Comments Often people use a variety of names, including legal names, 
married/maiden names, nicknames, assumed names, traditional 
names, etc. Even small differences in recording - such as the 
difference between MacIntosh and McIntosh - can make record 
linkage impossible. To minimise discrepancies in the recording and 
reporting of name information, agencies or establishments should 
ask the person for their full (formal) 'Given name' and 'Family name'. 
These may be different from the name that the person may prefer 
the agency or establishment workers to use in personal dealings. 
Agencies or establishments may choose to separately record the 
preferred names that the person wishes to be used by agency or 
establishment workers. In some cultures it is traditional to state the 
family name first. To overcome discrepancies in recording/reporting 
that may arise as a result of this practice, agencies or establishments 
should always ask the person to specify their first given name and 
their family name or surname separately. These should then be 
recorded as 'Given name' and 'Family name' as appropriate, 
regardless of the order in which they may be traditionally given. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents AS4846 Health Care Provider Identification, 2004, Sydney: 
Standards Australia 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 1 Personfamily name, text 
X[X(39)] 
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A5 Woman—given names, text  X[X(39)] 
Identifying and definitional attributes 
Data element name Given names 
Definition The woman's identifying name(s) within the family group or by which 
the woman is socially identified. 
Collection status Essential 
Value domain representational attributes 
Representation class Text 
Data type String 
Format X[X(39)] 
Maximum character length 40 
Data element attributes 
Collection and usage attributes 
Guide for use The agency or establishment should record the full given name(s) 
of the client on their information systems. 
Health care establishments may record given names (first and other 
given names) in one field or several fields. This metadata item 
definition applies regardless of the format of data recording.  
This metadata item should be recorded for all clients.  
A full history of names is to be retained. 
Collection methods Note that the following collection methods are not intended to 
be prescriptive, but rather are intended as resource that cervical 
screening registries may find useful. 
Given name(s) should be recorded in the format preferred by the 
person. The format should be the same as that indicated by the 
person (e.g. written on a form) or printed on an identification card, 
such as Medicare card, to ensure consistent collection of name data.  
It is acknowledged that some people use more than one given name 
(e.g. formal name, birth name, nick name or shortened name, or 
tribal name) depending on the circumstances. A person is able to 
change their name by usage in all States and Territories of Australia 
with the exception of Western Australia, where a person may only 
change their name under the Change of Name Act.  
The person should generally be registered using their preferred 
name as it is more likely to be used in common usage. The preferred 
name of the person may in fact be their legal (or Medicare card) 
name.  
Use of first initial:  
If the given name of the person is not known, but the first letter 
(initial) of the given name is known, record the first letter in the 
preferred 'Given name' field. Do not record a full stop following the 
initial.  
Registers may be able to enter a full stop (.) into the given names if 
one is not provided. For example this would allow letters to be 
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printed as Ms . Robertson. 
This assists Registers to format letter labels correctly and avoids 
confusion for data processing officers who may be unable to leave 
the data field blank. 
The person with only one name:  
Some people do not have a family name and a given name: they 
have only one name by which they are known. If the person has only 
one name, record it in the 'Family name' field and leave the 'Given 
name' blank.  
Multiple given names (middle, second, third etc. names):  
All of the given names of the person should be recorded in the 'Given 
name' field, leaving a space between each name.  
Record complete information:  
If the person has many given names and all of them cannot fit in the 
field, record as many names in full as possible, in preference to 
recording initials.  
Shortened or alternate first given name:  
If the person uses a shortened version or an alternate version of their 
first given name, record their preferred name, the actual name as 
their Medicare card name and any alternative versions as alias 
names as appropriate.  
e.g. The given name of the person is Jennifer but she prefers to be 
called Jenny. Record 'Jenny' as the preferred 'Given name' and 
'Jennifer' as her Medicare card name.  
Punctuation:  
If special characters form part of the given names they shall be 
included, e.g. hyphenated names shall be entered with the hyphen.  
·        Hyphen, e.g. Anne-Maree, Mary-Jane  
Do not leave a space before or after the hyphen, i.e. between last 
letter of 'Anne' and the hyphen, nor a space between the hyphen and 
the first letter of 'Maree'. 
If the person has recorded their given name as more than one word, 
displaying spaces in between the words, record their given names in 
data collection systems in the same way.  
e.g. Wendy Hilda  
Leave a single space between the person’s first name and each of 
their middle names.  
Aboriginal/Torres Strait Islander names not for continued use: 
For cultural reasons, an Aboriginal or Torres Strait Islander may 
advise an agency or establishment that they are no longer using the 
given name that they had previously registered and are now using an 
alternative current name.  
Record their current name as the preferred 'Given name' and record 
their previous used given name as an alias name.  
Ethnic Names:  
The Centrelink Naming Systems for Ethnic Groups publication 
provides the correct coding for ethnic names. Refer to Ethnic Names 
Condensed Guide for summary information.  
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Misspelled given names:  
If the given name of the person has been misspelled in error, update 
the Given name field with the correct spelling and record the 
misspelled given name as an Alias name. Recording misspelled 
names is important for filing documents that may be issued with 
previous versions of the person’s name. Discretion should be used 
regarding the degree of recording that is maintained.  
Comments Often people use a variety of names, including legal names, 
married/maiden names, nicknames, assumed names, traditional 
names, etc. Even small differences in recording - such as the 
difference between MacIntosh and McIntosh - can make record 
linkage impossible. To minimise discrepancies in the recording and 
reporting of name information, agencies or establishments should 
ask the person for their full (formal) 'Given name' and 'Family name'. 
These may be different from the name that the person may prefer 
the agency or establishment workers to use in personal dealings. 
Agencies or establishments may choose to separately record the 
preferred names that the person wishes to be used by agency or 
establishment workers. In some cultures it is traditional to state the 
family name first. To overcome discrepancies in recording/reporting 
that may arise as a result of this practice, agencies or establishments 
should always ask the person to specify their first given name and 
their family name or surname separately. These should then be 
recorded as 'Given name' and 'Family name' as appropriate, 
regardless of the order in which they may be traditionally given. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents AS4846 Health Care Provider Identification, 2004, Sydney: 
Standards Australia 
Relational attributes 
Related metadata 
references 
Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 2 Persongiven names, text 
X[X(40)] 
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A6 Woman—other family name, text [X(40)] 
Identifying and definitional attributes 
Data element name Other family name 
Definition That part of a name a woman has or had in common with some other 
members of her other or previous family(s), as distinguished from her 
other or previous given names. 
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [X(40)] 
Maximum character length 40 
Data element attributes 
Collection and usage attributes 
Guide for use The agency or establishment should record the client’s full other or 
previous family name on their information systems. 
 A full history of names is to be retained.  
Collection methods As for A4 Woman—family name, text X[X(39)]. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents AS4846 Health Care Provider Identification, 2004, Sydney: 
Standards Australia 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 3 Personother family name, 
text X[X(39)] 
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A7 Woman—date of birth, date DDMMYYYY 
Identifying and definitional attributes 
Data element name Date of birth 
Definition The date on which a woman was born. 
Collection status Essential 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format DDMMYYYY 
Maximum character length 8 
Data element attributes 
Collection and usage attributes 
Guide for use If date of birth is not known or cannot be obtained, provision should 
be made to collect or estimate age. Collected or estimated age 
would usually be in years.  
Collection methods Information on date of birth can be collected using the one question:  
What is your/(the person's) date of birth? 
In self-reported data collections, it is recommended that the following 
response format is used:  
Date of birth: _ _ / _ _ / _ _ _ _  
This enables easy conversion to the preferred representational 
layout (DDMMYYYY). 
Comments Privacy issues need to be taken into account in asking persons their 
date of birth. 
Wherever possible and wherever appropriate, date of birth should be 
used rather than age because the actual date of birth allows a more 
precise calculation of age. 
When date of birth is an estimated or default value, national health 
and community services collections typically use 0101 or 0107 or 
3006 as the estimate or default for DDMM.  
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 10 Persondate of birth, date 
DDMMYYYY 
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A8 Woman—Indigenous status, code N 
Identifying and definitional attributes 
Data element name Indigenous status 
Definition Whether a woman identifies as being of Aboriginal or Torres Strait 
Islander descent. This is in accord with the first two of three 
components of the Commonwealth definition. 
Collection status Essential where it is possible to be collected, and where the cervical 
screening register is capable of receiving it. 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format N 
Maximum character length 1 
Permissible values Value Meaning 
1 Aboriginal but not Torres Strait Islander origin 
2 Torres Strait Islander but not Aboriginal origin 
3 Both Aboriginal and Torres Strait Islander origin 
4 Neither Aboriginal nor Torres Strait Islander origin 
 
Supplementary codes 9 Not stated/inadequately described 
 
Collection and usage attributes 
Context Australia's Aboriginal and Torres Strait Islander peoples occupy 
a unique place in Australian society and culture. In the current 
climate of reconciliation, accurate and consistent statistics 
about Aboriginal and Torres Strait Islander peoples are needed 
in order to plan, promote and deliver essential services, to 
monitor changes in wellbeing and to account for government 
expenditure in this area. The purpose of this metadata item is to 
provide information about people who identify as being of 
Aboriginal or Torres Strait Islander origin. Agencies or 
establishments wishing to determine the eligibility of individuals 
for particular benefits, services or rights will need to make their 
own judgments about the suitability of the standard measure for 
these purposes, having regard to the specific eligibility criteria 
for the program concerned. 
Guide for use The collection of Aboriginal and Torres Strait Islander status is 
necessary for the government and other services to plan and 
deliver appropriate health services for all Australians, to assess 
the impact of services on particular groups in the community 
and to improve health care and to monitor changes in health 
and wellbeing over time (AIHW 2010). 
Aboriginal and Torres Strait Islander status is not routinely 
collected by the cervical screening registries, but where it is 
collected by the practitioner collecting the cervical cytology 
sample, and where this is transmitted to the pathology 
laboratory on the request form (or electronically), and where the 
cervical screening register is capable of receiving it, it is 
essential that Aboriginal and Torres Strait Islander status be 
provided to the cervical screening registries.  
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This metadata item is based on the Australian Bureau of 
Statistics (ABS) standard for Indigenous status. For detailed 
advice on its use and application please refer to the ABS 
Website as indicated in the Reference documents.  
The classification for Indigenous status has a hierarchical 
structure comprising two levels. There are four categories at the 
detailed level of the classification which are grouped into two 
categories at the broad level. There is one supplementary 
category for 'not stated' responses. The classification is as 
follows:  
Indigenous:  
 Aboriginal but not Torres Strait Islander origin.  
 Torres Strait Islander but not Aboriginal origin.  
 Both Aboriginal and Torres Strait Islander origin.  
Non-indigenous:  
 Neither Aboriginal nor Torres Strait Islander origin. 
Not stated/ inadequately described:  
This category is not to be available as a valid answer to the 
questions but is intended for use:  
 Primarily when importing data from other data collections 
that do not contain mappable data.  
 Where an answer was refused.  
 Where the question was not able to be asked prior to 
completion of assistance because the client was unable to 
communicate or a person who knows the client was not 
available. 
Only in the last two situations may the tick boxes on the 
questionnaire be left blank. 
Collection methods It is anticipated that collection of Aboriginal and Torres Strait 
Islander status will be collected through the inclusion of this field 
on pathology forms that accompany the cervical cytology 
sample to the laboratory. 
Laboratories reporting cervical cytology in Australia are required 
to send information to the cervical screening registries in each 
state and territory on a regular and timely basis, depending on 
each jurisdiction’s legislative requirements.  
In addition to the information that laboratories are currently 
required to send to the cervical screening registry in the 
woman’s jurisdiction of residence (including demographic 
information on the woman and cervical cytology test provider, 
cervical cytology results and recommendation, cervical 
histology results and HPV test results), Aboriginal and Torres 
Strait Islander status is also required to be sent to the cervical 
screening registry, where Aboriginal and Torres Strait Islander 
status is collected and transmitted to the pathology laboratory 
on the request form (or electronically), and where is legislatively 
permitted, possible and available to be collected, the cervical 
screening register is capable of receiving it and the cervical 
cytology screening register is able to store it.  
Data element attributes 
Collection and usage attributes 
Collection methods The standard question for Indigenous Status is as follows:  
[Are you] [Is the person] [Is (name)] of Aboriginal or Torres Strait 
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Islander origin? 
(For women of both Aboriginal and Torres Strait Islander origin, 
mark both 'Yes' boxes.)  
No....................................................  
Yes, Aboriginal...............................  
Yes, Torres Strait Islander............  
This question is recommended for self-enumerated or interview-
based collections. It can also be used in circumstances where a 
close relative, friend, or another member of the household is 
answering on behalf of the subject. It is strongly recommended that 
this question be asked directly wherever possible. 
When someone is not present, the person answering for them 
should be in a position to do so, i.e. this person must know well the 
person about whom the question is being asked and feel confident 
to provide accurate information about them. 
This question must always be asked regardless of data collectors' 
perceptions based on appearance or other factors. 
The Indigenous status question allows for more than one response. 
The procedure for coding multiple responses is as follows:  
If the respondent marks 'No' and either 'Aboriginal' or 'Torres Strait 
Islander', then the response should be coded to either Aboriginal or 
Torres Strait Islander as indicated (i.e. disregard the 'No' response).  
If the respondent marks both the 'Aboriginal' and 'Torres Strait 
Islander' boxes, then their response should be coded to 'Both 
Aboriginal and Torres Strait Islander origin. 
If the respondent marks all three boxes ('No', 'Aboriginal' and 
'Torres Strait Islander'), then the response should be coded to 'Both 
Aboriginal and Torres Strait Islander Descent' (i.e. disregard the 
'No' response).  
This approach may be problematical in some data collections, for 
example when data are collected by interview or using screen 
based data capture systems. An additional response category  
Yes, both Aboriginal and Torres Strait Islander... 
may be included if this better suits the data collection practices of 
the agency or establishment concerned. 
Comments The following definition, commonly known as 'The Commonwealth 
Definition', was given in a High Court judgement in the case of 
Commonwealth v Tasmania (1983) 46 ALR 625. 
'An Aboriginal or Torres Strait Islander is a person of Aboriginal or 
Torres Strait Islander descent who identifies as an Aboriginal or 
Torres Strait Islander and is accepted as such by the community in 
which he or she lives'. 
There are three components to the Commonwealth definition: 
 descent;  
 self-identification; and  
 community acceptance. 
In practice, it is not feasible to collect information on the community 
acceptance part of this definition in general purpose statistical and 
administrative collections and therefore standard questions on 
Indigenous status relate to descent and self-identification only. 
Source and reference attributes 
Origin National Health Data Committee 
National Community Services Data Committee 
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Reference documents Australian Bureau of Statistics 1999. Standards for Social, Labour 
and Demographic Variables. Cultural Diversity Variables, Canberra. 
Viewed 3 August 2005. 
Australian Institute of Health and Welfare 2010. National best 
practice guidelines for collecting Indigenous status in health data 
sets. Cat. no. IHW 29. Canberra: AIHW. 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 11 PersonIndigenous status, 
code N  
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A9 Woman—main language other than English spoken at 
home, code (ASCL 2011) {NN{NN}} 
Identifying and definitional attributes 
Data element name Main language other than English spoken at home 
Registration status Community Services, Superseded 13/10/2011 
Housing assistance, Standard 10/02/2006 
Health, Superseded 13/10/2011 
Definition The language reported by a person as the main language other than 
English spoken by that person in his/her home (or most recent 
private residential setting occupied by the person) to communicate 
with other residents of the home or setting and regular visitors, as 
represented by a code. 
Collection status Aspirational 
Value domain representational attributes 
Classification scheme Australian Standard Classification of Languages 2011 
Data type Number 
Format {NN{NN}} 
Maximum character length 4 
Collection and usage attributes 
Guide for use Not currently able to be collected routinely by cervical screening 
registers. 
The Australian Standard Classification of Languages (ASCL) has a 
three- level hierarchical structure. The most detailed level of the 
classification consists of base units (languages) which are 
represented by four-digit codes. The second level of the classification 
comprises narrow groups of languages (the Narrow Group level), 
identified by the first two digits. The most general level of the 
classification consists of broad groups of languages (the Broad 
Group level) and is identified by the first digit. The classification 
includes Australian Indigenous languages and sign languages. 
For example, the Lithuanian language has a code of 3102. In this 
case 3 denote that it is an Eastern European language, while 31 
denote that it is a Baltic language. The Pintupi Aboriginal language is 
coded as 8713. In this case 8 denote that it is an Australian 
Indigenous language and 87 denote that the language is Western 
Desert language. 
Language data may be output at the Broad Group level, Narrow 
Group level or base level of the classification. If necessary significant 
Languages within a Narrow Group can be presented separately while 
the remaining Languages in the Narrow Group are aggregated. The 
same principle can be  
adopted to highlight significant Narrow Groups within a Broad Group. 
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Data element attributes 
Collection and usage attributes 
Collection methods Recommended question:  
Do you/Does the person/Does (name) speak a language other than 
English at home? (If more than one language, indicate the one that is 
spoken most often.)  
 
Response options for detailed data:  
 
Alternative 1 
 
No, (English only) []  
 
Yes, Mandarin []  
 
Yes, Italian []  
 
Yes, Arabic []  
 
Yes, Cantonese []  
 
Yes, Greek []  
 
Yes, Vietnamese  []  
 
Yes, Spanish  []  
 
Yes, Hindi  []  
 
Yes, Tagalog  []  
 
Yes, Other (please specify) ______________________________  
 
The above list includes languages based on their statistical 
significance in the Australian context. The list is reviewed when data 
indicate that different languages have been more or less frequently 
reported in the Census. 
  
Alternative 2 
  
No, English only [] 
  
Yes, Other - please specify ______________________________  
 
Response option for minimum data: 
  
No, English only [] 
  
Yes, Other [] 
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Comments This metadata item is consistent with that used in the Australian 
Census of Population and Housing and is recommended for use 
whenever there is a requirement for comparison with Census data. 
 
This data element is important in identifying those people most likely 
to suffer disadvantage in terms of their ability to access services due 
to language and/or cultural difficulties. In conjunction with Indigenous 
status, Proficiency in spoken English and Country of birth this data 
element forms the minimum core set of cultural and language 
indicators recommended by the Australian Bureau of Statistics (ABS). 
 
Data on main language other than English spoken at home are 
regarded as an indicator of 'active' ethnicity and also as useful for the 
study of inter-generational language retention. The availability of such 
data may help providers of health and community services to 
effectively target the geographic areas or population groups that need 
those services. It may be used for the investigation and development 
of language services such as interpreter/ translation services. 
 
The ABS Language Standards, 2012, Version 1.1 (cat. no. 
1200.0.55.005) was released in September 2012. The recommended 
question recognises children under two years of age. 
Source and reference attributes 
Origin Health Data Standards Committee 
National Community Services Data Committee 
Australian Bureau of Statistics 2011. Australian Standard 
Classification of Languages (ASCL) 2011. Canberra: ABS. 
16/8/2011. 
Reference documents Australian Bureau of Statistics 2012. Language Standards, 2012, 
Version 1.1. Cat. no. 1200.0.55.05. Canberra: ABS. 
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A10 Woman—country of birth, code (SACC 2011) {NNNN} 
Identifying and definitional attributes 
Data element name Country of birth 
Registration status Community Services, Standard 13/10/2011 
Housing assistance, Standard 13/10/2011 
Health, Standard 13/10/2011 
Homelessness, Standard 13/10/2011 
WA Health, Draft 23/08/2012 
Independent Hospital Pricing Authority, Recorded 22/08/2012 
Definition The country in which the person was born, as represented by a code. 
Collection status Aspirational 
Value domain representational attributes 
Classification scheme Standard Australian Classification of Countries 2011 
Representation class Code 
Data type Number 
Format {NNNN} 
Maximum character length 4 
Collection and usage attributes 
Guide for use Not currently able to be collected routinely by cervical screening 
registers. 
The Standard Australian Classification of Countries 2011 (SACC) is 
a four-digit, three-level hierarchical structure specifying major group, 
minor group and country. 
A country, even if it comprises other discrete political entities such as 
states, is treated as a single unit for all data domain purposes. Parts 
of a political entity are not included in different groups. Thus, Hawaii 
is included in Northern America (as part of the identified country 
United States of America), despite being geographically close to and 
having similar social and cultural characteristics as the units 
classified to Polynesia. 
Data element attributes 
Collection and usage attributes 
Collection methods Some data collections ask respondents to specify their country of 
birth. In others, a pre-determined set of countries is specified as part 
of the question, usually accompanied by an ‘other (please specify)’ 
category. 
Recommended questions are:  
In which country were you/was the person/was (name) born? 
Australia  
Other (please specify) 
Alternatively, a list of countries may be used based on, for example 
common Census responses. 
In which country were you/was the person/was (name) born?  
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Australia  
England  
New Zealand  
Italy  
Viet Nam  
India  
Scotland  
Philippines  
Greece  
Germany  
Other (please specify) 
In either case coding of data should conform to the SACC.  
Sometimes respondents are simply asked to specify whether they 
were born in either 'English speaking' or 'non-English speaking' 
countries but this question is of limited use and this method of 
collection is not recommended. 
Comments This metadata item is consistent with that used in the ABS collection 
methods and is recommended for use whenever there is a 
requirement for comparison with ABS data (last viewed 2/6/2008). 
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A11 Woman—residential address, text [X(180)] 
Identifying and definitional attributes 
Data element name Residential address 
Definition The address where a woman usually resides.  
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [X(180)] 
Maximum character length 180 
Data element attributes 
Collection and usage attributes 
Guide for use Address is a composite of one or more standard address 
components that describes a low level of geographical/physical 
description of a location. Used in conjunction with the other high-
level address components i.e. Suburb/town/locality, Postcode - 
Australian, Australian state/territory, and Country, forms a complete 
geographical/physical address of a woman. 
Residential or a postal (mailing) address should be provided for a 
woman. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 4 Person (address)address 
line, text X[X(180)] 
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A12 Woman—residential suburb/town/locality name, text 
[A(50)] 
Identifying and definitional attributes 
Data element name Residential suburb/town/locality name 
Definition The suburb/town/locality where a woman usually resides. 
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [A(50)] 
Maximum character length 50 
Data element attributes 
Collection and usage attributes 
Guide for use Suburb/town/locality is the text that represents the full name of 
the locality contained within the specific address of a woman. 
The suburb/town/locality name, may be a town, city, suburb or 
commonly used location name such as a large agricultural 
property or Aboriginal community. The Australian Bureau of 
Statistics has suggested that a maximum field length of 50 
characters should be sufficient to record the vast majority of 
locality names. This metadata item may be used to describe 
the location of woman, organisation or event. It can be a 
component of a street or postal address. 
If there is no data for this item please refer to 'Woman—
alternative or other names for suburb/town/locality' as this may 
contain an alternative name the locality can be known by. 
Residential or a postal (mailing) address should be provided 
for a woman. 
Collection methods Enter 'Unknown' when the locality name or geographic area for 
a woman or event is not known. Enter 'No fixed address' when 
a woman has no fixed address or is homeless. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 5 Person 
(address)suburb/town/locality name, text [A(50)] 
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A13 Woman—residential alternative or other names for 
suburb/town/locality, text [A(50)] 
Identifying and definitional attributes 
Data element name Residential alternative or other names for suburb/town/locality 
Definition The alternative name or other name of the suburb/town/locality 
(for example an Indigenous name or a colloquial name for a 
locality that is different to the official or commonly used name) 
where a woman usually resides. 
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [A(50)] 
Maximum character length 50 
Data element attributes 
Collection and usage attributes 
Guide for use The alternative name or other name of the suburb/town/locality is, 
for example, an Indigenous name or a colloquial name for a 
locality that is different to the official or commonly used name, 
that is contained within the specific address of a woman. 
The alternative or other name for a suburb/town/locality may be 
used instead of, or in addition to, the official or commonly used 
name of the locality. 
Collection methods If there is not an alternative or other name for a locality other than 
the official or commonly used name, then do not enter any data 
for this item.  
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 6 Personalternative or 
other names for suburb/town/locality, text [A(50)] 
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A14 Woman—residential Australian state/territory name, 
code {AA[A]} 
Identifying and definitional attributes 
Data element name Residential Australian state/territory name 
Definition The name of the Australian state or territory for the address where a 
woman usually resides. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type Text 
Format {AA[A]} 
Maximum character length 3 
Permissible values Value Meaning 
 NSW New South Wales 
 VIC Victoria 
 QLD Queensland 
 WA Western Australia  
 SA South Australia 
 TAS Tasmania 
 ACT Australian Capital Territory  
 NT Northern Territory 
Data element attributes 
Collection and usage attributes 
Guide for use This data element is important for national reporting by the 
Australian Institute of Health and Welfare, but is not mandatory 
for collection by state and territory cervical screening registers. 
Where it is collected, it is preferable if this is known to be the 
state or territory of residence, rather than derived from the 
residential postcode alone, although this may not be possible.  
Although the definition states that this is the state or territory in 
which a woman usually resides, this may alternatively be used 
by the AIHW to represent the state or territory that supplied the 
woman’s data, which may be different to that in which the 
woman usually resides. This needs to be clearly defined in the 
documentation of AIHW databases that use this date element. 
The order presented here is the standard for the Australian 
Institute of Health and Welfare, and reflects the current order of 
states and then territories in order of most populated to least 
populated. 
Residential or a postal (mailing) address should be provided 
for a woman. 
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A15 Woman—residential Australian postcode, {NNNN} 
Identifying and definitional attributes 
Data element name Residential Australian postcode  
Definition The code that represents a postal delivery area, aligned with locality, 
suburb or place for the address where a woman usually resides. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format {NNNN} 
Maximum character length 4 
Collection and usage attributes 
Comments Must accept zero as the leading digit to accommodate all 
Australian postcodes. 
Australian Postcode may be used in the analysis of data on a 
geographical basis, which involves a conversion from 
postcodes to the Australian Bureau of Statistics (ABS) postal 
areas. This conversion results in some inaccuracy of 
information. However, in some data sets postcode is the only 
geographic identifier, therefore the use of other more accurate 
indicators is not always possible.  
When dealing with aggregate data, postal areas, converted 
from postcodes, can be mapped to Australian Statistical 
Geography Standard codes using an ABS concordance. 
The mailing postcode should only be used for correspondence 
purposes, and not for the calculation of geographic region or 
socioeconomic status in Indicators 1.2 and 1.3, unless there is 
no other postcode information stored for the woman. The 
postcode associated with the woman’s usual residence 
provides a more accurate indication of the geographic region 
and socioeconomic status in Indicators 1.2 and 1.3, since the 
denominator populations are derived from place of usual 
residence. 
Guide for use When used to supply data to the AIHW, it is preferable for the 
residential postcode to be “at the time of test”. 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 8 Person (address)Australian 
postcode, {NNNN} 
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A16 Woman—mailing address, text [X(180)] 
Identifying and definitional attributes 
Data element name Mailing address 
Definition The address where a woman prefers all correspondence to be 
delivered. 
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [X(180)] 
Maximum character length 180 
Data element attributes 
Collection and usage attributes 
Guide for use This should be collected if a woman has a different address to which 
she would prefer correspondence sent. 
Address is a composite of one or more standard address 
components that describes a low level of geographical/physical 
description of a location. Used in conjunction with the other high-
level address components i.e. Suburb/town/locality, Postcode - 
Australian, Australian state/territory, and Country, forms a complete 
geographical/physical address of a woman. 
Residential or a postal (mailing) address should be provided for a 
woman. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references  
  
 38 National Cervical Cancer Prevention Data Dictionary Version 1 
A17 Woman—mailing suburb/town/locality name, text 
[A(50)] 
Identifying and definitional attributes 
Data element name Mailing suburb/town/locality name 
Definition The suburb/town/locality where a woman prefers all correspondence 
to be delivered. 
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [A(50)] 
Maximum character length 50 
Data element attributes 
Collection and usage attributes 
Guide for use This should be collected if a woman has a different address to which 
she would prefer correspondence sent. 
Suburb/town/locality is the text that represents the full name of the 
locality contained within the specific address of a woman. 
The suburb/town/locality name, may be a town, city, suburb or 
commonly used location name such as a large agricultural property 
or Aboriginal community. The Australian Bureau of Statistics has 
suggested that a maximum field length of 50 characters should be 
sufficient to record the vast majority of locality names. This metadata 
item may be used to describe the location of woman, organisation or 
event. It can be a component of a street or postal address. 
If there is no data for this item please refer to 'Woman—alternative or 
other names for suburb/town/locality' as this may contain an 
alternative name the locality can be known by. 
Residential or a postal (mailing) address should be provided for a 
woman. 
Collection methods Enter 'Unknown' when the locality name or geographic area for a 
woman or event is not known. Enter 'No fixed address' when a 
woman has no fixed address or is homeless.  
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 5 Person 
(address)suburb/town/locality name, text [A(50)] 
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A18 Woman—mailing alternative or other names for 
suburb/town/locality, text [A(50)] 
Identifying and definitional attributes 
Data element name Mailing alternative or other names for suburb/town/locality 
Definition The alternative name or other name of the suburb/town/locality (for 
example an Indigenous name or a colloquial name for a locality that 
is different to the official or commonly used name) where a woman 
prefers all correspondence to be delivered. 
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [A(50)] 
Maximum character length 50 
Data element attributes 
Collection and usage attributes 
Guide for use The alternative name or other name of the suburb/town/locality is, for 
example, an Indigenous name or a colloquial name for a locality that 
is different to the official or commonly used name, that is contained 
within the specific address of a woman. 
The alternative or other name for a suburb/town/locality may be used 
instead of, or in addition to, the official or commonly used name of 
the locality. 
Collection methods If there is not an alternative or other name for a locality other than 
the official or commonly used name, then do not enter any data for 
this item.  
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 6 Personalternative or other 
names for suburb/town/locality, text [A(50)] 
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A19 Woman—mailing Australian state/territory name, code 
{AA[A]} 
Identifying and definitional attributes 
Data element name Mailing Australian state/territory name 
Definition The name of the Australian state or territory for the address where a 
woman prefers all correspondence to be delivered. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type Text 
Format {AA[A}} 
Maximum character length 3 
Permissible values Value Meaning 
 NSW New South Wales 
 VIC Victoria 
 QLD Queensland 
 WA Western Australia  
 SA South Australia 
 TAS Tasmania 
 ACT Australian Capital Territory  
 NT Northern Territory 
Data element attributes 
Collection and usage attributes 
Guide for use This data element is not mandatory for collection by state and 
territory cervical screening registers. 
Where it is collected, it is preferable if this is known to be the 
state or territory of the mailing address, rather than derived 
from the mailing address postcode alone, although this may 
not be possible.  
The order presented here is the standard for the Australian 
Institute of Health and Welfare, and reflects the current order 
of states and then territories in order of most populated to 
least populated. 
Residential or a postal (mailing) address should be provided 
for a woman. 
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A20 Woman—mailing Australian postcode, code {NNNN} 
Identifying and definitional attributes 
Data element name Mailing Australian postcode 
Definition The code that represents a postal delivery area, aligned with locality, 
suburb or place for the address where a woman prefers all 
correspondence to be delivered. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format {NNNN} 
Maximum character length 4 
Collection and usage attributes 
Comments Must accept zero as the leading digit to accommodate all Australian 
postcodes. 
The mailing postcode should only be used for correspondence 
purposes, and not for the calculation of geographic region or 
socioeconomic status in Indicators 1.2 and 1.3, unless there is no 
other postcode information stored for the woman. The postcode 
associated with the woman’s usual residence provides a more 
accurate indication of the geographic region and socioeconomic 
status in Indicators 1.2 and 1.3, since the denominator populations 
are derived from place of usual residence. 
Residential or a postal (mailing) address should be provided for a 
woman. 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 8 Person (address)Australian 
postcode, {NNNN} 
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A21 Woman—hysterectomy status, code N 
Identifying and definitional attributes 
Data element name Hysterectomy status 
Definition An indication as to whether a woman has had a total hysterectomy 
(removal of uterus and cervix). 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format N 
Maximum character length 1 
Permissible values Value Meaning 
 0 No hysterectomy reported 
 1 Hysterectomy reported 
Collection and usage attributes 
Business rule If A22 is populated, A21 must equal 1. 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 13 
PersonHysterectomy status, code N  
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A22 Woman—date of hysterectomy, date {DDMMYYYY} 
Identifying and definitional attributes 
Data element name Date of hysterectomy 
Definition The date a woman underwent a total hysterectomy (removal of 
uterus and cervix). 
Collection status Conditional 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format {DDMMYYYY} 
Maximum character length 8 
Collection and usage attributes 
Guide for use While it is preferable that this be an accurate date of a reported 
hysterectomy, part of the date may need to be estimated. 
Collection methods The collection of data for this data element is conditional on a 
woman having had a total hysterectomy. 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 14 Persondate of 
hysterectomy, date DDMMYYYY  
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A23 Woman—active status, code A 
Identifying and definitional attributes 
Data element name Active status 
Definition An indication as to whether a woman record is active or inactive  
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format A 
Maximum character length 1 
Permissible values Value Meaning 
 A Active 
 I Inactive 
Collection and usage attributes 
Guide for use Active status is to be used to reflect whether a woman’s 
record on the register is active or inactive. 
An ‘inactive’ record may be for any of a number of reasons, 
such as a request from the woman to not be contacted by the 
register, or because she has ‘opted off’ the register.  
‘Inactive’ will only indicate that a woman has ‘opted off’ the 
register in the states and territories in which test results for 
these woman are kept on the register; in those states and 
territories who remove all records for the woman, their 
inactive status will be removed along with all other details 
(see Appendix B for the different data implications for ‘opt off’ 
for states and territories). 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers  
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 35 Personregistry contact 
suspension flag, code N  
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A24 Woman—vital status, code [N] 
Identifying and definitional attributes 
Data element name Vital status 
Definition An indication as to whether a woman is alive or deceased. 
Context These data are essential to ensure that correspondence is not sent 
to deceased people to avoid potential distress for the woman's family 
or friends. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format [N] 
Maximum character length 1 
Permissible values Value Meaning 
 0 Alive 
 1 Deceased 
Collection and usage attributes 
Guide for use Most cervical screening registries record status and vital status as 
separate data elements. 
Business rule If A25 is populated, A24 must equal 1. 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references: Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 36 Personvital status, code N  
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A25 Woman—date of death, date {DDMMYYYY} 
Identifying and definitional attributes 
Data element name Date of death 
Definition The date of death of the woman.  
Context Required to prevent screening reminder letters or other 
correspondence being sent to people. 
Collection status Conditional 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format {DDMMYYYY} 
Maximum character length 8 
Collection and usage attributes 
Guide for use Record the date of death. 
This data element should always be recorded as an 8-digit valid date 
comprising day, month and year. Year should always be recorded in 
its full 4 digit format. For days and months with a numeric value of 
less than 10, zeros should be used to ensure that the date contains 
the required 8 digits. For example if the woman dies on 1 July 2005 
the Date of death should be recorded as 01072005 as specified in 
the representational layout. 
Collection methods If an accurate date of death cannot be recorded then do not enter 
any data, the completion of ‘Person—vital status’ will be sufficient. 
Data element attributes 
Collection and usage attributes 
Guide for use This item should only be recorded if notification of a death is 
received by the cervical screening registries.  
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 37 Womandate of death, 
DDMMYYYY  
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Vaccination data elements 
V1 Vaccination —HPV vaccine type, code N .........................................................................................48 
V2 Vaccination—HPV vaccination status, code N .................................................................................49 
V3 Vaccination—HPV vaccination completion date, date {DDMMYYYY} .............................................51 
V4 Vaccination—HPV vaccination episode date, date DDMMYYYY .....................................................52 
V5 Vaccination—HPV vaccine dose number, code [NN] .......................................................................53 
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V1 Vaccination —HPV vaccine type, code N 
Identifying and definitional attributes 
Data element name HPV vaccine type 
Definition The specific HPV vaccine used. 
Collection status Potential (requires development) 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format N 
Maximum character length 1 
Permissible values Value Meaning 
 1 Gardasil 
 2 Cervarix 
 8 Other 
 9 Unknown 
Collection and usage attributes 
Guide for use  
Data element attributes 
Collection and usage attributes 
Guide for use  
Source and reference attributes 
Origin National HPV Vaccination Program Register 
Relational attributes 
Related metadata references  
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V2 Vaccination—HPV vaccination status, code N 
Identifying and definitional attributes 
Data element name HPV vaccination status 
Definition An indication as to whether a woman is vaccinated against HPV. 
Collection status Potential (requires development) 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format N 
Maximum character length 1 
Permissible values Value Meaning 
 0 Unvaccinated 
 1 Complete 
 2 Incomplete 
 3 Too close 
 9 Unknown 
Collection and usage attributes 
Guide for use Vaccination status is according to clinical completion status, 
which is determined by the National HPV Vaccination 
Program Register (NHVPR), based on an algorithm that 
considers number of doses and length of time between 
doses.  
Definition of ‘unvaccinated’ refers to girls or women who have 
never received a dose of HPV vaccine, and as such, will not 
appear on the NHVPR. 
‘Complete’ refers to girls or women who received a full 
course of HPV vaccine at adequate intervals; ‘incomplete’ 
refers to girls or women who received only one or two doses 
of HPV vaccine rather than the currently recommended three 
doses; ‘too close’ refers to girls or women who received their 
HPV vaccine doses too close together, and as such their 
clinical status is uncertain. 
Definitions of ‘complete’, ‘incomplete’ and ‘too close’ are 
subject to change based on future research findings. 
A vaccination status of ‘unknown’ is to be used for girls or 
women who are on the NHVPR, but do not have a valid 
clinical completion status. These girls or women should not 
be interpreted as ‘unvaccinated’, which is to be reserved for 
girls or women who have never received a dose of HPV 
vaccine, and therefore do not appear on the NHVPR. 
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Data element attributes 
Collection and usage attributes 
Guide for use  
Source and reference attributes 
Origin National HPV Vaccination Program Register 
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V3 Vaccination—HPV vaccination completion date, date 
{DDMMYYYY} 
Identifying and definitional attributes 
Data element name HPV vaccination completion date 
Definition The date on which a woman is considered completely vaccinated 
with HPV vaccine.  
Context  
Collection status Potential (requires development) 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format {DDMMYYYY} 
Maximum character length 8 
Collection and usage attributes 
Guide for use Record the date that a girl or woman received an HPV vaccine 
dose that changed her status to ‘complete’ according to her 
clinical completion status, as shown in ‘V2 Woman—HPV 
vaccination status, code N’. 
This data element should always be recorded as an 8-digit valid 
date comprising day, month and year. Year should always be 
recorded in its full 4 digit format. For days and months with a 
numeric value of less than 10, zeros should be used to ensure 
that the date contains the required 8 digits. For example 1 July 
2007 should be recorded as 01072007 as specified in the 
representational layout. 
Business rule If V2 equals 1 (‘complete’), V3 must be populated. 
Data element attributes 
Collection and usage attributes 
Guide for use  
Source and reference attributes 
Origin National HPV Vaccination Program Register 
Relational attributes 
Related metadata 
references 
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V4 Vaccination—HPV vaccination episode date, date 
DDMMYYYY 
Identifying and definitional attributes 
Data element name HPV vaccination episode date 
Definition The date on which a woman receives an HPV vaccine dose.  
Context  
Collection status Potential (requires development) 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format DDMMYYYY 
Maximum character length 8 
Collection and usage attributes 
Guide for use Record the date of a woman’s vaccination episode. A separate 
episode date should be recorded for each dose a girl or woman 
receives. This can be any number one to many. 
This data element should always be recorded as an 8-digit valid date 
comprising day, month and year. Year should always be recorded in 
its full 4 digit format. For days and months with a numeric value of less 
than 10, zeros should be used to ensure that the date contains the 
required 8 digits. For example 1 July 2007 should be recorded as 
01072007 as specified in the representational layout. 
Collection methods  
Data element attributes 
Collection and usage attributes 
Guide for use  
Source and reference attributes 
Origin National HPV Vaccination Program Register 
Relational attributes 
Related metadata references  
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V5 Vaccination—HPV vaccine dose number, code [NN] 
Identifying and definitional attributes 
Data element name HPV vaccine dose number 
Definition The dose of HPV vaccine 
Collection status Potential (requires development) 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format [NN] 
Maximum character length 2 
Collection and usage attributes 
Guide for use Most girls and women receive either 1, 2 or 3 doses, but there 
can be more doses given under particular circumstances, and 
it is not yet known whether booster doses will need to be 
administered. 
Data element attributes 
Collection and usage attributes 
Guide for use  
Source and reference attributes 
Origin National HPV Vaccination Program Register 
Relational attributes 
Related metadata 
references 
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Provider data elements 
B1 Provider requesting test—Medicare provider number, Identifier X[X(7)] ..........................................55 
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National Cervical Cancer Prevention Data Dictionary Version 1 55 
B1 Provider requesting test—Medicare provider number, 
Identifier X[X(7)] 
Identifying and definitional attributes 
Data element name Medicare provider number  
Synonymous names Provider number 
Definition The Medicare provider number of the provider requesting a test. 
Collection status Essential 
Value domain representational attributes 
Representation class Identifier 
Data type String 
Format X[X(7)] 
Maximum character length 8 
Collection and usage attributes 
Guide for use Provider requesting test is the provider who is responsible for 
the test. Of the occupations of providers who collect specimens 
listed in B12, only general practitioners, nurse practitioners and 
specialists have a Medicare provider number, and can 
therefore be considered responsible for the test. 
However, the provider requesting the test is not necessarily the 
provider who collects the specimen; for example a person 
without a provider number (such as a registered nurse) may 
collect the sample in which case the provider number will be 
the provider number of the person who is considered 
responsible for the test (B12, B13, B14 and B15 are data items 
specific for provider collecting specimen if different to provider 
requesting the test). 
The Medicare-issued provider number is not always known or 
available. In these cases, a dummy provider number unique to 
the practitioner may be used. A generic dummy value of 
0000000Y may also be used, if there is no requirement for the 
dummy number to be unique to the practitioner.  
Comments Medicare provider numbers are allocated to individual 
providers and organisations to support payments and claims 
through government schemes such as Medicare Benefits and 
Pharmaceutical Benefits Schemes. 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 15 Provider taking 
specimenprovider identifier, Identifier N[N(11)] A 
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B2 Provider requesting test—healthcare provider identifier 
– individual (HPI-I), identifier {N(16)} 
Identifying and definitional attributes 
Data element name Requesting healthcare provider identifier – individual (HPI-I) 
Synonymous names Requesting HPI-I 
Definition The healthcare provider identifier - individual (HPI-I) of the provider 
requesting a test. 
A healthcare provider identifier - individual (HPI-I) is a unique 16 digit 
number that will be allocated to healthcare providers involved in 
providing patient care. 
Collection status Aspirational 
Value domain representational attributes 
Representation class Identifier 
Data type Number 
Format {N(16)} 
Maximum character length 16 
Collection and usage attributes 
Guide for use  
Data element attributes 
Collection and usage attributes 
Origin National E-Health Transition Authority (NEHTA) 
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B3 Provider requesting test—healthcare provider identifier 
– organisation (HPI-O), identifier {N(16)} 
Identifying and definitional attributes 
Data element name Requesting healthcare provider identifier – organisation 
 (HPI-O) 
Synonymous names Requesting HPI-O 
Definition The healthcare provider identifier – organisation (HPI-O) of the 
provider requesting a test. 
A healthcare provider identifier – organisation (HPI-O) is a unique 16 
digit number that will be allocated to organisations (such as a 
hospital or medical clinic) where healthcare is provided. 
Collection status Aspirational 
Value domain representational attributes 
Representation class Identifier 
Data type Number 
Format {N(16)} 
Maximum character length 16 
Collection and usage attributes 
Guide for use  
Data element attributes 
Collection and usage attributes 
Origin National E-Health Transition Authority (NEHTA) 
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B4 Provider requesting test—family name, text X[X(39)] 
Identifying and definitional attributes 
Data element name Provider family name 
Definition The part of a name a provider requesting a test usually has in 
common with some other members of his/her family(s), as 
distinguished from his/her given names. 
Context Administrative purposes and individual identification. 
Collection status Essential 
Value domain representational attributes 
Representation class Text 
Data type String 
Format X[X(39)] 
Maximum character length 40 
Collection and usage attributes 
Guide for use  
Data element attributes 
Collection and usage attributes 
Guide for use The agency or establishment should record the full family name of a 
person requesting a test on their information systems. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 16 Provider taking 
specimenfamily name, text X[X(39)]  
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B5 Provider requesting test—given names, text X[X(39)] 
Identifying and definitional attributes 
Data element name Provider given names 
Definition The given names or initial(s) of a provider requesting a test. 
Context Administrative purposes and individual identification. 
Collection status Essential 
Value domain representational attributes 
Representation class Text 
Data type String 
Format X[X(39)] 
Maximum character length 40 
Data element attributes 
Collection and usage attributes 
Guide for use The agency or establishment should record the full given name(s) 
of a person requesting a test on their information systems.  
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 17 Provider taking 
specimengiven names, text [X(40)]  
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B6 Provider requesting test—name of practice or medical 
centre, text [X(200)] 
Identifying and definitional attributes 
Data element name Name of practice or medical centre 
Definition The name of the practice or medical centre of the provider 
requesting a test. 
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [X(200)] 
Maximum character length 200 
Data element attributes 
Collection and usage attributes 
Guide for use The practice or medical centre should relate to the practice or 
medical centre at which the requesting provider is located.  
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 18 Provider taking specimen–
name of practice or medical centre, text [X(200)]  
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B7 Provider requesting test—practice address, text 
X[X(179)] 
Identifying and definitional attributes 
Data element name Practice address 
Definition The address where the practice of the provider requesting a test is 
located. 
Collection status Essential 
Value domain representational attributes 
Representation class Text 
Data type String 
Format X[X(179)] 
Maximum character length 180 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 19 Provider taking specimen 
(practice address)address line, text [X(180)]  
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B8 Provider requesting test—practice suburb/town/locality 
name, text A[A(49)] 
Identifying and definitional attributes 
Data element name Practice suburb/town/locality name 
Definition The suburb/town/locality where the practice of the provider 
requesting a test is located. 
Collection status Essential 
Value domain representational attributes 
Representation class Text 
Data type String 
Format A[A(49)] 
Maximum character length 50 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 20 Provider taking specimen 
(practice address)practice suburb/town/locality name, text [A(50)]  
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B9 Provider requesting test—alternative or other names for 
suburb/town/locality, text [A(50)] 
Identifying and definitional attributes 
Data element name Practice alternative or other names for suburb/town/locality 
Definition The alternative name or other name of the suburb/town/locality (for 
example an Indigenous name or a colloquial name for a locality that 
is different to the official or commonly used name) where the practice 
of the provider requesting a test is located. 
Collection status Desirable 
Value domain representational attributes 
Representation class Text 
Data type String 
Format [A(50)] 
Maximum character length 50 
Data element attributes 
Collection and usage attributes 
Guide for use The alternative or other name for a suburb/town/locality, may be 
used instead of, or in addition to, the official or commonly used name 
of the locality. 
Collection methods If there is not an alternative or other name for a locality other than 
the official or commonly used name, then do not enter any data for 
this item. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 21 Provider taking specimen 
(practice address)alternative or other names for 
suburb/town/locality, text [A(50)]  
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B10 Provider requesting test—Australian state/territory 
name, code AA{A} 
Identifying and definitional attributes 
Data element name Australian state/territory name 
Definition The name of the Australian state or territory in which the provider 
requesting a test is located. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type Text 
Format AA{A} 
Maximum character length 3 
Permissible values Value Meaning 
 NSW New South Wales 
 VIC Victoria 
 QLD Queensland 
 WA Western Australia  
 SA South Australia 
 TAS Tasmania 
 ACT Australian Capital Territory  
 NT Northern Territory 
Data element attributes 
Collection and usage attributes 
Guide for use The order presented here is the standard for the Australian Institute 
of Health and Welfare, and reflects the current order of states and 
then territories in order of most populated to least populated. 
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B11 Provider requesting test—Australian postcode, code 
NNNN 
Identifying and definitional attributes 
Data element name Practice postcode 
Definition The code that represents a postal delivery area, aligned with locality, 
suburb or place for the practice where a provider requesting a test is 
located. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format NNNN 
Maximum character length 4 
Collection and usage attributes 
Comments Must accept zero as the leading digit to accommodate all Australian 
postcodes. 
Australian Postcode may be used in the analysis of data on a 
geographical basis, which involves a conversion from postcodes to 
the Australian Bureau of Statistics (ABS) postal areas. This 
conversion results in some inaccuracy of information. However, in 
some data sets postcode is the only geographic identifier, therefore 
the use of other more accurate indicators is not always possible.  
When dealing with aggregate data, postal areas, converted from 
postcodes, can be mapped to Australian Statistical Geography 
Standard codes using an ABS concordance 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 22 Provider taking specimen 
(practice address)postcode, code {NNNN}  
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B12 Provider collecting specimen—occupation of person 
collecting specimen, code {A} 
Identifying and definitional attributes 
Data element name Collecting provider occupation 
Definition The occupation of the person who collects a specimen. 
Context Administrative purposes. 
Collection status Aspirational  
Value domain representational attributes 
Representation class Code 
Data type String 
Format {A} 
Maximum character length 1 
Permissible values Value Meaning 
 G General practitioner 
 N Nurse Practitioner 
 R Registered Nurse/Midwife 
 E Enrolled Nurse 
 S Specialists (Obstetricians and gynaecologists) 
 A Aboriginal and Torres Strait  
Islander health care worker 
 O Other 
 U Unassigned 
Collection and usage attributes 
Guide for use The occupation needs to reflect the occupation of the person who 
collected the specimen, not on the occupation of the provider 
number under which the specimen was collected (i.e. if a registered 
nurse collects the specimen under a GP’s provider number, the 
occupation needs to be recorded as nurse, not GP).  
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 23 Provider taking 
specimenoccupation of person taking specimen, code A 
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B13 Provider collecting specimen—identifier, identifier 
[X(20)] 
Identifying and definitional attributes 
Data element name Collecting provider identifier 
Definition Identifier number of the provider collecting specimen. 
Collection status Desirable 
Value domain representational attributes 
Representation class Identifier 
Data type String 
Format [X(20)] 
Maximum character length 20 
Collection and usage attributes 
Guide for use This identifier allows for the collection of a number allocated to a 
provider collecting specimen that is not a Medicare provider number; 
for example registered nurse Pap test providers do not have a 
Medicare provider number (the provider number of the general 
practitioner or specialist responsible for the test will be used), but may 
have an identifying number. 
Data element attributes 
Collection and usage attributes 
Origin State and Territory cervical screening registers 
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B14 Provider collecting specimen—healthcare provider 
identifier – individual (HPI-I), identifier {N(16)} 
Identifying and definitional attributes 
Data element name Collecting healthcare provider identifier – individual (HPI-I) 
Synonymous names Collecting HPI-I 
Definition A healthcare provider identifier - individual (HPI-I) is a unique 16 digit 
number that will be allocated to healthcare providers involved in 
providing patient care. 
Collection status Aspirational 
Value domain representational attributes 
Representation class Identifier 
Data type Number 
Format {N(16)} 
Maximum character length 16 
Collection and usage attributes 
Guide for use  
Data element attributes 
Collection and usage attributes 
Origin National E-Health Transition Authority (NEHTA) 
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B15 Provider collecting specimen—healthcare provider 
identifier – organisation (HPI-O), identifier {N(16)} 
Identifying and definitional attributes 
Data element name Collecting healthcare provider identifier – organisation  
(HPI-O) 
Synonymous names Collecting HPI-O 
Definition The healthcare provider identifier – organisation (HPI-O) of 
the provider collecting specimen. 
A healthcare provider identifier – organisation (HPI-O) is a 
unique 16 digit number that will be allocated to organisations 
(such as a hospital or medical clinic) where healthcare is 
provided. 
Collection status Aspirational 
Value domain representational attributes 
Representation class Identifier 
Data type Number 
Format {N(16)} 
Maximum character length 16 
Collection and usage attributes 
Guide for use  
Data element attributes 
Collection and usage attributes 
Origin National E-Health Transition Authority (NEHTA) 
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Laboratory data elements 
L1 Laboratory—pathology laboratory identifier, identifier XXX ..............................................................71 
L2 Laboratory—laboratory receipt date, date DDMMYYYY ...................................................................72 
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L1 Laboratory—pathology laboratory identifier, identifier 
XXX 
Identifying and definitional attributes 
Data element name 
Synonymous names 
Pathology laboratory identifier 
Lab code 
Definition A unique identification that cervical screening registers allocate to 
the laboratories that perform analyses on cervical screening tests. 
Collection status Essential 
Value domain representational attributes 
Representation class Identifier 
Data type String 
Format XXX 
Maximum character length 3 
Data element attributes 
Collection and usage attributes 
Collection methods Provided by pathology laboratories. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 24 Pathology 
laboratorylaboratory, identifier X(3)  
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L2 Laboratory—laboratory receipt date, date DDMMYYYY 
Identifying and definitional attributes 
Data element name Laboratory receipt date. 
Definition The date when a specimen was received by the laboratory. 
Context Used in reporting Part A Lab Performance Measures for the RCPA 
QAP for Laboratories Reporting Cytology. 
Collection status Desirable 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format DDMMYYYY 
Maximum character length 8 
Data element attributes 
Collection and usage attributes 
Collection methods Provided by pathology laboratories. 
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Test type data element 
T1 Type of test—code A 
Identifying and definitional attributes 
Data element name Type of test 
Definition Whether a specimen is sent to the laboratory for cytological 
examination, histological examination, or for detection of Human 
Papillomavirus (HPV) DNA. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format A 
Maximum character length 1 
Permissible values Value Meaning 
 C Cytology 
 H Histology 
 V HPV test 
Data element attributes 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 26 Pathology 
laboratorytest type, code AN 
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Cytology test data elements 
C1 Cytology test—laboratory accession number, identifier X[X(19)] .....................................................75 
C2 Cytology test—date of cytology test, date DDMMYYYY ..................................................................76 
C3 Cytology test—cytology specimen site, code AN .............................................................................77 
C4 Cytology test—cytology specimen type, code AN ............................................................................79 
C5 Cytology test—squamous cytology cell analysis, code AX ..............................................................81 
C6 Cytology test—endocervical (glandular) cytology cell analysis, code AX ........................................83 
C7 Cytology test—other/non-cervical cytology cell analysis, code AX ..................................................85 
C8 Cytology test—follow-up recommendation, code AX .......................................................................87 
C9 Cytology test—cytology result, code {AA} ........................................................................................89 
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C1 Cytology test—laboratory accession number, identifier 
X[X(19)] 
Identifying and definitional attributes 
Data element name 
Synonymous names 
Laboratory accession number for cytology test 
Cytology lab specimen ID 
Cytology lab record ID 
Definition A unique record identifier allocated by the cervical screening 
laboratory to a cervical specimen to distinguish it from all other 
specimens analysed by the laboratory. 
Collection status Essential 
Value domain representational attributes 
Representation class Identifier 
Data type String 
Format X[X(19)] 
Maximum character length 20 
Data element attributes 
Collection and usage attributes 
Collection methods Provided by pathology laboratories. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 25 Pathology 
laboratorycervical cytology accession number X(20) 
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C2 Cytology test—date of cytology test, date DDMMYYYY 
Identifying and definitional attributes 
Data element name 
Synonymous names 
Date of cytology test 
Cytology collection date 
Definition The date when a specimen was collected. 
Collection status Essential 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format DDMMYYYY 
Maximum character length 8 
Collection and usage attributes 
Guide for use Laboratory receipt date (L2) can be used instead of test date (C2), 
if date of cytology test is not known 
Data element attributes 
Collection and usage attributes 
Collection methods Provided by pathology laboratories. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 12 Persondate of 
cervical cytology screening specimen, date DDMMYYYY 
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C3 Cytology test—cytology specimen site, code AN 
Identifying and definitional attributes 
Data element name Cytology specimen site 
Definition The site from where a specimen of cells has been collected for the 
purpose of screening for cancer or pre-cancerous changes. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AN 
Maximum character length 2 
Permissible values Value Meaning 
 B1 Cervical 
 B2 Vaginal (with or without an intact cervix) 
 B3 Other gynaecological site 
 B0 Not stated 
Collection and usage attributes 
Guide for use B2 when T1 Type of test is C (cytological specimen): 
A vaginal sample can be collected whether or not a woman has an 
intact cervix; this item is meant to represent only an anatomical 
description of the origin of the specimen. It is the supplementary use 
of E- in item ’C6 Cytology test—endocervical (glandular) cell 
analysis, cytology code XX’ that indicates a vault smear, not the 
anatomical site sampled.  
To code a vault smear: record B2 for item ’C3 Cytology test—
specimen site, cytology code AN’ and E- for item ’C6 Cytology test—
endocervical (glandular) cell analysis, cytology code XX’.  
(NOTE: The use of B2 will be almost exclusively indicative of vault 
samples because ‘vaginal only’ smears in women with intact cervices 
are uncommon; however it is important to be able to distinguish 
whether a specimen is a vault smear or not for accurate reporting 
purposes.) 
Data element attributes 
Collection and usage attributes 
Collection methods Provided by pathology laboratories. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents National Cervical Cytology Coding Sheet, For Use by the Cervical 
Cytology Registries, Edition Date: 9 September 2005 
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Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 30 Personcervical cytology 
specimen site, cervical cytology screening code, AN 
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C4 Cytology test—cytology specimen type, code AN 
Identifying and definitional attributes 
Data element name Cytology specimen type 
Definition The type of specimen collected for the purpose of screening for 
cancer or pre-cancerous changes. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AN 
Maximum character length 2 
Permissible values Value Meaning 
A1 Conventional smear 
A2 Liquid based specimen 
A3 Conventional and liquid based specimen 
A0 Not stated 
 
Collection and usage attributes 
Guide for use A1 Conventional smear 
The Pap smear is a test whereby exfoliated cells are collected from 
the cervix and are transferred to a slide for staining and microscopic 
evaluation by a pathologist, cytologist or specially trained technician. 
A2 Liquid based specimen  
A liquid based specimen is where the sampling instrument/s is rinsed 
in a vial of fluid fixative which is processed to produce a 'monolayer' of 
cells on the slide. This facilitates reading of the slide either by 
cytotechnologist or by machine.  
A3 Conventional and liquid based specimen 
When both a liquid based specimen and a conventional (Pap) smear 
are obtained for examination. 
A0 Not stated 
This code should be used when there is no information on the type of 
screening test provided. 
Data element attributes 
Collection and usage attributes 
Collection methods As provided by laboratories. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents National Cervical Cytology Coding Sheet, For Use by the Cervical 
Cytology Registries, Edition Date: 9 September 2005. 
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Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary Cytology 
(first) sub-set data element 29 Personcervical cytology specimen 
type, cervical cytology screening code AN 
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C5 Cytology test—squamous cytology cell analysis, code 
AX 
Identifying and definitional attributes 
Data element name Squamous cytology cell analysis 
Definition The cytological analysis of squamous cells from the ectocervix 
obtained from a specimen for the purpose of screening for cancer or 
pre-cancerous changes to the cervix. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AX 
Maximum character length 2 
Permissible values Value Meaning 
 S1 Cell numbers and preservation satisfactory. No 
abnormality or only reactive changes 
 S2 Possible low-grade squamous intraepithelial lesion 
(LSIL) 
 S3 Low-grade squamous intraepithelial lesion (LSIL) 
(HPV and/or CIN I) 
 S4 Possible high-grade squamous intraepithelial 
lesion (HSIL) 
 S5 High-grade squamous intraepithelial lesion (HSIL) 
(CIN II/CIN III) 
 S6 High-grade squamous intraepithelial lesion (HSIL) 
with possible microinvasion/ invasion 
 S7 Squamous carcinoma 
 SU Unsatisfactory for evaluation 
Collection and usage attributes 
Guide for use S1 Cell numbers and preservation satisfactory. No abnormality or 
only reactive changes 
Record this code where there is no abnormality detected and cell 
numbers and preservation is satisfactory.  
S2 Possible low-grade squamous intraepithelial lesion (LSIL) 
This code encompasses changes in squamous cells where the 
reporting cytologist/pathologist believes the changes may represent 
a low grade squamous intraepithelial lesion but no definitive changes 
are present.  
S3 Low grade squamous intraepithelial lesion (LSIL)  
Record this code where the cytologist/pathologist observes changes 
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which would have been described as HPV effect or CIN I (i.e. 
incorporates HPV effect and/or CIN I).  
S4 Possible high grade squamous intraepithelial lesion (HSIL) 
Record this code when the presence of a high grade squamous 
abnormality such as CIN II, CIN III or SCC is suspected but the 
changes are insufficient to justify a confident cytological prediction of 
a high grade lesion.  
S5 High grade squamous intraepithelial lesion (HSIL) 
Record this code where the changes observed would have 
previously been described as CIN II or CIN III (i.e. code S5 
incorporates CIN II & CIN III.)  
S6 High grade squamous intraepithelial lesion (HSIL) with possible 
invasion 
Record this code when a definite HSIL is present, but the possibility 
of invasion cannot be excluded. 
 S7 Squamous carcinoma 
Record this when squamous carcinoma is present. 
 SU Unsatisfactory for evaluation  
Record this code if the specimen is unable to be assessed due to 
poor cellularity, poor preservation, cell detail obscured by 
inflammation/blood/degenerate cells.  
Data element attributes 
Collection and usage attributes 
Collection methods As provided by laboratories. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents National Cervical Cytology Coding Sheet, For Use by the Cervical 
Cytology Registries, Edition Date: 9 September 2005. 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 31 Person squamous cell 
analysis, cervical cytology screening code XX 
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C6 Cytology test—endocervical (glandular) cytology cell 
analysis, code AX 
Identifying and definitional attributes 
Data element name Endocervical (glandular) cytology cell analysis 
Definition The cytological analysis of endocervical (glandular) cells obtained 
from a specimen for the purpose of screening for cancer or pre-
cancerous changes to the cervix. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AX 
Maximum character length 2 
Permissible values Value Meaning 
 E0 No endocervical component 
 E- Not applicable: vault smear/previous hysterectomy 
 E1 Endocervical component present. No abnormality or 
only reactive changes 
 E2 Atypical endocervical cells of uncertain significance 
 E3 Possible high-grade endocervical glandular lesion 
 E4 Adenocarcinoma-in-situ 
 E5 Adenocarcinoma-in-situ with possible 
microinvasion/invasion 
 E6 Adenocarcinoma 
 EU Due to unsatisfactory nature of the smear, no 
assessment has been made 
Collection and usage attributes 
Guide for use E0 No endocervical component 
Record this when there is no endocervical component. 
E- Not applicable: vault smear/previous hysterectomy 
Record this when it is a vault smear or there has been a previous 
total hysterectomy. 
E1 Endocervical component present. No abnormality or only reactive 
changes 
Record if no abnormality is detected & cell numbers & preservation is 
satisfactory. 
E2 Atypical endocervical cells of uncertain significance 
Record where abnormal glandular cells are identified in a cervical 
cytology sample, but where the degree of abnormality is not 
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sufficient for a diagnosis of adenocarcinoma in situ to be made.  
E3 Possible high grade endocervical glandular lesion  
Record if adenocarcinoma in situ is suspected but a confident 
prediction is not possible.  
E4 Endocervical adenocarcinoma in situ 
Record when the reporting cytologist/pathologist is confident of the 
presence of an adenocarcinoma in situ.  
E5 Endocervical adenocarcinoma in situ with possible invasion  
Record this when a definite adenocarcinoma in situ is present, but 
the possibility of invasion cannot be excluded.  
E6 Endocervical adenocarcinoma  
Record this when a definite adenocarcinoma is present. 
EU Due to the unsatisfactory nature of the smear, no assessment 
has been made. 
Unable to be assessed due to poor cellularity, poor preservation, cell 
detail obscured by blood/inflammation/degenerate cells. If a smear is 
sub optimal but atypical/abnormal cells are detected, the abnormality 
overrides the unsatisfactory coding & should be coded to reflect the 
abnormality detected. 
Data element attributes 
Collection and usage attributes 
Collection methods As provided by laboratories. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents National Cervical Cytology Coding Sheet, For Use by the Cervical 
Cytology Registries, Edition Date: 9 September 2005. 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 32 Person endocervical cell 
analysis, cervical cytology screening code XX 
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C7 Cytology test—other/non-cervical cytology cell 
analysis, code AX  
Identifying and definitional attributes 
Data element name Other/non-cervical cytology cell analysis 
Definition The cytological analysis of other/non-cervical cells (cells from 
areas of the woman’s genital tract other than the cervix) 
obtained from a specimen for the purpose of screening for 
cancer or pre-cancerous changes. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AX 
Maximum character length 2 
Permissible values Value Meaning 
 O1 No other abnormal cells.  
 O2 Atypical endometrial cells of uncertain significance 
 O3 Atypical glandular cells of uncertain significance—
site unknown 
 O4 Possible endometrial adenocarcinoma  
 O5 Possible high-grade lesion—non-cervical 
 O6 Malignant cells—uterine body 
 O7 Malignant cells—vagina 
 O8 Malignant cells—ovary 
 O9 Malignant cells—other 
 OU Due to the unsatisfactory nature of the smear, no 
assessment has been made 
Collection and usage attributes 
Guide for use O1 No other abnormal cells 
Record this where there is no abnormality detected & cell numbers & 
preservation is satisfactory.  
O2 Atypical endometrial cells of uncertain significance  
Record this where there are changes in endometrial cells, but 
insufficient to raise the possibility of an endometrial carcinoma.  
O3 Atypical glandular cells of uncertain significance—site unknown  
Record this where there is uncertainty about whether the abnormal 
cells were endocervical or endometrial in origin. Use where changes 
are insufficient to raise the possibility of a neoplasm but are beyond 
a reactive process.  
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O4 Possible endometrial adenocarcinoma 
Record this if endometrial adenocarcinoma is suspected, but a 
confident prediction is not possible.  
O5 Possible high grade lesion— non cervical  
Record if abnormal cells are present but do not appear to be 
cervical, endometrial or vaginal in origin. 
O6 Malignant cells—uterine body  
Record when malignant endometrial cells are present.  
O7 Malignant cells—vagina  
Record if malignant cells are present in a vaginal or vault smear.  
O8 Malignant cells—ovary  
Record if malignant ovarian cells are present.  
O9 Malignant cells—other 
Record if malignant cells are present which belong to none of the 
above categories. 
OU Due to the unsatisfactory nature of the smear, no assessment 
has been made 
Record this code when smear is unable to be assessed due to poor 
cellularity, poor preservation, cell detail obscured by 
blood/inflammation/degenerate cells. If a smear is sub optimal but 
atypical/abnormal cells are detected, the abnormality overrides the 
unsatisfactory coding & should be coded to reflect the abnormality 
detected. 
Data element attributes 
Collection and usage attributes 
Collection methods As provided by laboratories. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents National Cervical Cytology Coding Sheet, For Use by the Cervical 
Cytology Registries, Edition Date: 9 September 2005. 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 33 Personother/non-cervical 
cell analysis, cervical cytology screening code XX 
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C8 Cytology test—follow-up recommendation, code AX 
Identifying and definitional attributes 
Data element name Follow-up recommendation 
Definition The recommended assessment action (as per NHMRC guidelines) 
based on the cytological analysis of cells for the purpose of 
screening for cancer or pre-cancerous changes to the cervix. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AX 
Maximum character length 2 
Permissible values Value Meaning 
 R0 No recommendation 
 R1 Repeat smear 3 years 
 R2 Repeat smear 2 years 
 R3 Repeat smear 12 months 
 R4 Repeat smear 6 months 
 R5 Repeat smear 6–12 weeks 
 R6 Colposcopy/biopsy recommended 
 R7 Already under gynaecological management 
 R8 Referral to specialist 
 R9 Other management recommended 
 RS Symptomatic - Clinical management required 
Data element attributes 
Collection and usage attributes 
Collection methods As provided by laboratories. 
Note that it is the practice in some registries to base follow-up 
recommendation on an internal recommendation code which 
generates follow-up protocols that comply with the recommended 
follow-up as laid out in the NHMRC guidelines. However, laboratory 
recommendation codes should still be stored using this data 
element regardless of any further internal coding that takes place. 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents National Cervical Cytology Coding Sheet, For Use by the Cervical 
Cytology Registries, Edition Date: 9 September 2005. 
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Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Cytology (first) sub-set data element 34 Personfollow-up 
recommendation, cervical cytology screening code XX 
  
  
National Cervical Cancer Prevention Data Dictionary Version 1 89 
C9 Cytology test—cytology result, code {AA} 
Identifying and definitional attributes 
Data element name Cytology result (AIHW-derived) 
Definition Cervical cytology result based on S and E codes as defined by the 
Australian Institute of Health and Welfare for national reporting 
purposes. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type String 
Format {AA} 
Maximum character length 2 
Permissible values Value Meaning 
 CU Unsatisfactory 
 CN Negative 
 CL Low-grade 
 CH High-grade  
 CC Cancer 
Collection and usage attributes 
Guide for use Note that for the purposes of national reporting of cervical cytology to 
the Australian Institute of Health and Welfare, categories are based 
only on S and E codes, and disregards O codes (the exception to 
this is that a negative result cannot include an O code of O3, as this 
could signify an endocervical abnormality). 
CU Unsatisfactory 
An unsatisfactory cytology result is defined as  
(C5 = SU & C6 = EU) or (C5 = SU & C6 = (E0 or E1)). 
CN Negative 
A negative cytology result is defined as  
C5 = S1 and C6 = (E0 or E1) and C7  O3. 
CL Low-grade 
A low-grade cytology result is defined as  
C5 = (S2 or S3) or C6 =E2 (C5 cannot be >S3 and C6 cannot be 
>E2). 
CH High-grade 
A high-grade cytology result is defined as  
C5 = (S4 or S5 or S6) or C6 = (E3 or E4 or E5) (C5 cannot be >S6 
and C6 cannot be >E5)*. 
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CC Cervical cancer 
A cervical cancer cytology result is defined as C5 = S7 or C6 = E6. 
* this differs from how a high-grade cytology result is defined for 
follow-up purposes. 
Note, too, that while S6 and E5 are included as high-grade for AIHW 
reporting, these codes are excluded from high-grade for NPAAC 
reporting. See Cervical screening in Australia  
2009–2010 (AIHW 2012) for further details. 
Data element attributes 
Collection and usage attributes 
Collection methods State and Territory cervical screening registers. 
These are AIHW-derived definitions used for reporting purposes only 
and may differ from definitions used for other purposes. Further, 
these differ from the cytology summary codes used by State and 
territory cervical screening registries, which may incorporate O codes 
into the category definitions. For the purposes of national reporting of 
cervical cytology to the Australian Institute of Health and Welfare, 
categories are based only on S and E codes, and disregards O 
codes (the exception to this is that a negative result cannot include 
an O code of O3, as this could signify an endocervical abnormality). 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
Reference documents National Cervical Cytology Coding Sheet, For Use by the Cervical 
Cytology Registries, Edition Date: 9 September 2005 
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Histology test data elements 
H1 Histology test—laboratory accession number, identifier X[X(19)] ....................................................92 
H2 Histology test—date of histology test, date DDMMYYYY .................................................................93 
H3 Histology test—histology specimen site, code AN ...........................................................................94 
H4 Histology—procedure used for obtaining specimen for histological analysis, code AANN ..............95 
H5 Histology—squamous histology cell analysis, code AAX[XXX] ........................................................96 
H6 Histology test—endocervical (glandular) histology cell analysis, code AAX[XXX] ...........................98 
H7 Histology test—vaginal histology cell analysis, code {AAX[XXX]} ..................................................100 
H8 Histology test—other or unspecified histology cell analysis, code {AAX[N]} ..................................101 
H9 Histology test—histology result, code {AA} ....................................................................................103 
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H1 Histology test—laboratory accession number, identifier 
X[X(19)] 
Identifying and definitional attributes 
Data element name 
Synonymous names 
Laboratory accession number for histology test 
Histology specimen ID 
Histology lab record ID 
Definition A unique record identifier allocated by the cervical screening 
laboratory to a cervical specimen to distinguish it from all other 
specimens analysed by the laboratory. 
Collection status Essential 
Value domain representational attributes 
Representation class Identifier 
Data type String 
Format X[X(19)] 
Maximum character length 20 
Data element attributes 
Collection and usage attributes 
Collection methods Provided by Pathology Laboratories 
Source and reference attributes 
Origin State and Territory cervical screening registers 
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H2 Histology test—date of histology test, date DDMMYYYY 
Identifying and definitional attributes 
Data element name 
Synonymous names 
Date of histology test 
Histology collection date 
Definition The date when a specimen was collected . 
Collection status Essential 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format DDMMYYYY 
Maximum character length 8 
Collection and usage attributes 
Guide for use Laboratory receipt date (L2) can be used instead of test date (H2), if 
date of histology test is not known 
Data element attributes 
Source and reference attributes 
Origin State and Territory cervical screening registers 
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H3 Histology test—histology specimen site, code AN 
Identifying and definitional attributes 
Data element name Histology specimen site 
Definition The site from where a specimen has been collected. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AN 
Maximum character length 2 
Permissible values Value Meaning 
 B1 Cervical 
 B2 Vaginal (with or without an intact cervix) 
 B3 Other gynaecological site 
 B0 Not stated 
Collection and usage attributes 
Guide for use 
 
Cervical specimen includes all cervical histology including cervical 
polyps and cervical samples obtained during hysterectomies for 
benign conditions. 
If both cervical and non-cervical tissues are sampled, use cervical 
report.  
Data element attributes 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Reference documents Cytology Codes for use by the Cervical Screening Registries, Edition 
Date: 6 October 2004. 
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H4 Histology—procedure used for obtaining specimen for 
histological analysis, code AANN 
Identifying and definitional attributes 
Data element name Procedure for histology specimen 
Definition The type of procedure used to collect a gynaecological specimen for 
histological analysis for the purpose of assessment of cancer or pre-
cancerous changes. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AANN 
Maximum character length 4 
Permissible values Value Meaning 
HP01 Biopsy (includes directed punch and random punch) 
HP02 Endocervical curettage (includes endocervical tissue 
obtained during D&C) 
HP03 LLETZ/LEEP loop biopsy  
HP04 Cone biopsy 
HP05 Polypectomy 
HP06 Subtotal hysterectomy  
HP07 Hysterectomy  
HP09 Amputated cervix  
HP99 Not disclosed  
 
Data element attributes 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
Reference documents State and Territory cervical cytology registers 
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H5 Histology—squamous histology cell analysis, code 
AAX[XXX] 
Identifying and definitional attributes 
Data element name Cervical histology result (AIHW-derived data element) 
Definition The histological analysis of a cervical specimen (squamous cells of 
the ectocervix) for the purpose of assessment of cancer or pre-
cancerous changes. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AAX[XXX] 
Maximum character length 6 
Permissible values Value Meaning 
HS01 Negative 
HS02 Low-grade squamous abnormality 
HS03 High-grade squamous abnormality 
HS03.1 High-grade (CIN NOS) 
HS03.2 High-grade (CIN II) 
HS03.3 High-grade (CIN III) 
HS04 Squamous cell carcinoma 
HS04.1 Squamous cell carcinoma (micro-invasive) 
HS04.2 Squamous cell carcinoma (invasive) 
HSU Unsatisfactory 
HSN Not applicable 
 
Collection and usage attributes 
Guide for use 
 
These codes represent a higher level coding system to which 
specific codes from State and Territory cervical screening registers 
can be mapped, in order to more accurately collate national data. 
Collection methods Pathology laboratories send histology results to State and Territory 
cervical screening registries, and these are either coded by each 
registry to their own histology coding sheets, or SNOMED codes are 
uploaded automatically. State and Territory cervical screening 
registries then use Appendix C ‘Histology code concordances’ to 
map the histology codes stored in their register to these codes. 
Note that unsatisfactory histology results are as defined in each state 
and territory 
Data element attributes 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
Reference documents State and territory Cervical Screening Registry histology coding 
sheets 
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Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Histology (second) sub-set data element 2 Personcervical 
(squamous) specimen analysis, histology code AANN 
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H6 Histology test—endocervical (glandular) histology cell 
analysis, code AAX[XXX] 
Identifying and definitional attributes 
Data element name Endocervical (glandular) histology cell analysis 
Definition The histological analysis of an endocervical specimen 
(glandular/columnar cells of the endocervix) for the purpose of 
assessment of cancer or pre-cancerous changes. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AAX[XXX] 
Maximum character length 6 
Permissible values Value Meaning 
HE01 Negative 
HE02 Endocervical atypia 
HE03 High-grade endocervical abnormality 
HE03.1 High-grade (endocervical dysplasia) 
HE03.2 
HE03.3 
High-grade (adenocarcinoma in situ) 
High-grade (mixed carcinoma in situ/ 
adenocarcinoma in situ) 
HE04 Endocervical adenocarcinoma 
HE04.1 Endocervical adenocarcinoma (microinvasive) 
HE04.2 
HE04.3 
HE04.4 
Endocervical adenocarcinoma (invasive) 
Adenosquamous carcinoma 
Carcinoma of the cervix (other) 
HEU Unsatisfactory 
HEN Not applicable 
 
Collection and usage attributes 
Guide for use 
 
These codes represent a higher level coding system to which 
specific codes from State and Territory cervical screening registers 
can be mapped, in order to more accurately collate national data. 
Collection methods Pathology laboratories send histology results to State and Territory 
cervical screening registries, and these are either coded by each 
registry to their own histology coding sheets, or SNOMED codes are 
uploaded automatically. State and Territory cervical screening 
registries then use Appendix C ‘Histology code concordances’ to 
map the histology codes stored in their register to these codes. 
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Data element attributes 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
Reference documents State and Territory Cervical Screening Registry histology coding 
sheets 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Histology (second) sub-set data element 3 Personendocervical 
(glandular) specimen analysis, histology code AANN 
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H7 Histology test—vaginal histology cell analysis, code 
{AAX[XXX]} 
Identifying and definitional attributes 
Data element name Vaginal histology cell analysis 
Definition The histological analysis of a vaginal specimen for the purpose of 
assessment of cancer or pre-cancerous changes. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type String 
Format {AAX[XXX]} 
Maximum character length 6 
Permissible values Value Meaning 
HV01 Negative 
HV02 Low-grade vaginal abnormality 
HV03 High-grade vaginal abnormality 
HV03.1 High-grade (VAIN NOS) 
HV03.2 High-grade (VAIN II) 
HV03.3 High-grade (VAIN III) 
HV04 Squamous cell carcinoma 
HV04.1 Squamous cell carcinoma (micro-invasive) 
HV04.2 Squamous cell carcinoma (invasive) 
HVU Unsatisfactory 
HVN Not applicable 
 
Collection and usage attributes 
Guide for use 
 
These codes represent a higher level coding system. At present, 
these histology codes are not mapped. 
Collection methods Pathology laboratories send histology results to State and Territory 
cervical screening registries, and these are either coded by each 
registry to their own histology coding sheets, or SNOMED codes are 
uploaded automatically.  
Data element attributes 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
Reference documents State and Territory Cervical Screening Registry histology coding 
sheets 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Histology (second) sub-set data element 4 Personvaginal 
specimen analysis, histology code AANN 
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H8 Histology test—other or unspecified histology cell 
analysis, code {AAX[N]} 
Identifying and definitional attributes 
Data element name Other or unspecified histology cell analysis 
Definition The histological analysis of a specimen from a gynaecological site 
other than the cervix, endocervix, or vagina, for the purpose of 
assessment of cancer or pre-cancerous changes to a woman’s other 
gynaecological tissues. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type String 
Format {AAX[N]} 
Maximum character length 4 
Permissible values Value Meaning 
H_01 Negative 
H_02 Low-grade abnormality 
H_03 High-grade abnormality 
H_04 Invasive / malignant 
H_U Unsatisfactory 
H_N Not applicable 
Replace the _ symbol with the appropriate letter from the list, 
according to the site from which the specimen was collected, as 
follows. 
Value Site 
F Fallopian tube 
L Vulva 
M Endometrium 
O Ovary 
U Other or unspecified 
For example, HM02 would refer to a histology specimen collected 
from the endometrium with a low-grade abnormality 
Collection and usage attributes 
Guide for use 
 
These codes represent a higher level coding system. At present, 
these histology codes are not mapped. 
Collection methods Pathology laboratories send histology results to State and Territory 
cervical screening registries, and these are either coded by each 
registry to their own histology coding sheets, or SNOMED codes are 
uploaded automatically.  
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Data element attributes 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
Reference documents State and Territory Cervical Screening Registry histology coding 
sheets 
Relational attributes 
Related metadata references Supersedes Standardised cervical screening data dictionary 
Histology (second) sub-set data element 5 Personother or 
unspecified gynaecological specimen analysis, histology code AANN 
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H9 Histology test—histology result, code {AA} 
Identifying and definitional attributes 
Data element name Histology result (AIHW-derived) 
Definition Cervical histology result based on HS and HE codes as defined by 
the Australian Institute of Health and Welfare for national reporting 
purposes. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type String 
Format {AA} 
Maximum character length 2 
Permissible values Value Meaning 
 HU Unsatisfactory 
 HN Negative 
 HL Low-grade 
 HH High-grade  
 HC Cancer 
Collection and usage attributes 
Guide for use Note that for the purposes of national reporting of cervical histology 
to the Australian Institute of Health and Welfare, categories are 
based only on HS and HE codes. 
HU Unsatisfactory 
An unsatisfactory histology result is defined as specified in each 
state or territory, since the entire pathology result is required to make 
an evaluation. For instance, the overall findings may be 
unsatisfactory, even if there are valid squamous and endocervical 
codes allocated, since a pathologist may code what can be 
observed, even in the case of an unsatisfactory sample. Hence it is 
not appropriate to define unsatisfactory histology using HS and HE 
codes.  
Note, however, that if high-grade or malignant cells are seen in an 
otherwise unsatisfactory specimen, the histology result category 
should reflect the high-grade or malignant finding, rather than the 
unsatisfactory nature of the sample. 
HN Negative 
A negative histology result is defined as any histology test that is not 
unsatisfactory and where there is no evidence of HPV infection, 
intraepithelial pre-neoplasia, or intraepithelial neoplasia.  
Note that there is no requirement for both squamous and 
endocervical components to be sampled and to be negative; a 
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histology result that only samples the squamous component and the 
squamous component is negative, or a histology result that only 
samples the endocervical component and the endocervical 
component is negative, are both counted as negative histology tests.  
A negative histology result can therefore be represented as  
(H5 = HS01 & H6 = HE01) or (H5 = HS01 & H6 = HEN) or  
(H5 = HSN & H6 = HE01), although this may not reflect how negative 
histology is coded by cervical screening registers. 
HL Low-grade 
A low-grade histology result is defined as  
H5 = HS02 or H6 = HE02 (H5 cannot be >HS02 and H6 cannot be 
>HE02). 
HH High-grade 
A high-grade histology result is defined as  
H5 = HS03 or H6 = HE03 (H5 cannot be >HS03 and  
H6 cannot be >HE03). 
HC Cervical cancer 
A cervical cancer histology result is defined as H5 = HS04 or H6 = 
HE04. 
Data element attributes 
Collection and usage attributes 
Collection methods: State and Territory cervical screening registers. 
These are AIHW-derived definitions used for reporting purposes only 
and may differ from definitions used for other purposes. For the 
purposes of national reporting of cervical histology to the Australian 
Institute of Health and Welfare, categories are based only on HS and 
HE codes. 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
Reference documents State and Territory Cervical Screening Registry histology coding 
sheets 
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HPV DNA test data elements 
HPV DNA testing is a relatively recent development in cervical screening, and new HPV 
DNA test methods are being developed all the time. The data elements for HPV DNA testing 
reflect what is currently available, but allow for future development of these data elements 
as technologies change. 
D1 HPV DNA test—laboratory accession number, identifier X[X(19)] .................................................106 
D2 HPV DNA test—date of HPV DNA test, date DDMMYYYY ............................................................107 
D3 HPV DNA test—HPV DNA specimen site, code AN ......................................................................108 
D4 HPV DNA test—HPV DNA sampling method, code {AN}...............................................................109 
D5 HPV DNA test—HPV DNA test type, code ANN ............................................................................110 
D6 HPV DNA test—High-risk HPV DNA result, code AX .....................................................................113 
D7 HPV DNA test—Low-risk HPV DNA result, code {AX} ...................................................................115 
D8 HPV DNA test—HPV DNA genotyping status, code N ...................................................................116 
D9 HPV DNA test—HPV DNA genotype test type, code ANN ............................................................117 
D10 HPV DNA test—HPV genotype, code X[XXXXX], X[XXXXX], X[XXXXX] ....................................118 
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D1 HPV DNA test—laboratory accession number, identifier 
X[X(19)] 
Identifying and definitional attributes 
Data element name 
Synonymous names 
Laboratory accession number for cervical HPV DNA test 
HPV DNA lab specimen ID 
HPV DNA lab record ID 
Definition A unique record identifier allocated by the cervical screening 
laboratory to a cervical specimen to distinguish it from all other 
specimens analysed by the laboratory. 
Collection status Essential 
Value domain representational attributes 
Representation class Identifier 
Data type String 
Format X[X(19)] 
Maximum character length 20 
Data element attributes 
Collection and usage attributes 
Guide for use Provided by Pathology Laboratories 
Source and reference attributes 
Origin State and Territory cervical screening registers 
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D2 HPV DNA test—date of HPV DNA test, date DDMMYYYY 
Identifying and definitional attributes 
Data element name 
Synonymous names 
Date of HPV DNA test 
HPV DNA collection date 
Definition The date when a specimen was collected. 
Collection status Essential 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format DDMMYYYY 
Maximum character length 8 
Collection and usage attributes 
Guide for use Laboratory receipt date (L2) can be used instead of test date (P2), if 
date of HPV DNA test is not known.  
Data element attributes 
Source and reference attributes 
Origin State and Territory cervical screening registers 
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D3 HPV DNA test—HPV DNA specimen site, code AN 
Identifying and definitional attributes 
Data element name HPV DNA specimen site 
Definition The site from where a sample has been collected. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AN 
Maximum character length 2 
Permissible values Value Meaning 
 B1 Cervical 
 B2 Vaginal (with or without an intact cervix) 
 B3 Other gynaecological site 
 B0 Not stated 
Data element attributes 
Source and reference attributes 
Origin State and Territory cervical screening registers 
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D4 HPV DNA test—HPV DNA sampling method, code {AN} 
Identifying and definitional attributes 
Data element name HPV DNA sampling method 
Definition The method of sampling used to determine whether a 
specimen contains HPV DNA. 
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type String 
Format {AN} 
Maximum character length 2 
Permissible values Value Meaning 
M1 LBC sample 
M2 Digene sampler 
M3 Self collect 
M8 Other 
M9 Not stated/Unknown 
  
Data element attributes 
Collection and usage attributes 
Guide for use  
Source and reference attributes 
Reference documents  
  
 110 National Cervical Cancer Prevention Data Dictionary Version 1 
D5 HPV DNA test—HPV DNA test type, code ANN 
Identifying and definitional attributes 
Data element name HPV DNA test type 
Definition The type of test used to determine whether a specimen contains 
HPV DNA. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format ANN 
Maximum character length 3 
Permissible values Value Meaning 
P01 Digene Hybrid Capture II Assay 
P02 Roche AMPLICOR HPV Test 
P03 HGS High-Risk HPV detection kit 
P04 Abbott RealTime High Risk (HR) HPV assay 
P05 Cervista™ HPV HR 
P06 Cervista HPV 16/18 assay 
P97 PCR (not otherwise specified) 
P98 Other  
P99 Not stated/Unknown 
  
Data element attributes 
Collection and usage attributes 
Guide for use The following are correct at time of preparation of this document; 
additional tests will be added as they become common. 
P01 Digene Hybrid Capture II Assay 
The second-generation nucleic acid hybridisation-based Digene 
Hybrid Capture II Assay (Digene Corporation) detects the presence 
of 13 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 
59, and 68) and 5 low-risk HPV types (6, 11, 42, 43, and 44).  
HC-II is approved for use by the Medical Services Advisory 
Committee following a histologically-confirmed high-grade cervical 
lesion. 
P02 Roche AMPLICOR HPV Test 
The polymerase chain reaction (PCR)-based Roche AMPLICOR 
HPV Test (Roche Molecular Systems) detects the presence of 13 
high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 
and 68).  
P03 HGS High-Risk HPV detection kit 
The HGS High-Risk HPV detection kit (Human Genetic Signatures) 
uses nucleic acid simplification technology and detects the 
presence of 13 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 
52, 56, 58, 59, and 68).  
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P04 Abbott RealTime High Risk (HR) HPV assay 
The RealTime High Risk (HR) HPV assay (Abbott Molecular) is a 
qualitative in vitro polymerase chain reaction (PCR) assay that 
detects the presence of 14 high-risk HPV types (16,18, 31, 33, 35, 
39, 45, 51, 52, 56, 58, 59, 66 and 68). 
P05 Cervista™ HPV HR 
The Cervista HPV HR test (Hologic) uses a unique signal 
amplification technique to detect the presence of 14 high-risk HPV 
DNA types (16,18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68). 
P06 Cervista HPV 16/18 assay 
The Cervista HPV 16/18 assay (Hologic) uses a unique signal 
amplification technique to detect the presence of the two high-risk 
HPV types 16 and 18. 
P97 Polymerase chain reaction (PCR)  
Polymerase chain reaction (PCR) techniques identify individual 
HPV types and require only small amounts of DNA. A consensus 
PCR is generally performed which identifies several HPV types in 
one assay. 
PCR is approved for use by the Medical Services Advisory 
Committee following a histologically confirmed high-grade cervical 
lesion. 
Source and reference attributes 
Submitting organisation Australian Institute of Health and Welfare 
Reference documents Arney, A. and Bennett, K.M. (2010). Molecular Diagnostics of 
Human Papillomavirus: Cervista HPV HR and Cervista HPV 16/18. 
Laboratory Medicine. 2010;41(9):523-530.  
Baleriola C, Millar D, Melki J, Coulsten N, Altman P, Rismanto N, & 
Rawlinson W (2008). Comparison of a novel HPV test with the 
Hybrid Capture II (hcII) and a reference PCR method shows high 
specificity and positive predictive value for 13 high-risk human 
papillomavirus infections. Journal of Clinical Virology 42: 22-26. 
Huang S, Tang N, Mak WB, Erickson B, Salituro J, Li Y, Krumpe E, 
Schneider G, Yu H, Robinson J, Abravaya K. (2009). Principles and 
analytical performance of Abbott RealTime High Risk HPV test. J 
Clin Virol. 45 Suppl 1:S13-7. 
Malloy C, Sherris J & Herdman C (2000). HPV DNA Testing: 
Technical and Programmatic Issues for Cervical Cancer Prevention 
in Low-Resource Settings, cited 25 May 2006, 
http://www.path.org/files/HPV-DNA-Testing-Issues.pdf 
MSAC Report: The use of human papilloma virus testing to 
monitor effectiveness of treatment of high-grade intraepithelial 
abnormalities of the cervix, cited 9 June 2006 
www.msac.gov.au/pdfs/reports/msacref12e.pdf. 
Poljak M, Fujs K, Seme K, Kocjan BJ & Vrtačnik-Bokal E (2005). 
Retrospective and prospective evaluation of the Amplicor HPV 
test for detection of 13 high-risk human papillomavirus genotypes 
on 862 clinical samples. Acta Dermatoven APA 14: 147-152. 
Soderlund-Strand A, Rymark P, Andersson P, Dillner J & Dillner 
L (2005). Comparison between the Hybrid Capture II Test and a 
PCR-based human papillomavirus detection method for 
diagnosis and posttreatment follow-up of cervical intraepithelial 
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neoplasia. Journal of Clinical Microbiology 43: 3260-3266. 
Stevens MP, Garland SM, Rudland E, Tan J, Quinn MA 7 Tabrizi 
SN (2007). Comparison of the Digene Hybrid Capture 2 Assay 
and Roche AMPLICOR and LINEAR ARRAY Human 
Papillomavirus (HPV) tests in detecting high-risk HPV genotypes 
in specimens from women with previous abnormal Pap smear 
results. Journal of Clinical Microbiology 45: 2130-2137. 
Relational attributes 
Related metadata references Supersedes Cytology (first) sub-set data element 28 PersonHPV 
DNA test type, code AAN 
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D6 HPV DNA test—High-risk HPV DNA result, code AX 
Identifying and definitional attributes 
Data element name High-risk HPV DNA result 
Definition An indication as to whether high-risk HPV DNA is detected in a 
specimen.  
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type String 
Format AX 
Maximum character length 2 
Permissible values Value Meaning 
D0 No high-risk HPV DNA detected  
D1 High-risk HPV DNA detected 
DE Equivocal result 
DU Unsatisfactory 
 
Collection and usage attributes 
Guide for use The result needs to be considered in light of the HPV DNA 
detection method used.  
The result code used should reflect only what is known about 
the result. For instance, if the test method used only detects 
the presence of high-risk types of HPV, then a negative result 
for this test should be coded as’ P0 No high-risk HPV DNA 
detected’. 
The strains of HPV DNA considered high risk (as at June 
2006) are viral types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 
58, 59, 68, 73 and 82. An additional three types (23, 53 and 
66) are considered probable high-risk. 
Those strains of HPV DNA that are understood to be 
relatively low risk for the development of cervical cancer are 
6, 11, 40, 42, 43 44, 54, 61, 70, 72, 81 and CP108. 
See guide for use for ‘V5 HPV DNA test—HPV DNA test, 
code AN’ for information on specific strains identified by each 
test. 
Data element attributes 
Source and reference attributes 
Reference documents Lab Tests Online 2006. Cited 9 June 2006, www.labtestsonline.org. 
NHMRC Screening to Prevent Cervical Cancer: Guidelines for the 
Management of Asymptomatic Women with Screen Detected 
Abnormalities, 2005, cited 9 June 2006 
www.nhmrc.gov.aupublications. 
MSAC Report: The use of human papilloma virus testing to monitor 
effectiveness of treatment of high-grade intraepithelial abnormalities 
of the cervix, cited 9 June 2006 
www.msac.gov.au/pdfs/reports/msacref12e.pdf. 
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Relational attributes 
Related metadata references Supersedes Cytology (first) sub-set data element 27 
PersonHPV DNA result, code N 
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D7 HPV DNA test—Low-risk HPV DNA result, code {AX} 
Identifying and definitional attributes 
Data element name Low-risk HPV DNA result 
Definition An indication as to whether low-risk HPV DNA is detected in a 
specimen.  
Collection status Desirable 
Value domain representational attributes 
Representation class Code 
Data type String 
Format {AX} 
Maximum character length 2 
Permissible values Value Meaning 
W0 No low-risk HPV DNA detected  
W1 Low-risk HPV DNA detected 
WE Equivocal result 
WU Unsatisfactory 
 
Collection and usage attributes 
Guide for use The result needs to be considered in light of the HPV DNA detection 
method used.  
The result code used should reflect only what is known about the 
result. 
Those strains of HPV DNA that are understood to be relatively low 
risk for the development of cervical cancer are 6, 11, 40, 42, 43 44, 
54, 61, 70, 72, 81 and CP108. 
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D8 HPV DNA test—HPV DNA genotyping status, code N 
Identifying and definitional attributes 
Data element name HPV DNA genotyping status 
Definition Whether or not genotyping was performed on a specimen in which 
HPV DNA was detected. 
Collection status Aspirational; requires development 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format N 
Maximum character length 1 
Permissible values Value Meaning 
1 Genotyping performed  
2 No genotyping performed 
9 Not stated/Unknown 
 
Data element attributes 
Source and reference attributes 
Origin Australian Institute of Health and Welfare Australian Institute of Health and Welfare 
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D9 HPV DNA test—HPV DNA genotype test type, code ANN 
Identifying and definitional attributes 
Data element name HPV DNA genotype test type 
Definition The type of test used to determine the specific 
genotype(s) of HPV DNA present in a specimen . 
Collection status Aspirational; requires development 
Value domain representational attributes 
Representation class Code 
Data type String 
Format ANN 
Maximum character length 3 
Permissible values Value Meaning 
G00 Not applicable (no test performed) 
G01 Roche Linear Array HPV genotyping test 
G08 Other 
G99 Not stated/Unknown 
 
Data element attributes 
Collection and usage attributes 
Guide for use G1 Roche Linear Array HPV genotyping test 
The polymerase chain reaction (PCR)-based Roche Linear Array 
HPV genotyping test (Roche Molecular Systems) is capable of 
detecting and distinguishing 37 individual genotypes of HPV, 
including 13 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 
56, 58, 59, and 68), 5 low-risk HPV types (6, 11, 42, 43, and 44), and 
also 26, 40, 53, 54, 55, 61, 62, 64, 66, 67, 69, 70, 71, 72, 73, 81, 82, 
83, 84, IS39, & CP6108. 
Source and reference attributes 
Submitting organisation Australian Institute of Health and Welfare 
Reference documents  
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D10 HPV DNA test—HPV genotype, code X[XXXXX], 
X[XXXXX], X[XXXXX] 
Identifying and definitional attributes 
Data element name HPV DNA genotype 
Definition The genotype/s of HPV detected in a specimen.  
Collection status Aspirational; requires development 
Value domain representational attributes 
Representation class Code 
Data type String 
Format X[XXXXX], X[XXXXX], X[XXXXX] 
Maximum character length 8 
Collection and usage attributes 
Guide for use X[XXXXX] represents the number of the HPV genotype detected, 
with the format allowing for up to three HPV genotypes to be 
recorded in the one sample. 
Unused genotypes in the format should not be left blank. 
Data items should be separated by commas, without any spaces 
For instance data for a woman with types 16 and 18 would be 
represented by 16,18,- or 16,18,0. 
Data element attributes 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
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Follow-up data elements 
F1 Follow-up—27 month reminder letter sent, code N ........................................................................120 
F2 Follow-up—date letter sent, date {DDMMYYYY} ............................................................................121 
 
  
 120 National Cervical Cancer Prevention Data Dictionary Version 1 
F1 Follow-up—27 month reminder letter sent, code N 
Identifying and definitional attributes 
Data element name 27 month reminder letter sent 
Definition Whether a 27 month reminder letter has been sent from a cervical 
screening register to a woman. 
Collection status Essential 
Value domain representational attributes 
Representation class Code 
Data type Number 
Format N 
Maximum character length 1 
Permissible values Value Meaning 
1 27 month reminder letter sent 
2 27 month reminder letter not sent 
9 Not stated/Unknown  
 
Collection and usage attributes 
Guide for use Follow-up and reminder letters are sent by cervical screening 
registries to both woman and practitioners to provide a safety net for 
women. 
The 27 month reminder letter is sent 27 months after a woman’s 
negative Pap test, if the cervical screening register has not received 
notice that the woman has had a repeat Pap test within that time, and 
has not received information that the woman has had a hysterectomy 
or died, or become no longer an active client on the cervical 
screening register. 
This data item specifies whether a letter was sent directly to women, 
and is required for Indicator 2.2, which measures the proportion of 
women who are re-screened within 3 months of being sent a 27 
month Pap test reminder letter. 
Data element attributes 
Source and reference attributes 
Origin Australian Institute of Health and Welfare 
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F2 Follow-up—date letter sent, date {DDMMYYYY} 
Identifying and definitional attributes 
Data element name Date letter sent 
Definition The date when the 27 month reminder letter was sent to a woman. 
Collection status Conditional 
Value domain representational attributes 
Representation class Date 
Data type Date/Time 
Format {DDMMYYYY} 
Maximum character length 8 
Collection and usage attributes 
Guide for use Follow-up and reminder letters are sent by cervical screening 
registries to both woman and practitioners to provide a safety net 
for women. 
The 27 month reminder letter is sent 27 months after a woman’s 
negative Pap test, if the cervical screening register has not 
received notice that the woman has had a repeat Pap test within 
that time, and has not received information that the woman has 
had a hysterectomy or died, or become no longer an active client 
on the cervical screening register. 
This data item specifies the date when the 27 month reminder 
letter was sent to women, and is required for Indicator 2.2, which 
measures the proportion of women who are re-screened within 3 
months of being sent a 27 month Pap test reminder letter. 
Data element attributes 
Collection and usage attributes 
Collection methods  
 
Source and reference attributes 
Origin State and Territory cervical screening registers 
Relational attributes 
Related metadata 
references 
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4 Performance indicators 
The effectiveness of the National Cervical Screening Program (NCSP) has been monitored 
since 1996–1997 using performance indicators that cover what were originally defined as 
essential aspects of the program by the then National Screening Information Advisory 
Group, in conjunction with the Australian Institute of Health and Welfare (AIHW) and state 
and territory program and data managers, with additional input from other experts in the 
field. Because it was recognised that changes to incidence and mortality—the ultimate aim of 
the program—would not be realised for a considerable length of time, indicators that could 
be measured in the shorter term and could monitor progress towards these longer term aims 
were initiated. For all reporting periods between 1996–1997 and 2007–2008, the indicators 
covered participation, early rescreening, low-grade abnormality detection, high-grade 
abnormality detection, incidence of cervical cancer, and mortality from cervical cancer.  
In 2009, a working group reviewed the original indicators, and considered additional 
essential aspects of the current NCSP and cervical screening environment. After this review 
process, the working group agreed to a set of performance indicators that would allow the 
program to be monitored optimally in the face of changes to cervical cancer and cervical 
screening, including the introduction of new Guidelines for the management of screen detected 
abnormalities in asymptomatic women (NHMRC 2005) by the National Health and Research 
Council (NHMRC) on 1 July 2006 and the commencement of the National HPV Vaccination 
Program from 1 April 2007. 
In August 2009, an expert advisory group was established to review the performance 
indicators proposed by the working group to ensure that these indicators would allow 
optimal monitoring of the important components of the NCSP. The expert advisory group 
considered the proposed performance indicators to be comprehensive and useful for 
monitoring the NCSP and, after several alterations were made to the data specifications, 
endorsed the performance indicators as described in this technical paper in September 2009. 
The expert advisory group was comprised of the following experts, all of whom had 
particular knowledge of cervical screening: 
 Ms Jennifer Muller (Senior Director, Cancer Screening Services, Queensland Dept of Health) 
 Associate Professor Marion Saville (Executive Director, Victorian Cytology Service) 
 Associate Professor Dorota Gertig (Director, Victorian Cervical Cytology Register) 
 Dr Mark Clements (Research Fellow, National Centre for Epidemiology and Population Health, 
Australian National University) 
 Dr Bronwen Harvey (Medical Advisor, Commonwealth Department of Health and Ageing). 
The expert advisory group considered the proposed performance indicators to be 
comprehensive and useful for monitoring the NCSP and, after several alterations were made 
to the data specifications, endorsed the performance indicators in September 2009. 
Later in 2009, the indicators were endorsed by the then-named Australian Population Health 
Development Principal Committee Screening Subcommittee. These made their debut in 
Cervical screening in Australia 2008–2009. 
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National performance indicators for the National 
Cervical Screening Program 
Performance indicators 
The 7 NCSP performance indicators are as follows: 
 Indicator 1 Participation 
 Indicator 2 Rescreening 
 Indicator 3 Cytology 
 Indicator 4 Histology 
 Indicator 5 Cytology-histology correlation 
 Indicator 6 Incidence 
 Indicator 7 Mortality 
Performance indicators specifications 
The following pages comprise definition, rational, and data specifications for the NCSP 
performance indicators. 
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Indicator 1 Participation 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition Percentage of women screened through the National Cervical 
Screening Program in a two-, three- or five-year period for the target 
age group 20–69. 
  The participation indicator measures the proportion of the population 
covered by the cervical screening programs. Women aged 20–69 are 
actively targeted to participate in cervical screening by recruitment 
initiatives at the state and territory level. Higher participation in 
cervical screening means that more women with precancerous 
abnormalities can be detected and treated, which is necessary for 
achieving the overall aim of reducing incidence and mortality from 
cervical cancer. 
While the definition of participation is for the target age group 20–69, 
data are collected for the following age groups: <20, 20–24, 25–29, 
30–34, 35–39, 40–44, 45–49, 50-54, 55–59, 60–64, 65–69, 70–74, 
75–79, 80–84, and 85+. 
Participation is measured over a two-year period in line with the 
current recommended screening interval. In addition, participation is 
measured over a three- and five-year period to evaluate participation 
outside the recommended screening interval, as well as allowing 
limited comparisons between Australia’s screening program and 
screening programs in countries with three- or five-year screening 
intervals. 
Two-year participation is measured by remoteness area and 
socioeconomic status to allow the program to better assess who in 
the population are participating in cervical screening, so that 
recruitment initiatives can be better tailored to those who are under-
represented. 
Remoteness area is coded using the Australian Statistical Geography 
Standard (ASGS), which is defined using the 
Accessibility/Remoteness Index for Australia (ARIA). ARIA is a 
measure of the remoteness of a location from the services provided 
by large towns or cities. A higher ARIA score denotes a more remote 
location. The five classes of the ASGS classification are: Major cities 
of Australia, Inner regional Australia, Outer regional Australia, 
Remote Australia, and Very remote Australia. 
Socioeconomic status is coded according to the Index of Relative 
Socioeconomic Disadvantage (IRSD). The IRSD is one of the 
socioeconomic indexes for areas (SEIFA indexes) developed by the 
Australian Bureau of Statistics to categorise geographic areas 
according to their social and economic characteristics. The IRSD 
relates to the average disadvantage of all people living in a 
geographic area. This index of socioeconomic status divides areas 
into five quintiles, in which the first quintile corresponds to the least 
disadvantaged and the fifth quintile corresponds to the most 
disadvantaged. 
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Collection and usage attributes 
Formula Number of women screened 
ABS ERP adjusted for proportion of women who have had a 
hysterectomy 
 
Numerator The number of individual women screened during a 24-month, 
 36-month or 60-month period by age group.  
Source State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier  
A7 Date of birth 
T1 Type of test 
C2 Date of cytology test  
C3 Specimen site 
C6 Endocervical (glandular) cytology cell analysis 
Numerator 
Specifications 
 Count is of individual women, not tests. 
 Count is the woman’s first screening episode in the reporting 
period. 
 Only includes cytology tests (T1=C) where C3 = B0 or B1 and  
C6  E-.  
 Excludes women who have opted off the register. 
 Excludes vault smears. 
 Remoteness area assigned using residential postcode (A15)  
at the time of test.  
 Socioeconomic status category assigned using residential 
postcode (A15) at time of test. 
Denominator The number of women resident in each state and territory, 
geographic region, socioeconomic status and Australia, using 
Australian Bureau of Statistics estimated resident female population 
(ERP) as at 30th June averaged over the relevant two-, three- or five-
years by age group, adjusted for the proportion of women who have 
had a hysterectomy. 
Source  ABS Estimated Resident Population 
National hysterectomy fractions derived from the AIHW National  
Morbidity Hospitals Database 
Administrative attributes 
Source document Developed for the National cervical cancer prevention data dictionary 
version 1 
Source organisation National Cervical Screening Program 
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Indicator 2 Rescreening 
2.1 Early rescreening 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition The proportion of women re-screened, by number of re-screens, 
during a 21-month period following a negative cytology test for 
women in the target age group 20–69. 
Context The National Cervical Screening Program seeks to maximise the 
reduction in mortality from cervical cancer within a cost-effective 
framework. Compliance with the recommended screening interval is 
important in maintaining both the effectiveness of the Program and its 
cost efficiency. Early rescreening, outside the NHMRC Guidelines, 
does not increase the effectiveness of the program but utilises 
resources that would be more effective if used to increase population 
coverage. 
This indicator tracks over a period of 21 months a cohort of women 
from all states and territories who had a negative cytology test result 
in February in the first year of the 2-year monitoring period, to 
determine the extent of early re-screening within the National 
Cervical Screening Program. 
Women who have had an abnormality in the preceding 36 months 
are excluded, as are cytology tests that are a valid repeat of an 
unsatisfactory cytology test, since rescreening within 21 months in 
these contexts is valid. 
It is not possible to know if there was a clinical reason for early 
rescreening, such as symptoms, which would also be valid.  
Collection and usage attributes 
Formula Number of women with a negative cytology test result in the index 
month who had a repeat cytology test within the 21 months following 
this negative cytology test 
Number of women with a negative cytology test result in the index 
month who have not had a cytological or histological abnormality 
within the preceding 36 months. 
 
The numerator is a subset of the denominator. Note that not all the 
data elements specified in the denominator are restated in the 
numerator. 
 
Numerator The number of women screened in the index period with a negative 
cytology test result (who have not had a cytological or histological 
abnormality within the preceding 36 months), who had a specific 
number of repeated screens (0, 1, 2, 3, 4, 5 or more, also without a 
cytological or histological abnormality within the preceding 36 
months)), and where the repeat screen is not a valid repeat of an 
unsatisfactory test, tracked for 21 months after the initial screen. 
Source State and territory cervical screening registers 
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Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
T1 Type of test 
C2 Date of cytology test  
C3 Specimen site 
C5 Squamous cytology cell analysis  
C6 Endocervical (glandular) cytology cell analysis 
H5 Squamous histology cell analysis 
H6 Endocervical (glandular) histology cell analysis 
Numerator 
specifications 
 
 
 Includes cytology tests that occur in the 21 months (640 days) 
following the index test (0 days < C2 – C2 (index test) <= 640 
days). 
 Only includes cytology tests (T1=C) where C3 = B0 or B1 and  
C6  E-. 
 Only includes cytology tests that do not have an immediately 
preceding cytological result of unsatisfactory ((C5 = SU & C6 = 
EU) or (C5 = SU & C6 = (E0 or E1))). 
 Only includes women who have not had a cytological (T1=C) or 
histological (T1=H) abnormality within the preceding 36 months 
(1096 days) of their index negative cytology (C2 (index)). 
 Excludes women who have opted off the register. 
 Excludes vault smears. 
 
 Abnormalities include: 
Abnormal squamous cytology 
C5 = S2 Possible low-grade intraepithelial lesion 
C5 = S3 Low-grade intraepithelial lesion 
C5 = S4 Possible high-grade intraepithelial lesion 
C5 = S5 High-grade intraepithelial lesion 
C5 = S6 High-grade intraepithelial lesion with possible 
microinvasion/invasion 
C5 = S7 Squamous carcinoma 
Abnormal endocervical cytology 
C6 = E2 Atypical endocervical cells of uncertain significance  
C6 = E3 Possible high-grade endocervical glandular lesion 
C6 = E4 Adenocarcinoma in situ 
C6 = E5 Adenocarcinoma in situ with possible 
microinvasion/invasion 
C6 = E6 Adenocarcinoma 
Abnormal squamous histology 
H5 = HS02 Low grade squamous abnormality 
H5 = HS03.1 High grade squamous abnormality, CIN NOS 
H5 = HS03.2 High grade squamous abnormality, CIN II 
H5 = HS03.3 High grade squamous abnormality, CIN III 
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H5 = HS04.1 Squamous cell carcinoma, microinvasive 
H5 = HS04.2 Squamous cell carcinoma, invasive 
Abnormal endocervical histology 
H6 = HE02 Endocervical atypia 
H6 = HE03.1 High-grade endocervical abnormality, endocervical 
dysplasia 
H6 = HE03.2 High-grade endocervical abnormality, 
adenocarcinoma in situ 
H6 = HE03.3 High-grade endocervical abnormality, mixed 
carcinoma in situ/adenocarcinoma in situ 
H6 = HE04.1 Endocervical adenocarcinoma, microinvasive  
H6 = HE04.2 Endocervical adenocarcinoma, invasive  
H6 = HE04.3 Adenosquamous carcinoma  
H6 = HE04.4 Carcinoma of the cervix (other) 
Denominator The number of women screened in the index period aged 20–69 with 
a negative cytology test result (who have not had a cytological or 
histological abnormality within the preceding 36 months). 
Source  State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
C2 Date of cytology test  
C3 Specimen site 
C5 Squamous cytology cell analysis  
C6 Endocervical (glandular) cytology cell analysis 
C7 Other/non-cervical cytology cell analysis 
H5 Squamous histology cell analysis 
H6 Endocervical (glandular) histology cell analysis 
Denominator 
Specifications 
 Count is of individual women, not tests. 
 Count is all women with a negative cytology test (T1 = C) with  
C3 = B0 or B1 and C5=S1 & C6 = (E0 or E1) & C7 O3 with C2 
in the index month. This negative cytology test is the index test. 
 Index month is February. 
 If a woman has more than one negative cytology test in the index 
month, the woman’s first negative cytology test is the index test. 
 Only includes women aged 20–69 at the time of test of the index 
test (C2 (index)). 
 Only includes women who have not had a cytological (T1=C) or 
histological (T1=H) abnormality within the preceding 36 months 
(1096 days) of their index negative cytology (C2 (index)).  
 Excludes women who have opted off the register. 
 Excludes vault smears. 
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 Abnormalities include: 
 
Abnormal squamous cytology 
C5 = S2 Possible low-grade intraepithelial lesion 
C5 = S3 Low-grade intraepithelial lesion 
C5 = S4 Possible high-grade intraepithelial lesion 
C5 = S5 High-grade intraepithelial lesion 
C5 = S6 High-grade intraepithelial lesion with possible  
microinvasion/invasion 
C5 = S7 Squamous carcinoma 
Abnormal endocervical cytology 
C6 = E2 Atypical endocervical cells of uncertain significance  
C6 = E3 Possible high-grade endocervical glandular lesion 
C6 = E4 Adenocarcinoma in situ 
C6 = E5 Adenocarcinoma in situ with possible 
microinvasion/invasion 
C6 = E6 Adenocarcinoma 
Abnormal squamous histology 
H5 = HS02 Low grade squamous abnormality 
H5 = HS03.1 High grade squamous abnormality, CIN NOS 
H5 = HS03.2 High grade squamous abnormality, CIN II 
H5 = HS03.3 High grade squamous abnormality, CIN III 
H5 = HS04.1 Squamous cell carcinoma, microinvasive 
H5 = HS04.2 Squamous cell carcinoma, invasive 
Abnormal endocervical histology 
H6 = HE02 Endocervical atypia 
H6 = HE03.1 High-grade endocervical abnormality, endocervical 
dysplasia 
H6 = HE03.2 High-grade endocervical abnormality, 
adenocarcinoma in situ 
H6 = HE03.3 High-grade endocervical abnormality, mixed 
carcinoma in situ/adenocarcinoma in situ 
H6 = HE04.1 Endocervical adenocarcinoma, microinvasive  
H6 = HE04.2 Endocervical adenocarcinoma, invasive  
H6 = HE04.3 Adenosquamous carcinoma  
H6 = HE04.4 Carcinoma of the cervix (other)  
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Administrative attributes 
Source document Developed for the National cervical cancer prevention data dictionary 
version 1 
Source organisation National Cervical Screening Program 
Comments Although women with an abnormality in the preceding 36 months 
have been removed, it should be noted that this will not remove 
women with a previous high-grade histology result who did not have 
a test of cure who are undergoing annual screening according to the 
previous NHMRC Guidelines that advised these women to have 
annual Pap tests ad infinitum. 
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Indicator 2 Rescreening  
2.2 Rescreening after 27 month cervical 
screening register reminder letter 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition The proportion of women rescreening within 3 months of the 27 
month cervical screening register reminder letter for women in the 
target age group 20–69. 
Context This indicator gives an indication of the proportion of women for 
whom the 27 month reminder letter is a prompt to rescreen.  
A lower proportion of women who rescreen within 3 months of 
receiving this letter could indicate either that this letter was not an 
effective prompt to rescreen, or a lower capacity of primary health 
services that provide the cervical screening service to women. 
Collection and usage attributes 
Formula Number of women who had a cytology test within 3 months of being 
sent a 27 month reminder letter 
Number of women who were sent a 27 month reminder letter  
 
The numerator is a subset of the denominator. Note that not all the 
data elements specified in the denominator are restated in the 
numerator. 
 
Numerator The number of women who had a cytology test within 3 months of 
being sent a 27 month reminder letter. 
Source State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
T1 Type of test 
C2 Date of cytology test  
F2          Date letter sent 
Numerator 
Specifications 
 Count is of individual women, not tests. 
 Includes cytology tests (T1=C) that occur in the 3 months  
(92 days) following the 27 month reminder letter 
 (0 days < C2 –F2 <= 92 days). 
 Excludes women who have opted off the register. 
Denominator The number of women who were sent a 27 month reminder letter. 
Source  State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements A1 Client identifier 
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 A7 Date of birth 
F1     27 month reminder letter sent 
F2     Date letter sent 
Denominator 
Specifications 
 Count is of individual women, not tests. 
 Count is all women who were sent a 27 month reminder letter in 
the 12-month period. 
 Only includes women aged 20–69 at the time the letter was sent 
(F2).  
 Excludes women who have opted off the register. 
Administrative attributes 
Source document Developed for the National cervical cancer prevention data dictionary 
version 1. 
Source organisation National Cervical Screening Program 
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Indicator 3 Cytology 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition Proportion of cytology test results in each result category in a  
12-month period for the target age group 20–69. 
Context This indicator provides a breakdown of cytology performed, by 
cytology report categories for squamous and endocervical 
component, using the categories defined by the National Cervical 
Cytology Coding Sheet.  
The primary screening tool of the National Cervical Screening 
Program is cervical cytology, using the Papaniculoau smear (or ‘Pap 
test’). The annual reporting of squamous and endocervical cytology 
result categories by year and by age allows trends in cytology results 
to be monitored. 
Data are collected for the following age groups: <20, 20–24, 25–29, 
30–34, 35–39, 40–44, 45–49, 50-54, 55–59, 60–64, 65–69, 70–74, 
75–79, 80–84, and 85+. 
Collection and usage attributes 
Formula Number of cytology test results in each squamous and  
endocervical result category in a 12-month period 
Number of cytology test results in the same 12-month period 
 
Numerator Number of cytology test results in each squamous and endocervical 
result category in a 12-month period. 
Source State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
C2 Date of cytology test  
C3 Specimen site 
C5 Squamous cytology cell analysis 
C6 Endocervical (glandular) cytology cell analysis 
Numerator 
Specifications 
 Count is of individual tests, not women.  
 Only includes cytology tests (T1=C) where C3 = B0 or B1 and  
C6  E-. 
 Excludes women who have opted off the register. 
 Excludes vault smears. 
 Cytology reporting categories are as follows: 
Unsatisfactory cytology 
Unsatisfactory = ((T1 = C) & (C3 = B0 or B1) & ((C5 = SU &  
C6 = EU) or (C5 = SU & C6 = (E0 or E1))) 
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Negative cytology 
Negative = ((T1 = C) & (C3 = B0 or B1) & ((C5 = S1 & C6 =  
(E0 or E1))) 
No endocervical component 
No endocervical component = ((T1 = C) & (C3 = B0 or B1) & 
 (C6 = E0)) 
Squamous cytology 
S2 Possible low-grade intraepithelial lesion = ((T1 = C) & 
 (C3 = B0 or B1) & (C5 = S2) & (C6  E-)) 
S3 Low-grade intraepithelial lesion = ((T1 = C) & (C3 = B0 or B1) 
& (C5 = S3) & (C6  E-)) 
S4 Possible high-grade intraepithelial lesion = ((T1 = C) &  
(C3 = B0 or B1) & (C5 = S4) & (C6  E-)) 
S5 High-grade intraepithelial lesion = ((T1 = C) & (C3 = B0 or B1) 
& (C5 = S5) & (C6  E-)) 
S6 High-grade intraepithelial lesion with possible microinvasion/ 
invasion = ((T1 = C) & (C3 = B0 or B1) & (C5 = S6) & (C6  E-)) 
S7 Squamous carcinoma = ((T1 = C) & (C3 = B0 or B1) &  
 (C5 = S7) & (C6  E-)) 
Endocervical cytology  
E2 Atypical endocervical cells of uncertain significance | 
= ((T1 = C) & (C3 = B0 or B1) & (C6 = E2)) 
E3 Possible high-grade endocervical glandular lesion = ((T1 = C) 
& (C3 = B0 or B1) & (C6 = E3)) 
E4 Adenocarcinoma in situ = ((T1 = C) & (C3 = B0 or B1) &  
(C6 = E4)) 
E5 Adenocarcinoma in situ with possible microinvasion/invasion 
= ((T1 = C) & (C3 = B0 or B1) & (C6 = E5)) 
E6 Adenocarcinoma = ((T1 = C) & (C3 = B0 or B1) & (C6 = E6)) 
Denominator Number of cytology test results in the same 12-month period. 
Source 
Data collection 
State and territory cervical screening registers 
National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
C2 Date of cytology test  
C3 Specimen site  
C6 Endocervical (glandular) cytology cell analysis 
Denominator 
Specifications 
 Count is of individual tests, not women.  
 Includes all cytology tests (T1= C) where C3 = B0 or B1 and 
 C6  E-. 
 Excludes women who have opted off the register. 
 Excludes vault smears. 
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Administrative attributes  
Source document Developed for the National cervical cancer prevention data dictionary 
version 1. 
Source organisation National Cervical Screening Program 
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Indicator 4 Histology 
4.1 Histology 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition Proportion of histology results in each squamous and endocervical 
result category in a 12-month period for the target age group 20–69. 
Context This indicator provides a breakdown of histology performed, by 
histology report categories for squamous cells and endocervical 
component, using the categories defined by the National cervical 
cancer prevention data dictionary version 1. 
Histology is the primary diagnostic tool of the National Cervical 
Screening Program. It is performed when cytology results suggest 
that an abnormality is present, as per the recommendations set out in 
the NHMRC Guidelines for the management of women with screen 
detected abnormalities (NHMRC 2005), but may also be performed 
for other reasons.  
The annual reporting of squamous and endocervical histology result 
categories by year and by age allows trends in histology results to be 
monitored. 
Data are collected for the following age groups: <20, 20–24, 25–29, 
30–34, 35–39, 40–44, 45–49, 50-54, 55–59, 60–64, 65–69, 70–74, 
75–79, 80–84, and 85+. 
Collection and usage attributes 
Formula Number of histology test results in each squamous and  
endocervical result category in a 12-month period 
Number of histology test results in the same 12-month period 
 
Numerator Number of histology tests in each squamous and endocervical result 
category in a 12-month period. 
Source State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
H2 Date of histology test  
H3 Specimen site 
H5 Squamous histology cell analysis 
H6 Endocervical (glandular) histology cell analysis 
Numerator 
Specifications 
 Count is of individual tests, not women. 
 Excludes colposcopies. 
 Excludes women who have opted off the register. 
 Histology reporting categories are as follows: 
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Negative histology 
Negative = ((T1 = H) & (H3 = B0 or B1) & (H5 = HS01 & H6 = 
HE01) or (H5 = HS01 & H6 = HEN) or (H5 = HSN & H6 = HE01). 
Squamous histology 
HS02 Low-grade squamous abnormality = ((T1 = H) & 
 (H3 = B0 or B1) & (H5 = HS02)) 
HS03.1 High-grade squamous abnormality: CIN NOS = ((T1 = H) 
& (H3 = B0 or B1) & (H5 = HS03.1))  
HS03.2 High-grade squamous abnormality: CIN II = ((T1 = H) &  
(H3 = B0 or B1) & (H5 = HS03.2)) 
HS03.3 High-grade squamous abnormality: CIN III = ((T1 = H) & 
(H3 = B0 or B1) & (H5 = HS03.3))  
HS04.1 Squamous cell carcinoma: microinvasive ((T1 = H) & 
(H3 = B0 or B1) & (H5 = HC04.1)) 
HS04.2 Squamous cell carcinoma: invasive ((T1 = H) &  
(H3 = B0 or B1) & (H5 = HC04.2) 
Endocervical histology 
HE02 Endocervical atypia = ((T1 = H) & (H3 = B0 or B1) &  
(H6 = HE02))  
HE03.1 High-grade endocervical abnormality: endocervical 
dysplasia = ((T1 = H) & (H3 = B0 or B1) & (H6 = HE03.1))  
HE03.2 High-grade endocervical abnormality: adenocarcinoma 
in situ = ((T1 = H) & (H3 = B0 or B1) & (H6 = HE03.2))  
HE03.3 High-grade endocervical abnormality: mixed carcinoma 
in situ/adenocarcinoma in situ = ((T1 = H) & (H3 = B0 or B1) & 
(H6 = HE03.3))  
HE04.1 Endocervical adenocarcinoma: microinvasive 
 = ((T1 = H) & (H3 = B0 or B1) & (H6 = HE04.1)) 
HE04.2 Endocervical adenocarcinoma: invasive = ((T1 = H) & 
(H3 = B0 or B1) & (H6 = HE04.2)) 
HE04.3 Adenosquamous carcinoma = ((T1 = H) &  
(H3 = B0 or B1) & (H6 = HE04.3)) 
HE04.4 Carcinoma of the cervix (other) = ((T1 = H) & 
(H3 = B0 or B1) & (H6 = HE04.4)) 
Denominator Number of histology test results in the same 12-month period  
Source State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
H2 Date of histology test  
H3 Specimen site 
Denominator 
Specifications 
 Count is of individual tests, not women.  
 Includes all histology tests (T1=H) where (H3 = B0 or B1). 
 Excludes colposcopies. 
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 Excludes women who have opted off the register. 
Administrative attributes 
Source document Developed for the National cervical cancer prevention data dictionary 
version 1. 
Source organisation National Cervical Screening Program 
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Indicator 4 Histology 
4.2 High-grade abnormality detection 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition Detection rate of histological high-grade intraepithelial abnormalities 
per 1,000 women screened in a 12-month period for the target age 
group 20–69. 
Context The detection of high-grade abnormalities is an indicator of program 
performance. High-grade abnormalities have a greater probability of 
progressing to invasive cancer than do low-grade lesions. Therefore, 
one of the aims of the National Cervical Screening Program is to set 
a screening interval that detects most of these lesions before they 
progress and become invasive.  
High-grade abnormalities of the cervix include cervical intraepithelial 
neoplasia (CIN) that has been graded as moderate (CIN II) or severe 
(CIN III), or for which the grade has not been specified, as well as 
endocervical dysplasia and adenocarcinoma in situ.  
Detection of high-grade abnormalities provides an opportunity for 
treatment before cancer can develop, thus the NCSP aims to detect 
high-grade abnormalities in line with its broader aim to reduce the 
incidence of cervical cancer. 
Data are collected for the following age groups: <20, 20–24, 25–29, 
30–34, 35–39, 40–44, 45–49, 50-54, 55–59, 60–64, 65–69, 70–74, 
75–79, 80–84, and 85+. 
Collection and usage attributes 
Formula Number of women with a high-grade intraepithelial abnormality  
detected by histology in a 12-month period 
Number of women screened in the same 12-month period 
 
Numerator Number of women with a high-grade intraepithelial abnormality 
detected by histology in a 12-month period 
Source State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
H2 Date of histology test  
H3 Specimen site 
H5 Squamous histology cell analysis 
H6 Endocervical (glandular) histology cell analysis 
Numerator 
Specifications 
 Count is of individual women, not tests. 
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 Includes women with a histology test (T1=H) where H3 = B0 or 
B1 and H5 = HS03.1 or HS03.2 or HS03.3 or H6 = HE03.1 or 
HE03.2 or HE03.3 in the 12-month reporting period. 
 Includes women with a high-grade histology result even if they 
have a histology result of cancer in the 12-month reporting 
period. 
 Excludes colposcopies. 
 Exclude women who have opted off the register. 
Denominator Number of women screened in the same 12-month period 
Source State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
C2 Date of cytology test 
C3 Specimen site 
C6 Endocervical (glandular) cytology cell analysis 
Denominator 
Specifications 
 Count is of individual women, not tests.  
 Count the woman’s first screening episode in the reporting 
period. 
 Only include cytology tests (T1 = C) where C3 = B0 or B1 and  
C6  E- 
 Exclude women who have opted off the register. 
 Exclude vault smears. 
Administrative attributes 
Source document Developed for the National cervical cancer prevention data dictionary 
version 1. 
Source organisation National Cervical Screening Program 
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Indicator 5 Cytology-histology correlation 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition The correlation between a woman’s cytology prediction and histology 
finding where the histology is performed within the six months 
following the cytology. 
Context The National Cervical Screening Program uses cervical cytology as 
its screening test, with cells sampled from the uterine cervix using the 
Pap test. Cervical cytology, like other screening tests, is not intended 
to be diagnostic. Rather, screening aims to identify people who are 
more likely to have a cervical abnormality or cervical cancer, and 
therefore require further investigation from diagnostic tests – 
histology in the case of cervical screening. 
In order to understand the characteristics of the screening test, it is 
useful to compare the results of screening tests performed with the 
“truth”. In reality, it is not possible to do this absolutely for cervical 
screening, since a large number of cervical cytology tests will not 
indicate the need for diagnostic follow-up. However, correlating the 
cervical cytology tests that are followed up with histology still provides 
an informative – if incomplete – measure of the accuracy of cervical 
cytology. 
In this indicator, all cervical cytology that is followed up by histology, 
where this histology occurs in the 6-month period following cytology, 
will be correlated to the most serious histology result within this 
 6-month period. This correlation will allow a measure of the accuracy 
of squamous and endocervical (glandular) cytological predictions of 
squamous and endocervical histology findings. 
Relational and representational attributes 
Formula Number of histology tests in each result category  
(where histology is within 183 days of cytology) 
Number of cytology tests in each result category 
 
This formula is applied cell by cell for each cytology and histology 
result, such that the number of tests in each histology reporting 
category that corresponds with each cytology reporting category is 
reported in a grid. 
 
Numerator Number of histology tests in each result category within 183 days of a 
cytology test in a 12-month period. 
Source State and territory cervical screening registers 
Data collection National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
C2 Date of cytology test 
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H2 Date of histology test  
H3 Specimen site 
H5 Squamous histology cell analysis 
H6 Endocervical (glandular) histology cell analysis 
Numerator 
Specifications 
 Correlation is based on the test, not the woman.  
 Includes the most serious histology test within 6 months  
(183 days) of cytology test 
 Only includes histology tests (T1=H) where H3 = B0 or B1. 
 Only includes women aged 20–69. 
 Excludes unsatisfactory histology. 
 Excludes colposcopies. 
 Excludes women who have opted off the register. 
 Histology reporting categories are as follows: 
Squamous histology 
HS01 Negative = ((T1 = H) & (H3 = B0 or B1) & (H5 = HS01)) 
HS02 Low-grade squamous abnormality = ((T1 = H) &  
(H3 = B0 or B1) & (H5 = HS02)) 
HS03.1 High-grade squamous abnormality: CIN NOS = ((T1 = H) 
& (H3 = B0 or B1) & (H5 = HS03.1))  
HS03.2 High-grade squamous abnormality: CIN II = ((T1 = H) &  
(H3 = B0 or B1) & (H5 = HS03.2)) 
HS03.3 High-grade squamous abnormality: CIN III = ((T1 = H) & 
(H3 = B0 or B1) & (H5 = HS03.3))  
HS04.1 Squamous cell carcinoma: microinvasive ((T1 = H) & 
(H3 = B0 or B1) & (H5 = HS04.1)) 
HS04.2 Squamous cell carcinoma: invasive ((T1 = H) &  
(H3 = B0 or B1) & (H5 = HS04.2) 
Endocervical histology 
HE01 Negative = ((T1 = H) & (H3 = B0 or B1) & (H6 = HE01)) 
HE02 Endocervical atypia = ((T1 = H) & (H3 = B0 or B1) &  
(H6 = HE02))  
HE03.1 High-grade endocervical abnormality: endocervical 
dysplasia = ((T1 = H) & (H3 = B0 or B1) & (H6 = HE03.1))  
HE03.2 High-grade endocervical abnormality: adenocarcinoma 
in situ = ((T1 = H) & (H3 = B0 or B1) & (H6 = HE03.2))  
HE03.3 High-grade endocervical abnormality: mixed carcinoma 
in situ/adenocarcinoma in situ = ((T1 = H) & (H3 = B0 or B1) & 
(H6 = HE03.3))  
HE04.1 Endocervical adenocarcinoma: microinvasive 
 = ((T1 = H) & (H3 = B0 or B1) & (H6 = HE04.1)) 
HE04.2 Endocervical adenocarcinoma: invasive = ((T1 = H) & 
(H3 = B0 or B1) & (H6 = HE04.2)) 
HE04.3 Adenosquamous carcinoma = ((T1 = H) &  
(H3 = B0 or B1) & (H6 = HE04.3)) 
HE04.4 Carcinoma of the cervix (other) = ((T1 = H) &  
(H3 = B0 or B1) & (H6 = HE04.4)) 
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Denominator Number of cytology tests each result category that are followed, 
within 183 days, by histology 
Source State and territory cervical screening registers 
Data collection  National cervical cancer prevention data dictionary version 1 
Data elements 
 
A1 Client identifier 
A7 Date of birth 
T1 Type of test 
C2 Date of cytology test  
C3 Specimen site 
C5 Squamous cytology cell analysis 
C6 Endocervical (glandular) cytology cell analysis 
Denominator 
specifications 
 Correlation is based on individual cytology tests, not the woman.  
 Includes all cytology tests in the 12-month reporting period 
followed by a histology test within 183 days. 
 Only includes cytology tests (T1=C) where C3 = B0 or B1 and  
C6  E-. 
 Only includes women aged 20–69. 
 Excludes unsatisfactory cytology. 
 Excludes women who have opted off the register. 
 Excludes vault smears. 
 
 Cytology reporting categories are as follows: 
Squamous cytology 
S1 Negative = ((T1 = C) & (C3 = B0 or B1) &(C5 = S1) &  
(C6  E-)) 
S2 Possible low-grade intraepithelial lesion = ((T1 = C) &  
(C3 = B0 or B1) & (C5 = S2) & (C6  E-)) 
S3 Low-grade intraepithelial lesion = ((T1 = C) & (C3 = B0 or B1) 
& (C5 = S3) & (C6  E-)) 
S4 Possible high-grade intraepithelial lesion = ((T1 = C) &  
(C3 = B0 or B1) & (C5 = S4)& (C6  E-)) 
S5 High-grade intraepithelial lesion = ((T1 = C) & (C3 = B0 or B1) 
& (C5 = S5) & (C6  E-)) 
S6 High-grade intraepithelial lesion with possible microinvasion/ 
invasion = ((T1 = C) & (C3 = B0 or B1) & (C5 = S6) & (C6  E-)) 
S7 Squamous carcinoma = ((T1 = C) & (C3 = B0 or B1) &  
(C5 = S7) & (C6  E-)) 
Endocervical cytology  
E0 No endocervical component = ((T1 = C) & (C3 = B0 or B1) & 
(C6 = E0)) 
E1 Negative = ((T1 = C) & (C3 = B0 or B1) & (C6 = E1)) 
E2 Atypical endocervical cells of uncertain significance 
 = ((T1 = C) & (C3 = B0 or B1) & (C6 = E2)) 
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E3 Possible high-grade endocervical glandular lesion = ((T1 = C) 
& (C3 = B0 or B1) & (C6 = E3)) 
E4 Adenocarcinoma in situ = ((T1 = C) & (C3 = B0 or B1) &  
(C6 = E4)) 
E5 Adenocarcinoma in situ with possible microinvasion/invasion 
= ((T1 = C) & (C3 = B0 or B1) & (C6 = E5)) 
E6 Adenocarcinoma = ((T1 = C) & (C3 = B0 or B1) & (C6 = E6)) 
Administrative attributes 
Source document Developed for the National cervical cancer prevention data dictionary  
version 1. 
Source organisation National Cervical Screening Program 
  
  
National Cervical Cancer Prevention Data Dictionary Version 1 145 
Indicator 6 Incidence 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition Incidence rate of cervical cancer (squamous, adenocarcinoma, 
adenosquamous and other cervical cancer) per 100,000 estimated 
resident female population in a 12-month period for females of all 
ages and for the target age group 20–69. 
Context This indicator measures the incidence rates of all cervical cancers by 
histological type in women in Australia. 
Collection and usage attributes 
Formula Number of new cases of cervical cancer in a 12-month period 
ABS ERP for the same 12-month period 
 
Numerator The number of new cases of cervical cancer 
Source  AIHW Australian Cancer Database 
Numerator 
specifications 
 All cervical cancer is defined as ICD10 code C53. 
 Carcinoma is defined as ICD10 code C53 and 8010 ≤ ICDO3 
code ≤ 8380 or 8382 ≤ ICDO3 code ≤ 8576. 
 Squamous cell carcinoma is defined as ICD10 code C53 and 
8050 ≤ ICDO3 code ≤ 8078 or ICDO3 code 8083,8084 . 
 Adenocarcinoma is defined as ICD10 code C53 and ICDO3 code 
8140,8141,8230,8231,8260,8261,8262,8263,8310,8380,8382,83
83,8384,8576 or 8190 ≤ ICD03 code ≤  8211 or 8440 ≤  ICD03 
code ≤ 8490 or 8570 ≤ ICDO3 code ≤ 8574. 
 Adenosquamous carcinoma is defined as ICD10 code C53 and 
ICDO3 code 8560. 
 Sarcoma is defined as ICD10 code C53 and 8800 ≤ ICDO3 code 
≤ 8811 or 8840 ≤ ICDO3 code ≤ 8921 or 9040 ≤ ICDO3 code ≤ 
9044 or 9120 ≤ ICDO3 code ≤ 9133 or 9540 ≤ ICDO3 code ≤ 
9581 or ICDO3 code 8830,8990,8991, 9150. 
 Other and unspecified cervical cancer is defined as ICD10 code 
C53 and ICDO3 code not equal to those specified for carcinoma 
or sarcoma. 
 Aboriginal and Torres Strait Islander cancer incidence 
calculations are restricted to New South Wales, Queensland, 
Western Australia and the Northern Territory. 
Denominator The number of women in that particular age group, using Australian 
Bureau of Statistics estimated resident female mid-year population 
Source ABS Estimated Resident Population 
  
 146 National Cervical Cancer Prevention Data Dictionary Version 1 
Indicator 7 Mortality 
Identifying and definitional attributes 
Data element type Performance indicator 
Definition Mortality from cervical cancer per 100,000 estimated resident female 
population in a 12-month period for women of all ages and for the 
target age group 20–69. 
Context Cervical cancer is one of the few cancers for which there is an 
efficacious screening test for detection of precursors of the disease. 
Most deaths due to cervical cancer are potentially avoidable (Marcus 
& Crane 1988). The objective of the National Cervical Screening 
Program is to reduce this mortality rate. 
Changes in mortality rates will not be evident for a number of years 
following an improvement in the participation rates. Therefore, the 
effectiveness of this measure needs to be viewed in the longer rather 
than the shorter term. 
Collection and usage attributes 
Formula Number of deaths from cervical cancer in a 12-month period 
ABS ERP for the same 12-month period 
 
Numerator The number of deaths from cervical cancer 
Source AIHW National Mortality Database 
Numerator 
specifications 
 Cervical cancer is defined as ICD9 code 180 for years 1982–
1996 and ICD10 code C53 for years 1997–current. 
 Based on year of death, apart from the most recent year that is 
based on year of registration of death. 
 Aboriginal and Torres Strait Islander cancer mortality calculations 
are restricted to New South Wales, Queensland, Western 
Australia, South Australia and the Northern Territory. 
Denominator The number of women in that particular age group, using Australian 
Bureau of Statistics estimated resident female mid-year population 
Source ABS Estimated Resident Population 
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Appendix A: Data and the cervical 
screening registries  
The following flowchart (Figure A1) describes the way in which data are received by the 
cervical screening registries. Note that this is a generic diagram, with each jurisdiction 
having slight differences in the way data are received and compiled. 
Note that this flowchart only covers the flow of data to the cervical screening registers; it 
does not include clinical pathways. 
 
Figure A1: Generic flowchart showing the way in which data are received by the cervical 
screening registries 
Woman has  cervical screening test performed by healthcare professional 
(Cytology/Histology/HPV DNA) 
Test sample and details 
 
Pathology laboratory sends test results and details of woman and provider to Cervical Screening 
Register 
 
Data matching of woman’s details to determine 
if she is already on the Register or a new client 
Test results and details of woman and provider 
stored in Cervical Screening Register 
Cervical Screening Register 
Pathology laboratory 
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Appendix B: Class diagrams 
In order to better model the relationships, the data elements have been categorised into 
object classes. The object classes are very similar to the data element sections identified in 
this document (see Chapter 3) but are more in line with the standards used by the AIHW. In 
addition, domain or object class diagrams have been added in order to show the most 
important relationships between the object classes.  
The table below (Table B1) outlines the descriptions associated with object classes that are 
interlinked to represent data relationships. 
 
Table B1: Object classes 
Object classes Description 
 A class: a named collection of data elements 
representing a class of real world objects e.g. 
clients. 
 
 An abstract class (note the italics): a class that is a 
generalisation of some more specific classes. E.g. 
a Test is a generalisation of the specific types of 
cytology, histology, and HPV DNA tests. 
Abstract classes need not exist independently of 
the specific classes. 
 
 Generalisation/specialisation: a relationship 
between two classes that shows one is a 
generalisation of the other. Alternatively, the 
latter is a specialisation of the former. E.g. The 
Cytology class is a specialisation of the Test class 
i.e. Cytology is a type of Test. 
 
 Association: a relationship that indicates that one 
class is associated with another. The relationship 
can indicate the cardinality (multiplicity) of the 
association in each direction. The relationship 
can also be named and have an arrow indicating 
in which direction the name is to be read. E.g. a 
Test is analysed by at least 1 and at most 1 
Laboratory. A Laboratory analysed possibly 0 
and at most n Tests. Common cardinalities are: 
0..1, 1..1, 0..n, & 1..n although any range is 
possible. "n" need not be replaced by a specific 
number in which case it means "many". 
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Listed below are the class definitions and how they relate to the current data elements: 
Woman 
Class elements relating to the woman (excluding address details). Reflected within the 
following data element sections: 
 Woman A1 to A10  
 Woman A21 to A25 
Laboratory 
Class elements relating to the laboratory. Reflected within the following data element 
sections: 
 L1—Pathology laboratory 
 L2—Laboratory receipt date 
Cytology 
Class elements relating to a cytology test. Reflected within the following data element 
sections: 
 Cytology—C1 to C9 
Histology 
Class elements relating to a histology test. Reflected within the following data element 
sections: 
 Histology—H1 to H9 
HPV DNA 
Class elements relating to an HPV DNA test. Reflected within the following data element 
selections: 
 HPV DNA—D1 to D10 
HPV vaccination 
Class elements relating to a single HPV vaccination episode. Reflected within the following 
data element selections: 
 V4—HPV vaccination episode date 
 V5—HPV vaccine dose 
Vaccination (course) 
Class elements related to a linked set of vaccination episodes (see abstract class definitions 
below). Reflected within the following data element selections: 
 V1—HPV vaccine type 
 V2—HPV vaccination status 
 V3—HPV vaccination completion date 
27 month reminder letter to women 
A class of elements related to the 27 month reminder letter to a woman. Reflected within the 
following data element selections: 
 F1—Reminder letter sent 
 F2—Date letter sent 
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Address 
Class elements related to address details. Reflected within the following data element 
sections: 
 Woman A11 to A15 : Residential Address 
 Woman A16 to A20 : Mailing Address 
 Provider B7 to B11 : Provider Requesting Test Address 
Practice 
Class elements related to practice details (exc. address). Reflected within the following data 
element selections: 
 B1—Medicare provider number (Provider requesting test) 
 B3 & B15—HPI-O (Provider requesting test / Provider collecting test) 
 B6—Practice Name (Provider requesting test) 
Provider 
Class elements related to provider details. Reflected within the following data element 
selections: 
 B2 & B14—HPI-I (Provider requesting test / Provider collecting test) 
 B4—Family Name (Provider requesting test) 
 B5—Given Names (Provider requesting test) 
 B12—Occupation (Provider collecting test) 
 B13—Identifier (Provider collecting test)   
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Figure B1: Class diagram: Woman and Events 
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Figure B2: Class diagram: Tests 
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Figure B3: Class diagram: Follow-up 
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Figure B4: Class diagram: Vaccinations 
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Appendix C: Definition of ‘opt off’ in the 
National Cervical Screening Program 
Women are able to ‘opt off’ the cervical screening register. A woman may do this at the time 
of her Pap test or related cervical test by electing not to have her results forwarded to the 
Register, or she may do this post registration. The following describes what ‘opt off’ means 
in terms of data implications for each state and territory. It should be appreciated that these 
decisions are largely a function of the over-arching health department policies that exist 
within each jurisdiction. 
Table C1: Opt off 
States and territories Data implications of opt off 
New South Wales An opt-off test cannot be linked to a woman’s existing 
record in the register. Her existing register record 
remains active.  
The woman’s record is de-identified, which means her 
identifying details including names, address and DOB 
are removed from her record. Her existing register 
record is inactivated and her previous tests in the 
record are de-linked. The NSW PTR retains her test 
results for statistical purposes. 
Victoria The woman’s record is deleted from the database.  
Queensland The woman’s record is removed from the Register; she 
will not appear in any statistics. 
Western Australia Western Australia enables a woman to ‘opt off’ the 
Register, and also to specify that a test is ‘not for 
register’. 
The woman’s identifying details are changed to 
‘withdrawn’. DOB, suburb, postcode and test are kept 
on the register for statistical purposes. 
South Australia TBA 
Tasmania Tasmania legislatively enables a female to ‘opt off’ the 
Register, and also to specify that a test is ‘not for 
register’. 
The woman’s identifying details are changed to 
'deleted’ including address details. All comments on her 
Register entry are deleted, but test results remain to 
allow reporting. 
Women must specify at each test that the result is ‘not 
for register’. These results are not sent by pathology 
laboratories to the Register. 
Australian Capital Territory The woman’s demographics are de-identified; her 
screening data remain for statistical purposes  
Northern Territory An opt-off test result will not be sent to the Register. 
The woman’s identity related data and test results are 
removed. Date of birth and initial letters of first name 
and surname are kept for statistical reasons. She is 
marked permanently inactive. 
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Appendix D: Histology code concordances  
Although cytology results are coded consistently across states and territories using the 
national Cervical Cytology Coding Sheet, state and territory cervical screening registries 
each have their own histology coding sheets for the coding of histology results, which means 
that there are no nationally consistent histology codes.  
The histology result codes that have been developed in this document are therefore only 
useful if each state and territory cervical screening registry is able to map their histology 
result codes to this higher level coding system. This Appendix therefore comprises 
concordances of histology result codes for each state and territory, to allow this mapping to 
occur. 
There are three histology data elements that require concordances. These are: H4 Histology 
test—procedure used for obtaining specimen for histological analysis; H5 Histology  
test—cervical (squamous) cell analysis; and H6 Histology test—endocervical (glandular) cell 
analysis. For each of these data elements, the state and territory histology result codes for 
each permissible value are listed. 
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New South Wales 
H4 Histology test—procedure used for obtaining specimen for histological 
analysis  
HP01: Biopsy 
The following codes signify that the specimen was obtained by biopsy 
SNOMED International  
P103000 Excision, NOS/Resection, NOS/Incision and removal, NOS/Extirpation, 
NOS/Ablation, NOS/Abscission, NOS 
P103002 Complete excision/complete incision and removal 
P103100 Biopsy, NOS 
P103101 Excisional biopsy 
P103102 Incisional biopsy 
P103112 Punch biopsy 
P103122 Fine needle biopsy, NOS/Aspiration biopsy, NOS/Fine needle aspiration biopsy, 
NOS 
P183400 Cervical biopsy, NOS 
P183425 Punch biopsy of cervix 
P183460 Endocervical biopsy 
HP02: Endocervical curettage 
The following codes signify that the specimen was obtained by endocervical curettage 
SNOMED International 
P103150 Curettage, NOS/Curettement, NOS 
P103151 Dilation and curettage 
P183314 Diagnostic aspiration curettage of uterus/Aspiration curettage of 
endometrium/Endometrial biopsy by suction 
P750600 Diathermy, NOS/ Physical medicine diathermy treatment to one area 
HP03: LLETZ/LEEP loop biopsy 
The following codes signify that the specimen was obtained by LLETZ/LEEP loop biopsy 
SNOMED International  
P103126 Loop electrosurgical excision procedure, NOS LEEP 
P183423 Loop electro excision of cervix, LEEP procedure of cervix 
HP04: Cone biopsy 
The following codes signify that the specimen was obtained by cone biopsy 
SNOMED International  
P183420 Cone biopsy of cervix, NOS/Conization of uterine cervix/Cone biopsy of cervix 
without dilation and curettage, without repair 
P183422 Excision of cervix by electroconization 
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HP05: Polypectomy 
The following codes signify that the specimen was obtained by polypectomy 
SNOMED International  
P103210 Polypectomy, NOS 
HP06: Subtotal hysterectomy 
The following codes signify that the specimen was obtained by hysterectomy, but it is not specified as 
to whether the hysterectomy was total or subtotal 
SNOMED International 
P183350 Hysterectomy, NOS 
HP07: Hysterectomy 
The following codes signify that the specimen was obtained by hysterectomy 
SNOMED International 
P183353 Total hysterectomy with removal of both tubes and ovaries /Bilateral 
hysterosalpingo-ovariectomy 
P183356 Total hysterectomy with unilateral removal of tube and ovary 
P183360 Vaginal Hysterectomy 
HP09: Amputated cervix 
The following codes signify that the specimen was obtained by amputated cervix 
P183440 amputation of cervix/Cervicectomy / Trachelectomy / Excision of cervical stump / 
Hysterotracheletomy 
HP10: Not disclosed 
No codes for this jurisdiction 
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H5 Histology test—cervical (squamous) cell analysis 
Note that all negative and unsatisfactory histology codes have been allocated to cervical (squamous) 
cell analysis, and not repeated for either endocervical (glandular) or vaginal cell analysis. This is due 
to the nature in which New South Wales receives histology results from laboratories, which does not 
readily allow differentiation between cervical (squamous) and endocervical (glandular) results from 
these categories.  
HS01: Negative cervical specimen 
The following histology codes signify that a cervical specimen analysis result is negative (for the 
purposes of assessment for cancer or pre-cancerous changes) 
SNOMED International  
Topography code for the cervix and: 
M00100U Normal tissue, NOS/Normal tissue morphology, NOS/Normal appearance of tissue, 
NOS 
M00110 No pathological diagnosis/No pathologic finding/No abnormality seen/No diagnostic 
abnormality 
M09410 No evidence of neoplasm/No evidence of tumour 
M09460 Negative for tumour cells 
D771510 Cervicitis, NOS 
D771512 Acute cervicitis 
D771514 Chronic cervicitis 
D771520 Cervicitis with erosion 
D771522 Cervicitis with ectropion 
D771524 Chronic cervicitis with erosion 
D771526 Chronic cervicitis with ectropion 
D771550 Nabothian gland cyst/Nabothian follicles/Naboth’s follicles/Nabothion cyst 
D772000 Endometriosis, NOS 
D772106 Endometriosis of cervix 
D775722 Squamous metaplasia of cervix 
D775784 Mucous polyp of cervix 
D775788 Cyst of cervix 
M11600 Radiation injury, NOS/radiation effect on tissue, NOS 
M11620 Radiation injury with inflammation 
M11640 Radiation injury with fibrosis/Radiation injury with proliferation/Radiation fibromatosis 
M38000 Ulcer, NOS/Ulceration, NOS/Ulcerative lesion, NOS/Ulcus, NOS 
M38350 Superficial ulcer/Erosion/Superficial ulceration 
M40000 Inflammation, NOS/Inflammatory reaction, NOS/Inflammatory cell infiltration, 
NOS/Inflammatory infiltration, NOS/Leucocytic infiltrate, NOS 
M40100 Exudative inflammation, NOS/Inflammatory exudate, NOS 
M40750 Ulcerative inflammation, NOS/Erosive inflammation, NOS 
M41000 Acute inflammation, NOS/Acute inflammatory reaction, NOS/Acute inflammatory cell 
infiltration, NOS/Polymorphonuclear leucocyte infiltration, NOS 
M41100 Acute exudative inflammation, NOS/Acute inflammatory exudate 
M41400 Acute membranous inflammation, NOS/Acute inflammatory membrane, NOS/Acute 
pyogenic membrane, NOS 
M41602 Pus, NOS 
M41610 Abscess/Acute abscess 
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M42000 Subacute inflammation, NOS/Acute and chronic inflammation, NOS/Active chronic 
inflammation, NOS/Subacute inflammatory cell infiltration, NOS/Subacute 
inflammatory cell infiltrate, NOS 
M43000 Chronic inflammation, NOS/Chronic inflammatory reaction, NOS/Chronic 
inflammatory cell infiltration, NOS 
M43020 Follicular inflammation, NOS 
M43060 Plasma cell inflammation, NOS/Plasma cell infiltration, NOS/Plasmacytic infiltrate, 
NOS 
M43750 Chronic ulcerative inflammation, NOS/Chronic erosive inflammation, NOS 
M44000 Granulomatous inflammation, NOS/Granuloma, NOS/Histiocytic 
granuloma/Epithelioid granuloma 
M45020 Granulation tissue 
M60000 Normal cytology/Normal cellular morphology 
M67050 Inflammatory atypia 
M67051 Mild inflammatory atypia 
M67052 Moderate inflammatory atypia 
M68020 Estrogen effect, NOS 
M68070 Progesterone effect present 
M71000 Hypertrophy, NOS/Enlargement, NOS 
M72000 Hyperplasia, NOS/Cellular hyperplasia/Hypercellularity 
M72020 Secondary hyperplasia/Reactive hyperplasia/Compensatory hyperplasia 
M72040 Polypoid hyperplasia 
M72120 Basal cell hyperplasia/Reserve cell hyperplasia 
M72160 Acanthosis, NOS 
M72600 Hyperkeratosis, NOS/Keratosis, NOS/Excessive cornification/Skin 
callus/Callosity/Keratoma/Tyloma/Tylosis 
M72760 Benign squamous keratosis 
M72830 Leukoplakia, NOS 
M72860 Keratoacanthoma, NOS/Localized keratoacanthoma 
M73000 Metaplasia, NOS 
M73200 Epithelial metaplasia, NOS/Epithelialisation, NOS 
M73220 Squamous metaplasia/Epidermoid metaplasia/Epidermalisation 
M73230 Keratin pearl formation/Epithelial pearl 
M73260 Transitional cell metaplasia 
M76000 Proliferation, NOS 
M76800 Polyp, NOS 
M76810 Fibroepithelial polyp/Fibroepithelial papilloma/Fibrous polyp/Skin tag/Acrochordon 
M76820 Inflammatory polyp/Pseudopolyp, NOS/Inflammatory pseudopolyp 
M78000 Fibrosis, NOS/Fibroplasia, NOS/Fibrous repair/Desmoplasia/Fibrous thickening 
M78060 Scar, NOS/Scar tissue/Cicatrix 
M78290 Healing scar 
M78400U Adhesion, NOS 
M79900 Regeneration, NOS 
M81400 Adenoma, NOS 
M82100 Adenomatous polyp, NOS/Polypoid adenoma 
M84700 Mucinous cystadenoma, NOS/Mucinous cystoma/Pseudomucinous cystadenoma, 
NOS 
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HS02: Low-grade squamous abnormality 
The following histology codes signify a low-grade squamous abnormality 
SNOMED International  
Topography code for the cervix and: 
DE32A00 Disease due to Papilloma virus, NOS 
DE32A10 Papovavirus infection subgroup A, NOS 
DE32A20 Condyloma acuminatum/Venereal wart/Anogenital wart 
L35600 Papillomavirus, NOS/Papillomavirus group, NOS/Papovavirus, NOS 
L35610 Human papillomavirus group, NOS 
L35620 Human papillomavirus, NOS/Warts virus/Verruca vulgaris virus 
L35621 Human papillomavirus type 1 
L35622 Human papillomavirus type 2 
L35623 Human papillomavirus type 3 
L35624 Human papillomavirus type 4 
L35625 Human papillomavirus type 5 
L35626 Human papillomavirus type 6 
L35627 Human papillomavirus type 7 
L35628 Human papillomavirus type 8 
L35629 Human papillomavirus type 9 
L36210 Human herpes simplex virus, NOS/HSV/Herpes virus, NOS 
L36212 Human herpes simplex virus type 2 
M01000U Morphologic abnormality, NOS/Morphologic alteration, NOS/Morphologic change, 
NOS/Abnormal tissue appearance, NOS 
M67000 Cytologic atypia, NOS/Atypical cell present, NOS 
M67001 Mild cytologic atypia 
M67010 Squamous cell atypia 
M67011 Mild squamous cell atypia 
M67012 Moderate squamous cell atypia 
M67013 Severe squamous cell atypia 
M67016 Low grade squamous intraepithelial lesion/CIN 1 
M67090 Koilocytotic atypia, NOS/Koilocytosis, NOS 
M67091 Mild koilocytotic atypia 
M67092 Moderate koilocytotic atypia 
M67093 Severe koilocytotic atypia 
M72005 Atypical hyperplasia 
M73225 Atypical squamous metaplasia 
M80500 Papilloma, NOS 
M80520 Squamous cell papilloma/Squamous papilloma/Keratotic papilloma 
M80600 Papillomatosis, NOS 
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HS03: High-grade squamous abnormality 
The following histology codes signify a high-grade squamous abnormality 
HS03.1: High-grade (CIN NOS) 
SNOMED International  
Topography code for the cervix and: 
D775720 Dysplasia of cervix 
M67015 Squamous intraepithelial lesion, NOS/SIL 
M67060 Atypia suspicious for malignancy/Suspect cell present 
M67200 Dyskaryosis 
M74000 Dysplasia, NOS/Acquired dysplasia, NOS  
M80001 Neoplasm, uncertain whether benign or malignant/Neoplasm, NOS/Tumour, 
NOS/Unclassified tumour, uncertain whether benign or malignant 
HS03.2: High-grade (CIN II) 
No codes for this jurisdiction 
HS03.3: High-grade (CIN III) 
SNOMED International  
Topography code for the cervix and: 
M67017 High grade squamous intraepithelial lesion/High grade SIL/CIN II/CIN III 
M80102 Carcinoma in situ, NOS/Intraepithelial carcinoma, NOS 
M80702 Squamous cell carcinoma in situ, NOS/Epidermoid carcinoma in situ, 
NOS/Intraepidermal carcinoma, NOS/Intraepithelial squamous cell carcinoma 
M80762 Squamous cell carcinoma in situ with questionable stromal invasion/Epidermoid 
carcinoma in situ with questionable stromal invasion 
M80772 Intraepithelial neoplasia, grade III, of cervix, vulva and vagina 
HS04: Squamous cell carcinoma 
The following histology codes signify an invasive or malignant result 
HS04.1: Squamous cell carcinoma (microinvasive) 
SNOMED International  
Topography code for the cervix and: 
M80763 Squamous cell carcinoma, microinvasive 
M80773 Microinvasive squamous cell carcinoma, described as FIGO state 1A1 
M80783 Microinvasive squamous cell carcinoma, described as FIGO state 1A2 
M80873 Microinvasive squamous cell carcinoma, described as FIGO state 1A1 
M80883 Microinvasive squamous cell carcinoma, described as FIGO state 1A2 
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HS04.2: Squamous cell carcinoma (invasive) 
Note: There is inconsistency with how the term metastatic is used by pathology laboratories. Metastatic cancers 
should only be included if they are primary cervical cancers that have metastasised elsewhere, not if they are 
primary cancers from other sites that have metastasised to the cervix or endocervix. 
SNOMED International  
Topography code for the cervix and: 
M80003 Neoplasm, malignant/Tumour, malignant, NOS/Malignancy/Cancer/Unclassified 
tumour, malignant/Blastoma, NOS 
M80103 Carcinoma, NOS/Epithelial tumour, malignant 
M80123 Large cell carcinoma, NOS 
M80213 Carcinoma, anaplastic, NOS 
M80523 Papillary squamous cell carcinoma/Papillary epidermoid carcinoma 
M80703 Squamous cell carcinoma, NOS/Epidermoid carcinoma, NOS/Squamous 
carcinoma/Squamous cell epithelioma 
M80713 Squamous cell carcinoma, keratinising, NOS 
M80723 Squamous cell carcinoma, large cell, nonkeratinising/Squamous cell carcinoma, 
nonkeratinising, NOS/Epidermoid carcinoma, large cell, nonkeratinising 
M80733 Squamous cell carcinoma, small cell, non-keratinising/Epidermoid carcinoma, small 
cell, nonkeratinising 
M80743 Squamous cell carcinoma, spindle cell/Epidermoid carcinoma, spindle cell 
M80753 Adenoid squamous cell carcinoma/Pseudoglandular squamous cell carcinoma 
HSU: Unsatisfactory specimen 
The following histology codes signify that a cervical specimen is unsatisfactory 
SNOMED International  
Topography code for the cervix and: 
M00001 Morphology unknown 
M00003U Morphology not assigned in SNOMED 
M09005 Specimen less than optimal for diagnosis/Specimen less than optimal for 
interpretation 
M09010 Specimen unsatisfactory for diagnosis/Specimen insufficient for diagnosis/Specimen 
inadequate for diagnosis 
M09011 Insufficient tissue for diagnosis/Insufficient material for diagnosis/Scant cellularity on 
smear 
M09030 Artifact, NOS/Morphologic artifact, NOS 
M09150 Tissue lost in processing 
HSN Not applicable 
No codes for this jurisdiction 
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H6 Histology test—endocervical (glandular) cell analysis 
Note that all negative and unsatisfactory histology codes have been allocated to cervical (squamous) 
cell analysis, and not repeated for either endocervical (glandular) or vaginal cell analysis. This is due 
to the nature in which New South Wales receives histology results from laboratories, which does not 
readily allow differentiation between cervical (squamous) and endocervical (glandular) results from 
these categories.  
HE02: Endocervical atypia 
The following histology codes signify Endocervical atypia  
SNOMED International  
Topography code for the cervix and: 
M67020 Columnar cell atypia 
M67030 Glandular cell atypia 
M67031 Mild glandular cell atypia 
M67032 Moderate glandular cell atypia 
M67033 Severe glandular cell atypia 
HE03: High-grade endocervical abnormality 
The following histology codes signify a high-grade endocervical abnormality 
HE03.1: High-grade (endocervical dysplasia) 
No codes for this jurisdiction 
HE03.2: High-grade (adenocarcinoma in situ) 
SNOMED International  
Topography code for the cervix and: 
M81402 Adenocarcinoma in situ 
HE03.3: High-grade (mixed carcinoma in situ/adenocarcinoma in situ) 
SNOMED International  
Topography code for the cervix and: 
M85602 Adenosquamous carcinoma in situ/Mixed adenocarcinoma and squamous cell 
carcinoma in situ/Mixed adenocarcinoma and epidermoid carcinoma in situ 
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HE04: Endocervical adenocarcinoma 
The following histology codes signify endocervical adenocarcinoma (includes adenosquamous 
carcinoma and carcinoma of the cervix (other)) 
HE04.1: Endocervical adenocarcinoma (microinvasive) 
No codes for this jurisdiction 
HE04.2: Endocervical adenocarcinoma (invasive) 
SNOMED International  
Topography code for the cervix and: 
M81403 Adenocarcinoma, NOS 
M82603 Papillary adenocarcinoma 
M83103 Clear cell adenocarcinoma, NOS/Clear cell adenocarcinoma, mesonephroid/Clear 
cell carcinoma 
M83803 Endometrioid carcinoma 
M83823 Endometrioid adenocarcinoma, secretory variant 
M83833 Endometrioid adenocarcinoma, ciliated cell variant 
M83843 Adenocarcinoma, endocervical type 
M84803 Mucinous adenocarcinoma/Mucinous carcinoma/Colloid adenocarcinoma/Colloid 
carcinoma/Gelatinous adenocarcinoma/Gelatinous carcinoma/Mucoid 
adenocarcinoma/Mucoid carcinoma/Mucous adenocarcinoma/Mucous carcinoma 
M84813 Mucin-producing adenocarcinoma/Mucin-producing carcinoma/Mucin-secreting 
adenocarcinoma/Mucin-secreting carcinoma 
M85703 Adenocarcinoma with squamous metaplasia/Adenoacanthoma 
HE04.3: Adenosquamous carcinoma 
SNOMED International  
Topography code for the cervix and: 
M85603 Adenosquamous carcinoma/Mixed adenocarcinoma and squamous cell 
carcinoma/Mixed adenocarcinoma and epidermoid carcinoma 
HE04.4:Carcinoma of the cervix (other) 
SNOMED International  
Topography code for the cervix and: 
M80203 Carcinoma, undifferentiated, NOS 
M80413 Small cell carcinoma, NOS/Reserve cell carcinoma/Round cell carcinoma 
M82403 Carcinoid tumour, NOS/Carcinoid, NOS 
M82463 Neuroendocrine carcinoma 
M89803 Carcinosarcoma, NOS 
M82003 Adenoid cystic carcinoma/Cylindroma, NOS/Adenocarcinoma, cylindroid 
type/Adenocystic carcinoma 
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Victoria 
H4 Histology test—procedure used for obtaining specimen for histological 
analysis  
HP01: Biopsy 
The following codes signify that the specimen was obtained by biopsy 
1 Target punch biopsy 
4 Random punch biopsy 
HP02: Endocervical curettage 
The following codes signify that the specimen was obtained by endocervical curettage 
0 Endocervical curettage 
HP03: LLETZ/LEEP loop biopsy 
The following codes signify that the specimen was obtained by LLETZ/LEEP loop biopsy 
9 LLETZ/LEEP loop biopsy 
HP04: Cone biopsy 
The following codes signify that the specimen was obtained by cone biopsy 
2 Cone biopsy 
HP05: Polypectomy 
The following codes signify that the specimen was obtained by polypectomy 
7 Polypectomy 
HP06: Subtotal hysterectomy 
The following codes signify that the specimen was obtained by subtotal hysterectomy 
10 Sub-total hysterectomy 
HP07: Hysterectomy 
The following codes signify that the specimen was obtained by hysterectomy 
3 Hysterectomy 
HP09: Amputated cervix 
The following codes signify that the specimen was obtained by amputated cervix 
11 Amputated cervix 
HP10: Not disclosed 
No codes for this jurisdiction 
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H5 Histology test—cervical (squamous) cell analysis 
HS01: Negative cervical specimen  
The following histology codes signify that a cervical specimen analysis result is negative (for the 
purposes of assessment for cancer or pre-cancerous changes) 
1100 Normal cervical epithelium 
1101 Atrophic cervical epithelium 
2109 Cervix - benign lesion 
HS02: Low-grade squamous abnormality 
The following histology codes signify a low-grade squamous abnormality 
2106 Cervix - HPV 
2118 Cervix - possible low-grade squamous abnormality +/- HPV 
4105 Cervix - mild dysplasia +/- HPV 
4111 Cervix - low-grade squamous abnormality +/- HPV 
HS03: High-grade squamous abnormality 
The following histology codes signify a high-grade squamous abnormality 
HS03.1: High-grade (CIN NOS) 
4104 Cervix - dysplasia +/- HPV 
4112 Cervix - possible high grade squamous abnormality +/- HPV 
4113 Cervix - high grade squamous abnormality +/- HPV 
HS03.3: High-grade (CIN II) 
4106 Cervix - moderate dysplasia +/- HPV 
HS03.3: High-grade (CIN III) 
4107 Cervix - moderate/severe dysplasia +/- HPV 
5100 Cervix - severe dysplasia/carcinoma in situ +/- HPV 
5101 Cervix - carcinoma in situ +/- HPV 
5118 Cervix - squamous carcinoma in situ with questionable microinvasion +/- HPV 
HS04: Squamous cell carcinoma 
The following histology codes signify an invasive or malignant result 
HS04.1: Squamous cell carcinoma (microinvasive) 
5102 Cervix - microinvasive carcinoma +/- HPV 
HS04.2: Squamous cell carcinoma (invasive) 
5103 Cervix - squamous cell carcinoma +/- HPV 
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HSU: Unsatisfactory specimen 
0100 Non-diagnostic biopsy (unsatisfactory) 
HSN: Not applicable 
No codes for this jurisdiction 
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H6 Histology test—endocervical (glandular) cell analysis 
HE01: Negative endocervical specimen  
The following histology codes signify that an endocervical specimen analysis result is negative (for 
the purposes of assessment for cancer or pre-cancerous changes) 
2102 Endocervical polyp/hyperplasia 
HE02: Endocervical atypia 
The following histology codes signify Endocervical atypia  
2112 Endocervix - possible low-grade abnormality +/- HPV 
4805 Endocervix - mild dysplasia +/- HPV 
4811 Endocervix - low-grade glandular abnormality +/- HPV 
4814 Cervix - possible low grade mixed adenosquamous abnormality +/- HPV 
4815 Cervix - low grade mixed adenosquamous abnormality +/- HPV 
HE03: High-grade endocervical abnormality 
The following histology codes signify a high-grade endocervical abnormality 
HE03.1: High-grade (endocervical dysplasia) 
4804 Endocervix - dysplasia +/- HPV 
4806 Endocervix - moderate dysplasia +/- HPV 
4812 Endocervix - possible high-grade glandular abnormality +/- HPV 
4813 Endocervix - high grade glandular abnormality +/- HPV 
4816 Cervix - possible high grade adenosquamous abnormality +/- HPV 
4817 Cervix - high grade adenosquamous abnormality +/- HPV 
HE03.2: High-grade (adenocarcinoma in situ) 
4807 Endocervix - moderate/severe dysplasia +/- HPV 
5114 Endocervix - adenocarcinoma in situ 
5115 Endocervix - adenocarcinoma in situ & HPV 
5119 Endocervix - adenocarcinoma in situ with questionable microinvasion +/- HPV 
HE03.3: High-grade (carcinoma in situ/adenocarcinoma in situ) 
5117 Cervix - mixed adenosquamous/carcinoma in situ 
 
HE04: Endocervical adenocarcinoma 
The following histology codes signify endocervical adenocarcinoma (includes adenosquamous 
carcinoma and carcinoma of the cervix (other)) 
HE04.1: Endocervical adenocarcinoma (microinvasive) 
5116 Endocervix - microinvasive adenocarcinoma 
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HE04.2: Endocervical adenocarcinoma (invasive) 
5106 Endocervix – adenocarcinoma 
5107 Cervix - embryonal/clear cell carcinoma* 
HE04.3: Adenosquamous carcinoma 
5105 Cervix - mixed adenosquamous carcinoma 
HE04.4: Carcinoma of the cervix (other) 
5104 Cervix - small cell carcinoma 
5108 Cervix - other malignant lesion* 
HEU: Unsatisfactory specimen 
No codes for this jurisdiction 
HEN: Not applicable 
No codes for this jurisdiction 
*may include tumours of non-epithelial origin 
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Queensland 
H5 Histology test—cervical (squamous) cell analysis 
Note that all negative and unsatisfactory histology codes have been allocated to cervical 
(squamous) cell analysis, and not repeated for endocervical (glandular) cell analysis. This is due to 
the nature in which Queensland receives histology results from laboratories, which does not readily 
allow differentiation between cervical (squamous) and endocervical (glandular) results from these 
categories.  
HS01: Negative cervical specimen 
The following histology codes signify that a cervical specimen analysis result is negative (for the 
purposes of assessment for cancer or pre-cancerous changes) 
SNOMED International  
Topography code for the cervix and: 
M00100 Normal tissue morphology, NOS 
M00100U U normal tissue, NOS 
M00110 No pathologic diagnosis 
M00120 Normal cellular morphology 
M09410 No evidence of neoplasm 
M09450 No evidence of malignancy 
M33400 Cyst, NOS 
M37000 Haemorrhage, NOS 
M38000 Ulcer, NOS 
M40000 Inflammation, NOS 
M41000 Acute inflammation, NOS 
M42000 Subacute inflammation, NOS 
M42100 Acute and chronic inflammation, NOS 
M43000 Chronic inflammation, NOS 
M54000 Necrosis, NOS 
M58000 Atrophy 
M67055 Post-radiation cytologic changes without dysplasia 
M72480 Microglandular hyperplasia 
M72600 Hyperkeratosis, NOS 
M73000 Metaplasia, NOS 
M73220 Squamous metaplasia 
M74470 Parakeratosis, NOS 
M76500 Endometriosis, NOS 
M76800 Polyp, NOS 
M76810 Fibroepithelial polyp 
M83400 Nabothian cyst 
M88900 Leiomyoma, NOS 
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SNOMED 2 
Topography code for the cervix and: 
M00100 Normal tissue morphology, NOS 
M00110 Normal microscopic morphology 
M00120 Normal cellular morphology 
M09450 No evidence of malignancy 
M33400 Cyst, NOS 
M37000 Haemorrhage, NOS 
M38000 Ulcer, NOS 
M40000 Inflammation, NOS 
M41000 Acute inflammation, NOS 
M42000 Subacute inflammation 
M42100 Acute and chronic inflammation, NOS 
M43000 Chronic inflammation, NOS 
M54000 Necrosis, NOS 
M58000 Atrophy, NOS 
M67055 Post-radiation cytologic changes without dysplasia 
M72480 Hyperplasia, microglandular 
M72600 Hyperkeratosis, NOS 
M73000 Metaplasia, NOS 
M73220 Metaplasia, squamous 
M74030 Parakeratosis, NOS 
M76500 Endometriosis, NOS 
M76800 Polyp, NOS 
M76810 Polyp, fibroepithelial 
M83400 Nabothian cyst 
M88900 Leiomyoma, NOS 
HS02: Low-grade squamous abnormality 
The following histology codes signify a low-grade squamous abnormality 
SNOMED International  
Topography code for the cervix and: 
M67000 Cytologic atypia, NOS 
M67010 Squamous cell atypia 
M67016 Low grade intraepithelial lesion (CIN 1) 
M67056 Post-radiation cytologic changes with dysplasia 
M67090 Koilocytotic, NOS 
M69790 Koilocytotic atypia (HPV) 
M72005 Atypical hyperplasia 
M74001 Dysplasia – mild 
M74430 Dyskeratosis, NOS 
M76700 Condyloma, NOS 
M76720 Condyloma acuminatum 
M80500 Papilloma, NOS (except papilloma of bladder M81201) 
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SNOMED 2  
Topography code for the cervix and: 
M67016 CIN I 
M67056 Post-radiation cytologic changes with dysplasia 
M67090 Koilocytotic atypia 
M69700 Atypia, cytologic, NOS 
M69710 Squamous cell atypia 
M69790 Koilocytotic atypia 
M72005 Hyperplasia, atypical 
M74006 Dysplasia - mild (CIN 1) 
M74010 Dyskeratosis, NOS 
M76700 Condyloma, NOS 
M76720 Condyloma acuminatum 
M80500 Papilloma, NOS (except Papilloma of urinary bladder M81201)  
HS03: High-grade squamous abnormality (HSIL) 
The following histology codes signify a high-grade squamous abnormality (HSIL) 
HS03.1: High-grade (CIN NOS) 
SNOMED International  
Topography code for the cervix and: 
M67015 Squamous intraepithelial lesion, NOS 
M74000 Dysplasia, NOS 
SNOMED 2  
Topography code for the cervix and: 
M67015 Squamous intraepithelial lesion, NOS 
M74000 Dysplasia, NOS 
 
HS03.2: High-grade (CIN II) 
SNOMED International  
Topography code for the cervix and: 
M74002 Dysplasia – moderate 
SNOMED 2  
Topography code for the cervix and: 
M67017 CIN II 
M74007 Dysplasia - moderate (CIN 2) 
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HS03.3: High-grade (CIN III) 
SNOMED International  
Topography code for the cervix and: 
M67017 High grade intraepithelial lesion (CIN2/3) 
M74003 Dysplasia - severe 
M80001 Neoplasm, uncertain whether benign or malignant 
M80102 Carcinoma in situ, NOS 
M80702 Squamous cell carcinoma in situ, NOS 
M80762 Squamous cell carcinoma in situ 
M80772 Intraepithelial neoplasia, grade III, of cervix, vulva and vagina 
SNOMED 2  
Topography code for the cervix and: 
M74008 Dysplasia - severe (CIN 3) 
M80001 Neoplasm, uncertain whether benign or malignant 
M80102 Carcinoma in situ, NOS 
M80702 Squamous cell carcinoma in situ, NOS 
M80762 Squamous cell carcinoma in situ with questionable stromal invasion 
M80772 CIN III 
HS04: Squamous cell carcinoma 
The following histology codes signify an invasive or malignant result 
HS04.1: Squamous cell carcinoma (microinvasive) 
SNOMED International  
Topography code for the cervix and: 
M80763 Squamous cell carcinoma, microinvasive 
SNOMED 2  
Topography code for the cervix and: 
M80715 Microinvasive squamous cell carcinoma 
M80763 Squamous cell carcinoma, microinvasive 
 
HS04.2: Squamous cell carcinoma (invasive) 
SNOMED International  
Topography code for the cervix and: 
M80003 Malignancy, NOS 
M80009 Neoplasm, malignant, uncertain whether primary or metastatic 
M80103 Carcinoma, NOS 
M80513 Verrucous carcinoma, NOS 
M80703 Squamous cell carcinoma, NOS 
M80713 Squamous cell carcinoma, keratinising, NOS 
M80723 Squamous cell carcinoma, non-keratinising large cell type 
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SNOMED 2  
Topography code for the cervix and: 
M80003 Neoplasm, malignant 
M80009 Neoplasm, malignant, uncertain whether primary or metastatic 
M80103 Carcinoma, NOS 
M80513 Verrucous carcinoma, NOS 
M80703 Squamous cell carcinoma, NOS 
M80713 Squamous cell carcinoma, keratinising, NOS 
M80723 Squamous cell carcinoma, large cell, non-keratinising type 
HSU: Unsatisfactory specimen 
The following histology codes signify that a cervical specimen is unsatisfactory 
SNOMED International  
Topography code for the cervix and: 
M09000 Specimen unsatisfactory for diagnosis 
M09010 Specimen unsatisfactory for diagnosis 
M09011 Insufficient tissue for diagnosis 
M09100 No tissue received 
SNOMED 2  
Topography code for the cervix and: 
M09000 Insufficient tissue for diagnosis 
M09010 Tissue insufficient for diagnosis 
M09100 No tissue received 
HSN: Not applicable 
No codes for this jurisdiction 
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H6 Histology test—endocervical (glandular) cell analysis 
Note that all negative and unsatisfactory histology codes have been allocated to cervical 
(squamous) cell analysis, and not repeated for endocervical (glandular) cell analysis. This is due to 
the nature in which Queensland receives histology results from laboratories, which does not readily 
allow differentiation between cervical (squamous) and endocervical (glandular) results from these 
categories.  
HE02: Endocervical atypia 
The following histology codes signify endocervical atypia  
SNOMED International  
Topography code for the cervix and: 
M67020 Columnar cell atypia 
M67030 Glandular cell atypia 
SNOMED 2  
Topography code for the cervix and: 
M69720 Columnar cell atypia 
HE03: High-grade endocervical abnormality 
The following histology codes signify a high-grade endocervical abnormality 
HE03.1: High-grade (endocervical dysplasia) 
SNOMED International  
No codes for this jurisdiction 
SNOMED 2  
No codes for this jurisdiction 
HE03.2: High-grade (adenocarcinoma in situ) 
SNOMED International  
Topography code for the cervix and: 
M81402 Adenocarcinoma in situ 
SNOMED 2  
Topography code for the cervix and: 
M81402 Adenocarcinoma in situ 
HE04: Endocervical adenocarcinoma 
The following histology codes signify endocervical adenocarcinoma (includes adenosquamous 
carcinoma and carcinoma of the cervix (other)) 
  
National Cervical Cancer Prevention Data Dictionary Version 1 177 
HE04.1: Endocervical adenocarcinoma (microinvasive) 
SNOMED International  
No codes for this jurisdiction 
SNOMED 2  
No codes for this jurisdiction 
HE04.2: Endocervical adenocarcinoma (invasive) 
SNOMED International  
Topography code for the cervix and: 
M81403 Adenocarcinoma 
M81443 Adenocarcinoma, intestinal type 
M83103 Clear cell adenocarcinoma 
M83803 Endometroid carcinoma 
SNOMED 2  
Topography code for the cervix and: 
M81403 Adenocarcinoma, NOS 
M81443 Adenocarcinoma, intestinal type 
M83103 Clear cell adenocarcinoma, NOS 
M83803 Endometroid carcinoma 
HE04.3: Adenosquamous carcinoma 
SNOMED International  
Topography code for the cervix and: 
M85603 Adenosquamous carcinoma 
SNOMED 2  
Topography code for the cervix and: 
M85603 Adenosquamous carcinoma 
 
HE04.4: Carcinoma of the cervix (other) 
SNOMED International  
Topography code for the cervix and: 
M80413 Small cell carcinoma, NOS 
SNOMED 2  
Topography code for the cervix and: 
M80413 Small cell carcinoma, NOS 
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Western Australia  
H4 Histology test—procedure used for obtaining specimen for histological 
analysis  
HP01: Biopsy 
The following codes signify that the specimen was obtained by biopsy 
T1 Punch biopsy of cervix (for specimens with B1 at data element T1) 
T7 Vaginal biopsy (for specimens with B2 at data element T1) 
HP02: Endocervical curettage 
The following codes signify that the specimen was obtained by endocervical curettage 
T2 Endocervical curettage 
HP03: LLETZ/LEEP loop biopsy 
The following codes signify that the specimen was obtained by LLETZ/LEEP loop biopsy 
T3 Large loop excision of TZ 
HP04: Cone biopsy 
The following codes signify that the specimen was obtained by cone biopsy 
T4 Cone biopsy 
HP05: Polypectomy 
The following codes signify that the specimen was obtained by polypectomy 
TP Cervical polyp 
HP06: Subtotal hysterectomy 
The following codes signify that the specimen was obtained by subtotal hysterectomy 
TS Subtotal hysterectomy 
HP07: Hysterectomy 
The following codes signify that the specimen was obtained by hysterectomy 
T6 Hysterectomy 
HP09: Amputated cervix 
The following codes signify that the specimen was obtained by amputated cervix 
TA Amputated cervix 
HP10: Not disclosed 
The following codes signify that the procedure by which specimen obtained was not disclosed 
T0 Not disclosed 
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H5 Histology test—cervical (squamous) cell analysis 
HS01: Negative cervical specimen  
The following histology codes signify that a cervical specimen analysis result is negative (for the 
purposes of assessment for cancer or pre-cancerous changes) 
S1  Native squamous epithelium: squamous metaplasia; immature squamous metaplasia 
with or without inflammatory or reactive changes; atrophy and  
W1   Wart virus absent 
HS02: Low-grade squamous abnormality  
The following histology codes signify a low-grade squamous abnormality 
S2   Atypia. Atypical immature squamous metaplasia 
S2   Atypia. Atypical immature squamous metaplasia and 
W2  Equivocal HPV 
S3   HPV effect and 
W3  Human papillomavirus 
S4   Mild dysplasia (CIN 1) 
HS03: High-grade squamous abnormality  
The following histology codes signify a high-grade squamous abnormality (HSIL) 
HS03.1: High-grade (CIN NOS) 
No codes for this jurisdiction 
HS03.2: High-grade (CIN II) 
S5  Moderate dysplasia (CIN2) 
HS03.3: High-grade (CIN III) 
S6  Severe dysplasia (CIN3) 
HS04: Squamous cell carcinoma 
The following histology codes signify an invasive or malignant result 
HS04.1: Squamous cell carcinoma (microinvasive) 
S7 Micro-invasive squamous cell carcinoma 
HS04.2: Squamous cell carcinoma (invasive) 
S8 Invasive squamous cell carcinoma 
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HSU: Unsatisfactory specimen 
The following histology codes signify that a cervical specimen is unsatisfactory 
SØ   Unsatisfactory for evaluation  
WU Due to unsatisfactory nature of the biopsy, no assessment has been made 
HSN: Not applicable 
The following histology codes signify that a cervical specimen analysis result is not applicable 
S-   Not applicable (no squamous epithelium collected) 
W- Not applicable (no squamous epithelium collected) 
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H6 Histology test—endocervical (glandular) cell analysis 
HE01: Negative endocervical specimen  
The following histology codes signify that an endocervical specimen analysis result is negative (for 
the purposes of assessment for cancer or pre-cancerous changes) 
E1 Normal, inflammatory or reactive changes, endocervical polyp 
E2 Mild nuclear changes (probably reactive) 
HE02: Endocervical atypia 
The following histology codes signify endocervical atypia  
No codes for this jurisdiction 
HE03: High-grade endocervical abnormality 
The following histology codes signify a high-grade endocervical abnormality 
HE03.1: High-grade (endocervical dysplasia) 
E3  Endocervical dysplasia 
HE03.2: High-grade (adenocarcinoma in situ) 
E4  Adenocarcinoma in situ 
HE04: Endocervical adenocarcinoma 
The following histology codes signify endocervical adenocarcinoma or adenosquamous carcinoma 
HE04.1: Endocervical adenocarcinoma (microinvasive) 
E5 Microinvasive adenocarcinoma 
HE04.2: Endocervical adenocarcinoma (invasive) 
E6 Invasive adenocarcinoma 
HE04.3: Adenosquamous carcinoma 
E7 Adenosquamous carcinoma (cervix) 
HE04.4: Carcinoma of the cervix (other) 
E8 Carcinoma of cervix (other) 
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HEU: Unsatisfactory specimen 
The following histology codes signify that an endocervical specimen is unsatisfactory 
EU Due to unsatisfactory nature of biopsy no assessment has been made 
HEN: Not applicable 
The following histology codes signify that an endocervical specimen analysis result is not 
applicable 
E- Not applicable 
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South Australia 
H4 Histology test—procedure used for obtaining specimen for histological 
analysis  
HP01: Biopsy 
The following codes signify that the specimen was obtained by biopsy 
T1 Biopsy of cervix (for specimens with B1 at data element T1) 
T5 Vagina (for specimens with B2 at data element T1) 
HP02: Endocervical curettage 
The following codes signify that the specimen was obtained by endocervical curettage 
T2 Endocervical curettage/ T2 Endometrial curettage 
HP03: LLETZ/LEEP loop biopsy 
The following codes signify that the specimen was obtained by LLETZ/LEEP loop biopsy 
T3 Large loop excision of TZ (Lletz/Leep) 
HP04: Cone biopsy 
The following codes signify that the specimen was obtained by cone biopsy 
T4 Cone biopsy 
HP05: Polypectomy 
The following codes signify that the specimen was obtained by polypectomy 
TP Cervical polyp 
HP06: Subtotal hysterectomy 
The following codes signify that the specimen was obtained by subtotal hysterectomy 
TS Subtotal hysterectomy 
HP07: Hysterectomy 
The following codes signify that the specimen was obtained by hysterectomy 
T7 Hysterectomy 
HP09: Amputated cervix 
The following codes signify that the specimen was obtained by amputated cervix 
TA Amputated cervix 
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HP10: Not disclosed 
The following codes signify that the procedure by which specimen obtained was not disclosed 
T0 Not disclosed 
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H5 Histology test—cervical (squamous) cell analysis 
HS01: Negative cervical specimen  
The following histology codes signify that a cervical specimen analysis result is negative (for the 
purposes of assessment for cancer or pre-cancerous changes) 
S1 Normal squamous and metaplastic epithelium; atrophy 
HS02: Low-grade squamous abnormality  
The following histology codes signify a low-grade squamous abnormality 
S1  Normal squamous and metaplastic epithelium; atrophy and 
W2 Equivocal HPV  
S1  Normal squamous and metaplastic epithelium; atrophy and 
W3 Human papillomavirus 
S2 Mild squamous atypia, falling short of dysplasia and including HPV or suggestive of 
HPV 
S3 CIN I (mild dysplasia) 
HS03: High-grade squamous abnormality 
The following histology codes signify a high-grade squamous abnormality  
HS03.1: High-grade (CIN NOS) 
S6 CIN NOS 
HS03.2: High-grade (CIN II) 
S4 CIN II (moderate dysplasia) 
HS03.3: High-grade (CIN III) 
S5 CIN III (severe dysplasia/carcinoma in situ) 
HS04: Squamous cell carcinoma 
The following histology codes signify an invasive or malignant result 
HS04.1: Squamous cell carcinoma (microinvasive) 
S7 Micro-invasive squamous cell carcinoma 
HS04.2: Squamous cell carcinoma (invasive) 
S8 Invasive squamous cell carcinoma 
HSU: Unsatisfactory specimen 
The following histology codes signify that a cervical specimen is unsatisfactory 
O3 Unsatisfactory specimen for diagnosis 
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HSN: Not applicable 
The following histology codes signify that a cervical specimen analysis result is not applicable 
S0   Not applicable 
W0 Not applicable 
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H6 Histology test—endocervical (glandular) cell analysis 
HE01: Negative endocervical specimen  
The following histology codes signify that an endocervical specimen analysis result is negative (for 
the purposes of assessment for cancer or pre-cancerous changes) 
E1 Normal; inflammatory or reactive changes; endocervical polyp 
HE02: Endocervical atypia 
The following histology codes signify endocervical atypia  
E2 Minor non specific change 
HE03: High-grade endocervical abnormality 
The following histology codes signify a high-grade endocervical abnormality 
HE03.1: High-grade (endocervical dysplasia) 
E3 High-grade endocervical dysplasia/Adenocarcinoma in situ 
HE03.2: High-grade (adenocarcinoma in situ) 
E4 Adenocarcinoma in situ 
HE04: Endocervical adenocarcinoma 
The following histology codes signify endocervical adenocarcinoma (includes adenosquamous 
carcinoma and carcinoma of the cervix (other)) 
HE04.1: Endocervical adenocarcinoma (microinvasive) 
E5 Microinvasive adenocarcinoma 
HE04.2: Endocervical adenocarcinoma (invasive) 
E6 Invasive adenocarcinoma 
HE04.3: Adenosquamous carcinoma 
E7 Adenosquamous carcinoma (cervix) 
HE04.4: Carcinoma of the cervix (other) 
No codes for this jurisdiction 
HEU: Unsatisfactory specimen 
The following histology codes signify that an endocervical specimen is unsatisfactory 
O3 Unsatisfactory specimen for diagnosis 
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HEN: Not applicable 
The following histology codes signify that an endocervical specimen analysis result is not 
applicable 
E0 Not applicable 
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Tasmania 
H4 Histology test—procedure used for obtaining specimen for histological 
analysis  
HP01: Biopsy 
The following codes signify that the specimen was obtained by biopsy 
T2 Punch biopsy of the cervix 
HP02: Endocervical curettage 
The following codes signify that the specimen was obtained by endocervical curettage 
T3 Endocervical curettage 
HP03: LLETZ/LEEP loop biopsy 
The following codes signify that the specimen was obtained by LLETZ/LEEP loop biopsy 
T4 Large loop excision of TZ 
HP04: Cone biopsy 
The following codes signify that the specimen was obtained by cone biopsy 
T5 Cone biopsy 
HP05: Polypectomy 
The following codes signify that the specimen was obtained by polypectomy 
T12 Endocervical polyp 
HP06: Subtotal hysterectomy 
The following codes signify that the specimen was obtained by subtotal hysterectomy 
T13 Sub-total hysterectomy 
HP07: Hysterectomy 
The following codes signify that the specimen was obtained by hysterectomy 
T7 Total hysterectomy 
HP09: Amputated cervix 
The following codes signify that the specimen was obtained by amputated cervix 
T 11 Manchester Repair (Amputated Cervix) 
HP10: Not disclosed 
The following codes signify that the procedure by which specimen obtained was not disclosed 
T1 Not disclosed 
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H5 Histology test—cervical (squamous) cell analysis 
HS01: Negative cervical specimen  
The following histology codes signify that a cervical specimen analysis result is negative (for the 
purposes of assessment for cancer or pre-cancerous changes) 
S1   Native squamous epithelial; squamous metaplasia; immature squamous metaplasia 
with or without inflammatory or reactive changes; atrophy 
S1   Native squamous epithelial; squamous metaplasia; immature squamous metaplasia 
with or without inflammatory or reactive changes; atrophy and 
W1  Wart virus absent 
S2  Atypia 
HS02: Low-grade squamous abnormality 
The following histology codes signify a low-grade squamous abnormality 
S3   HPV effect and 
W2  Equivocal HPV 
S3   HPV effect and 
W3 Human papillomavirus 
S4  Mild dysplasia (CIN1) 
HS03: High-grade squamous abnormality 
The following histology codes signify a high-grade squamous abnormality (HSIL) 
HS03.1: High-grade (CIN NOS) 
No codes for this jurisdiction 
HS03.2: High-grade (CIN II) 
S5  Moderate dysplasia (CIN2) 
HS03.3: High-grade (CIN III) 
S6  Severe dysplasia/CIS (CIN3) 
HS04: Squamous cell carcinoma 
The following histology codes signify an invasive or malignant result 
HS04.1: Squamous cell carcinoma (microinvasive) 
S7 Microinvasive squamous cell carcinoma 
HS04.2: Squamous cell carcinoma (invasive) 
S8 Invasive squamous cell carcinoma 
HSU: Unsatisfactory specimen 
No codes for this jurisdiction 
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HSN Not applicable 
No codes for this jurisdiction 
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H6 Histology test—endocervical (glandular) cell analysis 
HE01: Negative endocervical specimen  
The following histology codes signify that an endocervical specimen analysis result is negative (for 
the purposes of assessment for cancer or pre-cancerous changes) 
E1  Normal; inflammatory or reactive changes; endocervical polyp/hyperplasia 
E2  Mild nuclear changes (probably reactive) 
HE02: Endocervical atypia 
The following histology codes signify endocervical atypia  
No codes for this jurisdiction 
HE03: High-grade endocervical abnormality 
The following histology codes signify a high-grade endocervical abnormality 
HE03.1: High-grade (endocervical dysplasia) 
E3 Endocervical dysplasia 
HE03.2: High-grade (adenocarcinoma in situ) 
E4 Adenocarcinoma in situ 
HE04: Endocervical adenocarcinoma 
The following histology codes signify endocervical adenocarcinoma (includes adenosquamous 
carcinoma and carcinoma of the cervix (other)) 
HE04.1: Endocervical adenocarcinoma (microinvasive) 
E5 Microinvasive adenocarcinoma 
HE04.2: Endocervical adenocarcinoma (invasive) 
E6 Invasive adenocarcinoma  
HE04.3: Adenosquamous carcinoma 
E7 Adenosquamous carcinoma (cervix)  
HE04.4: Carcinoma of the cervix (other) 
E8 Carcinoma of cervix (other)* 
*may include tumours of non-epithelial origin 
HEU: Unsatisfactory specimen 
No codes for this jurisdiction 
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HEN: Not applicable 
The following histology codes signify that an endocervical specimen analysis result is not 
applicable 
E0 Not applicable 
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Australian Capital Territory 
H4 Histology test—procedure used for obtaining specimen for histological 
analysis  
HP01: Biopsy 
The following codes signify that the specimen was obtained by biopsy 
T2 Punch biopsy of the cervix 
HP02: Endocervical curettage 
The following codes signify that the specimen was obtained by endocervical curettage 
T3 Endocervical curettage 
T6 Endometrial curettage 
HP03: LLETZ/LEEP loop biopsy 
The following codes signify that the specimen was obtained by LLETZ/LEEP loop biopsy 
T4 Large loop excision of TZ 
HP04: Cone biopsy 
The following codes signify that the specimen was obtained by cone biopsy 
T5 Cone biopsy 
HP05: Polypectomy 
The following codes signify that the specimen was obtained by polypectomy 
T12 Endocervical polyp 
HP06: Subtotal hysterectomy 
The following codes signify that the specimen was obtained by subtotal hysterectomy 
T13 Sub-total hysterectomy 
HP07: Hysterectomy 
The following codes signify that the specimen was obtained by hysterectomy 
T7 Total hysterectomy 
HP09: Amputated cervix 
The following codes signify that the specimen was obtained by amputated cervix 
T 11 Manchester Repair (Amputated Cervix) 
HP10: Not disclosed 
The following codes signify that the procedure by which specimen obtained was not disclosed 
T0 Not disclosed 
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H5 Histology test—cervical (squamous) cell analysis 
HS01: Negative cervical specimen  
The following histology codes signify that a cervical specimen analysis result is negative (for the 
purposes of assessment for cancer or pre-cancerous changes) 
S1   Native squamous epithelial; squamous metaplasia; immature squamous metaplasia 
with or without inflammatory or reactive changes; atrophy 
S1   Native squamous epithelial; squamous metaplasia; immature squamous metaplasia 
with or without inflammatory or reactive changes; atrophy and 
W1  Wart virus absent 
S2   Atypia 
HS02: Low-grade squamous abnormality  
The following histology codes signify a low-grade squamous abnormality 
S3   HPV effect and 
W2  Equivocal HPV 
S3   HPV effect and 
W3  Human papillomavirus 
S4   Mild dysplasia (CIN1) 
HS03: High-grade squamous abnormality 
The following histology codes signify a high-grade squamous abnormality (HSIL) 
HS03.1: High-grade (CIN NOS) 
S9 Possible high grade abnormality 
HS03.2: High-grade (CIN II) 
S5 Moderate dysplasia (CIN2) 
HS03.3: High-grade (CIN III) 
S6 Severe dysplasia/CIS (CIN3) 
HS04: Squamous cell carcinoma 
The following histology codes signify an invasive or malignant result 
HS04.1: Squamous cell carcinoma (microinvasive) 
S7 Microinvasive squamous cell carcinoma  
HS04.2: Squamous cell carcinoma (invasive) 
S8 Invasive squamous cell carcinoma 
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HSU: Unsatisfactory specimen 
The following histology codes signify that a cervical specimen is unsatisfactory 
No codes for this jurisdiction 
HSN Not applicable 
The following histology codes signify that a cervical specimen analysis result is not applicable 
S0   Not applicable  
W0 Information not available (no squamous cells collected) 
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H6 Histology test—endocervical (glandular) cell analysis 
HE01: Negative endocervical specimen  
The following histology codes signify that an endocervical specimen analysis result is negative (for 
the purposes of assessment for cancer or pre-cancerous changes) 
E1  Normal; inflammatory or reactive changes; endocervical polyp/hyperplasia 
E2  Mild nuclear changes (probably reactive) 
HE02: Endocervical atypia 
The following histology codes signify endocervical atypia  
No codes for this jurisdiction 
HE03: High-grade endocervical abnormality 
The following histology codes signify a high-grade endocervical abnormality 
HE03.1: High-grade (endocervical dysplasia) 
E3 Endocervical dysplasia 
HE03.2: High-grade (adenocarcinoma in situ) 
E4 Adenocarcinoma in situ 
HE04: Endocervical adenocarcinoma 
The following histology codes signify endocervical adenocarcinoma or adenosquamous carcinoma 
HE04.1: Endocervical adenocarcinoma (microinvasive) 
E5 Microinvasive adenocarcinoma 
HE04.2: Endocervical adenocarcinoma (invasive) 
E6 Invasive adenocarcinoma 
HE04.3: Adenosquamous carcinoma 
E7 Adenosquamous carcinoma (cervix) 
HE04.4: Carcinoma of the cervix (other) 
E8 Carcinoma of cervix (other) 
HEU: Unsatisfactory specimen 
No codes for this jurisdiction 
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HEN: Not applicable 
The following histology codes signify that an endocervical specimen analysis result is not 
applicable 
E0 Not applicable 
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Northern Territory 
H4 Histology test—procedure used for obtaining specimen for histological 
analysis  
HP01: Biopsy 
The following codes signify that the specimen was obtained by biopsy 
T1 Punch biopsy of the cervix (for specimens with B1 at data element T1) 
T8 Vaginal biopsy (for specimens with B2 at data element T1) 
HP02: Endocervical curettage 
The following codes signify that the specimen was obtained by endocervical curettage 
T2 Endocervical curettage (incl endometrial curettage with cervical component) 
HP03: LLETZ/LEEP loop biopsy 
The following codes signify that the specimen was obtained by LLETZ/LEEP loop biopsy 
T3 LLETZ/LEEP 
HP04: Cone biopsy 
The following codes signify that the specimen was obtained by cone biopsy 
T4 Cone biopsy 
HP05: Polypectomy 
The following codes signify that the specimen was obtained by polypectomy 
T5 Endocervical polyp 
HP06: Subtotal hysterectomy 
The following codes signify that the specimen was obtained by subtotal hysterectomy 
T7 Sub-total hysterectomy 
HP07: Hysterectomy 
The following codes signify that the specimen was obtained by hysterectomy 
T6 Total hysterectomy 
HP09: Amputated cervix 
No codes for this jurisdiction 
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HP10: Not disclosed 
The following codes signify that the procedure by which specimen obtained was not disclosed 
T0 Not disclosed 
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H5 Histology test—cervical (squamous) cell analysis 
To code for this site, NT specimen code must be one of: T1, T2, T3, T4, T5, T6 or T7 only 
HS01: Negative cervical specimen  
The following histology codes signify that a cervical specimen analysis result is negative (for the 
purposes of assessment for cancer or pre-cancerous changes) 
S1 Native squamous epithelial; squamous metaplasia; immature squamous metaplasia 
with or without inflammatory or reactive changes; atrophy; hyperkeratosis or 
parakeratosis 
S2 Atypia; Atypical immature squamous metaplasia; HPV effect and  
W1 Wart virus absent 
HS02:  Low-grade squamous abnormality 
The following histology codes signify a low-grade squamous abnormality 
S2  Atypia; Atypical immature squamous metaplasia; HPV effect  and 
W2 Equivocal HPV 
S2  Atypia; Atypical immature squamous metaplasia; HPV effect  and 
W3 Human papillomavirus 
S3  Mild dysplasia (CIN1) 
HS03: High-grade squamous abnormality 
The following histology codes signify a high-grade squamous abnormality (HSIL) 
HS03.1: High-grade (CIN NOS) 
S6 High grade CIN (level not determined) 
HS03.2: High-grade (CIN II) 
S4 Moderate dysplasia (CIN2) 
HS03.3: High-grade (CIN III) 
S5 Severe dysplasia (CIN3)/Carcinoma in situ 
HS04: Squamous cell carcinoma 
The following histology codes signify an invasive or malignant result 
HS04.1: Squamous cell carcinoma (microinvasive) 
S7 Microinvasive squamous cell carcinoma  
HS04.2: Squamous cell carcinoma (invasive) 
S8 Invasive squamous cell carcinoma 
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HSU: Unsatisfactory specimen 
The following histology codes signify that a cervical specimen is unsatisfactory 
H0 Unsatisfactory 
HSN: Not applicable 
The following histology codes signify that a cervical specimen analysis result is not applicable 
S0   Not applicable (or information not available) 
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H6 Histology test—endocervical (glandular) cell analysis 
To code for this site, NT specimen code must be one of: T1, T2, T3, T4, T5, T6 or T7 only  
HE01: Negative endocervical specimen  
The following histology codes signify that an endocervical specimen analysis result is 
negative (for the purposes of assessment for cancer or pre-cancerous changes) 
E1  Normal; inflammatory or reactive changes; normal endocervical polyp 
E2  Mild nuclear changes (probably reactive) 
HE02: Endocervical atypia 
The following histology codes signify endocervical atypia  
No codes for this jurisdiction 
HE03: High-grade endocervical abnormality 
The following histology codes signify a high-grade endocervical abnormality 
HE03.1: High-grade (endocervical dysplasia) 
E3 Endocervical dysplasia 
HE03.2: High-grade (adenocarcinoma in situ) 
E4 Adenocarcinoma in situ 
HE04: Endocervical adenocarcinoma 
The following histology codes signify endocervical adenocarcinoma (includes 
adenosquamous carcinoma and carcinoma of the cervix (other)) 
HE04.1: Endocervical adenocarcinoma (microinvasive) 
E5 Microinvasive adenocarcinoma 
HE04.2: Endocervical adenocarcinoma (invasive) 
E6 Invasive adenocarcinoma 
HE04.3: Adenosquamous carcinoma 
E7 Adenosquamous carcinoma (cervix) 
HE04.4: Carcinoma of the cervix (other) 
E8 Carcinoma of cervix (other) 
HEU: Unsatisfactory specimen 
The following histology codes signify that an endocervical specimen is unsatisfactory 
H0 Unsatisfactory 
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HEN: Not applicable 
The following histology codes signify that an endocervical specimen analysis result is not 
applicable 
E0 Not applicable 
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Appendix E: Change management 
protocol: request for change 
 
National cervical cancer prevention data dictionary version 1 
Request for change 
 
To be completed by person requesting change 
Date of endorsement  
  
Person requesting change  
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Requested change  
  
  
  
Reasons for requesting change  
  
  
  
  
  
  
To be completed by Cancer and screening unit, Australian Institute of Health and Welfare 
AIHW comment on requested 
change 
 
  
Other data elements or definitions 
affected 
 
  
Recommendation  
□Endorse □Do not endorse 
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